Datos del Hospital Universitario de Burgos,

recolectados en la Unidad de Investigación a fecha 2025-03-12

Publicaciones

Factor de impacto total: 7.200.

• Fernández de Alba I, Brigido C, Carretero P
  Eosinophilia highly probable induced by carbapenems: A case report.
  Rev Med Chil . 2024; 152(1): 124-127.
  FI: 0.5
• Rodríguez Pérez R , Del Pozuelo S, Pulido E et al [Brígido C, Carretero P]
  Chemiluminescence-based IgE dot-blot assay to diagnose a case of anaphylaxis caused by Prontosan
  J Investig Allergol Clin Immunol . 2024; 34(2): 141-142.
  FI: 6.7

Publicaciones

Factor de impacto total: 35.700.

• Aguilar-Iglesias L, Merino-Merino A, Sanchez-Corral E, Garcia-Sanchez MJ, Santos-Sanchez I, Dominguez-Calvo J, Saez-Maleta R, Perez-Rivera JA
  Prognostic effect of systematic geriatric assessment on patients with acute heart failure
  ESC Heart Fail. 2024; 11(2): 1194-1204.
  FI: 3.2
• Aguilar-Iglesias L, Merino-Merino A, Sanchez-Corral E et al
  Impact of geriatric syndromes on the prognosis of young patients admitted for acute heart failure [Abstract]
  ESC Heart Fail. 2024; 26:324-324.
  FI: 16.9
• Blasco M, Quiroga B, García-Aznar JM et al [ Izquierdo MJ, Sanchez-Ospina D]
  Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study.
  Am J Kidney Dis . 2024; 84(6): 719-730.e1.
  FI: 9.4
• Romaris P, Ortiz M, Cahuana NH et al [Martin Audera P]
  Comparison of two methods for the determination of glucose in an Atellica Siemens analyzer [Abstract]
  Clin Chim Acta. 2024; 558; 1.
  FI: 3.2
• Sánchez-Ospina D, Mas-Fontao S, Gracia-Iguacel C et al
  Displacing the Burden: A Review of Protein-Bound Uremic Toxin Clearance Strategies in Chronic Kidney Disease
  J Clin Med . 2024; 13(5): 1428.
  FI: 3

PREMIOS

• 1º Premio a la Investigación del Colegio de Médicos de Burgos (Médicos Internos Residentes) en Burgos: Dr. Didier Sánchez Ospina Displacing the Burden: A Review of Protein-Bound Uremic Toxin Clearance Strategies in Chronic Kidney Disease

Publicaciones

Factor de impacto total: 46.900.

• Díaz-Calvillo P, Gómez-Jiménez C, Sabushimike D et al
  Expanding the Spectrum of Skin Neoplasms in Muir-Torre Syndrome: Beyond Sebaceous Tumours
  Am J Dermatopathol . 2024; 46(3): 189-191.
  FI: 1.1
• Gutierrez Perez C, Rodriguez Ledesma I, Pumares Gonzalez M et al
  Single-center analysis on a real-world cohort of patients with metastatic urothelial carcinoma studied by NGS: Molecular landscape and efficacy of targeted therapies [Abstract]
  J Clin Oncol. 2024; 42: 661-661.
  FI: 42.1
• Hernandez S, Conde E, Molero A et al [Garcia-Toro E, Saiz-Lopez P]
  Efficient Identification of Patients With NTRK Fusions Using a Supervised Tumor-Agnostic Approach
  Arch Pathol Lab Med . 2024; 148(3): 318-326.
  FI: 3.7

Publicaciones

Factor de impacto total: 2.900.

• Pandiella S, García-Belenguer P, Baena MC et al
  Negative pressure pulmonary edema in an unexpected condition: sedation interventional procedure in prone position in patient with severe obstructive sleep apnea-hypopnea syndrome
  Minerva Anestesiol. 2024; 90: 943-944.
  FI: 2.9

Publicaciones

Factor de impacto total: 2.100.

• Camino Ramos S, Martín Rosique A, Terán Redondo M, Patricio Jacome Tapia X, Gabriel Yepez León F, Teresa Yerovi León E, Camarero Temiño V, Abaigar Luquin P, Agúndez Gomez I.
  Kidney transplant with refractory hypertension in a case of mid aortic syndrome
  Nefrologia (Engl Ed) . 2024; 44(2): 276-277.
  FI: 2
• Fuente-Garrido R, González-Pérez G, Moradillo-Renuncio N, Agúndez-Gómez
  Answer to: "Population screening for abdominal aortic aneurysms. Pilot study in Salamanca"
  Angiologia. 2024; 76: 350-351.
  FI: 0.1

• Nº de orden del CEIC: 3117.
  Registro propectivo y multicéntrico español de indicadores de calidad y eventos adversos de la Colangiopancreatografía retrógada endoscópica. REGISTRO-CPRE.
  Investigador principal: Gonzalo González Gete.
  
• Nº de orden del CEIC: 3121.
  Evaluación de los cirterios de respuesta a segunda línea en pacientes con colangitis biliar primaria.
  Investigador principal: Judith Gomez Camarero.
  

Publicaciones

Factor de impacto total: 490.900.

• Aguas M, Del Hoyo J, Vicente R et al [Sicilia B]
  Telemonitoring with TECCU of active Inflammatory Bowel Disease is Not Inferior to Standard Care: Short-term Results of a Multicentre Randomized Controlled Trial of GETECCU.
  J Med Internet Res . 2024; 26: e60966.
  FI: 5.8
• Ampuero J, Aller R, Gallego-Durán R et al [Gómez-Camarero J]
  The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis
  J Gastroenterol . 2024; 59(7): 586-597.
  FI: 6.9
• Ampuero J, Lucena A, Berenguer M et al [Gómez-Camarero J]
  Predictive factors for decompensating events in cirrhotic patients with primary biliary cholangitis under different lines of therapy
  Hepatology . 2024; 80(4): 791-806.
  FI: 13
• Andrés L, García S , Hontoria S et al
  Enteric infection by Mycobacterium avium. Infección entérica por Mycobacterium avium.
  Gastroenterol Hepatol . 2024; 47(6): 625-626.
  FI: 2.2
• Andres Pascual L, Arias Garcia L, Saiz Chumillas RM, Chivato Martin-Falquina I, Sicilia Aladren B
  Switching from intravenous vedolizumab to subcutaneous maintains clinical remission even in intensified patients with Inflammatory Bowel Disease. One year follow-up [Abstract P555]
  J Crohns Colitis. 2024; 18: I1083-I1084.
  FI: 8.3
• Barreira-Díaz A, Riveiro-Barciela M, Fernández-Bonilla EM et al [Gómez-Camarero J]
  Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
  Ann Hepatol . 2024; 29(3): 101489.
  FI: 3.7
• Barrio Azaceta M, Sala Llinas M, Horta D et al [Gomez-Camarero J]
  Diabetes mellitus (DM) is associated with worse outcomes in patients with primary biliary cholangitis (PBC) regardless of the presence of liver steatosis: results from the ColHai registry [AbstractTHU-154-YI]
  J Hepatol. 2024; 80: S717-S718.
  FI: 26.8
• Berengue M, García-Villarreal L, Olveira A et al [Gomez-Camarero J]
  Transaminase Pattern Over Time Is Not Associated with a More Aggressive Hepatic Evolution: Results from the AEEH Wilson Registry [AbstractWED-172]
  J Hepatol. 2024; 80: S717-S718.
  FI: 26.8
• Calafat M, Torres P, Tosca-Cuquerella J et al [Arias L]
  Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry
  Therap Adv Gastroenterol . 2024: 17: 17562848231221713.
  FI: 3.9
• Casanova MJ, Caballol B, García MJ et al [ Sicilia B]
  Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU.
  Dig Liver Dis . 2024; 56(11): 1845-1853.
  FI: 4
• Casas Deza D, Julián Gomara AB, Caudevilla Biota E et al [Sicilia B]
  A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study).
  Gastroenterol Hepatol . 2024; 47(7): 821-833.
  FI: 2.2
• Casas Deza D, Julián Gomara AB, Caudevilla Biota E et al [Sicilia B]
  Impact of mesalazine on the response to COVID-19 vaccination in patients with inflammatory bowel disease: Results of a prospective multicentre study of GETECCU (VACOVEII study)
  Gastroenterol Hepatol . 2024; 47(7): 750-758.
  FI: 2.2
• Casas Deza D, Polo Cuadro C, de Francisco R et al [Sicilia B]
  Initial Management of Intra-abdominal Abscesses and Preventive Strategies for Abscess Recurrence in Penetrating Crohn's Disease: A National, Multicentre Study Based on ENEIDA Registry
  J Crohns Colitis . 2024; 18(4): 578-588.
  FI: 8
• Chaparro M, Hermida S, Acosta D et al [Sicilia B]
  Short and long-term effectiveness and safety of ustekinumab in Ulcerative Colitis in real life: the ULISES study [Abstract DOP74]
  J Crohns Colitis. 2024; 18: I207-I209.
  FI: 8.3
• Chaparro M, Garcia Donday M, Nunez Ortiz A et al [Arias L]
  Prevalence and factors associated with Inflammatory Bowel Disease (IBD) activity during pregnancy: updated data from the DUMBO Registry [Abstract DOP80]
  J Crohns Colitis. 2024; 18: I221-I224.
  FI: 8.3
• Chaparro M, Garre A, Nunez Ortiz A et al [Arias L]
  Long-term outcomes of newly diagnosed Inflammatory Bowel Disease (IBD) patients: results from the nationwide EpidemIBD study of GETECCU [Abstract P1170]
  J Crohns Colitis. 2024; 18: I2071-I2074.
  FI: 8.3
• Chaparro M, Hermida S, Acosta D et al [Sicilia B]
  Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study
  Aliment Pharmacol Ther. 2024; 60(10): 1325-1338.
  FI: 6.6
• Diaz-Gonzalez A, Ferreiro E, Gomez-Dominguez E et al [Gomez-Camarero J]
  Prophylaxis for tuberculosis and pneumocystis jirovecii does not seem necessary in patients with autoimmune hepatitis treated with corticosteroid therapy: spanish multicentre study [Abstract THU-118]
  J Hepatol. 2024; 80: S318-S319.
  FI: 26.8
• Diaz-Gonzalez A, Ferreiro E, Gomez-Dominguez E et al [Gomez-Camarero J]
  Incidence of fungal and other opportunistic infections in patients with autoimmune hepatitis: a spanish multicentre study [AbstractTHU-155]
  J Hepatol. 2024; 80: S330-S331.
  FI: 26.8
• Fernandez-Gordon Sanchez F, Rodriguez-Tajes S, Londono MC et al [Gomez-Camarero J]
  Optimization of treatment in patients with primary biliary cholangitis: Gamma-glutamyl transferase levels as an early prognostic marker for ursodeoxycholic acid response. Results from the ColHai registry [ AbstractTHU-189]
  J Hepatol. 2024; 80: S344-S344S.
  FI: 26.8
• Ferreiro-Iglesias R, Porto Silva S, Marín S et al [Arias L, Sicilia B]
  Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry
  Aliment Pharmacol Ther. 2024; 60(5): 604-612.
  FI: 6.6
• Fuentes-Valenzuela E, Baston-Rey I,Garcia-Alonso FJ et al [Saiz Chumillas, RM]
  Effectiveness and safety of rectal tacrolimus in patients with ulcerative colitis. TACRO-TOPIC study. A multicenter study from the young group of GETECCU [Abstract P949]
  J Crohns Colitis. 2024; 18: I1715-I1716.
  FI: 8.3
• García MJ, Rivero M, Fernández-Clotet A et al [Sicilia B, Arias L]
  Comparative Study Of The Effectiveness Of Vedolizumab Versus Ustekinumab After Anti-Tnf Failure In Crohn's Disease (Versus-Cd): Data From Eneida Registry.
  J Crohns Colitis . 2024; 18(1): 65-74.
  FI: 8
• Gargallo-Puyuelo CJ, Ricart E, Iglesias E et al [Sicilia B]
  Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA
  Clin Gastroenterol Hepatol . 2024; 22(11): 2280-2290.
  FI: 11.6
• Giordano A, Perez Martinez I, Gisbert, JP et al [Arias L]
  Impact of Crohn's Disease Location on Biologic Therapy Persistence and the Risk of Intestinal Surgery: Insights from the ENEIDA Registry (the DISCOLOC Study) [Abstract P987]
  J Crohns Colitis. 2024; 18: I1781-I1782.
  FI: 8.3
• Gómez-Labrador C, Ricart E, Iborra M et al [Arias L]
  Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA
  Pharmaceutics . 2024; 16(5): 629.
  FI: 4.9
• González-Muñoza C, Calafat M, Gisbert JP et al [Sicilia B]
  Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA project
  Postgrad Med J . 2024; 100(1189): 836-844.
  FI: 3.6
• Gratacos-Gines J, Del Barrio M, Ruz-Zafra P et al [Badia-Aranda E]
  The interaction between metabolic syndrome and alcohol consumption after an episode of alcohol-associated hepatitis is associated with increased mortality: results from de spanish registry of alcohol-associated liver disease (REHALC) [Abstract SAT-267]
  J Hepatol. 2024; 80: S142-S143.
  FI: 26.8
• Gratacos-Gines J, Ruz-Zafra P, Celada-Sendino M et al [Badia-Aranda E]
  Hepatorenal syndrome markedly impacts prognosis of patients with alcohol-associated hepatitis. Results from the spanish registry of alcohol-associated liver disease (REHALC) [AbstractSAT-257]
  J Hepatol. 2024; 80: 139-S140.
  FI: 26.8
• Gratacós-Ginès J, Ruz-Zafra P, Celada-Sendino M et al [Badia-Aranda E]
  Recurrent alcohol-associated hepatitis is common and is associated with increased mortality
  Hepatology . 2024; 80(3): 621-632.
  FI: 13
• Guardiola Capon J, Iborra M, Padró A et al [Sicilia B]
  Effect of the HLA-DQA1*05 allele on the efficacy of ustekinumab in patients with Crohn's Disease. Multicenter study based on the ENEIDA registry of GETECCU [Abstract OP37]
  J Crohns Colitis. 2024; 18: I67-I67.
  FI: 8.3
• Guerra I, Barros F, Chaparro M et al [Sicilia B]
  Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry
  Dig Dis. 2024; 42(3): 257-264.
  FI: 2
• Gutiérrez Pérez C, Rodríguez Ledesma I, Blanco Abad C, López Muñoz AM, Chivato Martín-Falquina I, Durán Domínguez M, Lastra Aras E
  Stage IV perihilar cholangiocarcinoma with loss of expression of MSH2 and MSH6: hereditary cancer syndrome?
  Rev Esp Enferm Dig . 2024; 116(4): 234-235.
  FI: 2
• Gutiérrez Pérez C, Rodríguez Ledesma I, Blanco Abad C, López Muñoz AM, Chivato Martín-Falquina I, Durán Domínguez M, Lastra Aras E.
  Stage IV mixed adenoneuroendocrine carcinoma of sigmoid colon in complete response after immunotherapy. Closer to curing neuroendocrine neoplasms?
  Gastroenterol Hepatol . 2024; 47(3): 262-263.
  FI: 2.2
• Iborra M, Caballol B, Garrido A et al [Arias García L]
  Subcutaneous infliximab cut-off points in a large cohort of Spanish patients with inflammatory bowel disease and factors associated with long-term outcomes [Abstract P516]
  J Crohns Colitis. 2024; 18: I1013-I1014.
  FI: 8.3
• Martín-Cardona A, Horta D, Flórez-Díez P et al [Sicilia B]
  Safety and effectiveness of direct-acting antiviral drugs in the treatment of hepatitis C in patients with inflammatory bowel disease
  Dig Liver Dis . 2024; 56(3): 468-476.
  FI: 4
• Mesonero F, Zabana Y, Fernández-Clotet A et al [Sáiz-Chumillas RM]
  Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU.
  Dig Liver Dis . 2024 .
  FI: 4
• Pabón-Carrasco M, Keco-Huerga A, Castro-Fernández M et al Gomez-Camarero, J
  Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management
  United European Gastroenterol J . 2024; 12(1): 122-138.
  FI: 6
• Palomino Perez LM, Velasco Rodriguez-Belvis M, Brenes Ruiz Y et al [Arias L]
  Unveiling the impact on in utero exposure to biologic treatments for inflammatory bowel disease (IBD) on children's psychomotor development: Insights from the DUMBO registry of GETECCU [Abstract P676]
  J Crohns Colitis. 2024; 18: I1272-I1274.
  FI: 8.3
• Rodriguez-Lago I, Vela M, Ordás I et al [SiciliaB]
  Characteristics and management of pyoderma gangrenosum and erythema nodosum in patients with inflammatory bowel disease: PIONOSO multicenter study [Abstract P1115]
  J Crohns Colitis. 2024; 18: I1987-I1988.
  FI: 8.3
• Romero-Gutiérrez M, Alonso P, Berenguer M et al [Gómez J]
  Reproductive and pregnancy control in Wilson disease patients in Spain
  Eur J Gastroenterol Hepatol . 2024; 36(11): 1340-1345.
  FI: 2.3
• Romero-Gutierrez M, Barajas J, Gomez M et al [Fernandez C]
  Systemic therapy of hepatocellular carcinoma on non-cirrhotic liver: a prospective spanish multicentre study [AbstractTHU-493]
  J Hepatol. 2024; 80: S453-S453.
  FI: 26.8
• Romero-Gutiérrez M, Pascual S, Márquez L et al [Fernández C]
  Spontaneously ruptured hepatocellular carcinoma on non-cirrhotic liver: A prospective case series
  Gastroenterol Hepatol . 2024; 47(7): 683-690.
  FI: 2.2
• Romero-Mascarell C, Giordano A, Riestra S et al [Sicilia B]
  Proximal Crohn's disease location is associated with a more benign course of perianal Crohn's disease (the PERIAPROX study) [Abstract P419]
  J Crohns Colitis. 2024; 18: I857-I858.
  FI: 8.3
• Rubin De Celix C, Ricart E, Martín-Arranz MD et al [Arias L]
  Frequency and effectiveness of dose de-escalation of biologic therapy in Inflammatory Bowel Disease: The RAINBOW-IBD study of ENEIDA [Abstract P844]
  J Crohns Colitis. 2024; 18: I1557-I1559.
  FI: 8.3
• Ruiz Ramirez P, Loras C, Gornals J et al [Sicilia B]
  Long-term follow-up of the PROTDILAT study; LONG-PROTDILAT Prospective multicenter randomized comparative study of endoscopic treatment of strictures in Crohn's disease (CD): self-expandable metal stent (SEMS) vs endoscopic balloon dilatation (EBD) [Abstract P649]
  J Crohns Colitis. 2024; 18: I1226-I1226.
  FI: 8.3
• Ruiz-Cobo JC, Llaneras J, Forns X et al [Badía E]
  Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
  Aliment Pharmacol Ther . 2024; 60(2): 201-211.
  FI: 6.6
• Sanz Segura P, Gomollón F, Casas D et al [Arias L]
  Psoriasis induced by antiTNF therapy in inflammatory bowel disease: Therapeutic management and evolution of both diseases in a nationwide cohort study.
  Dig Liver Dis . 2024; 56(12): 2060-2068.
  FI: 4
• Suárez Ferrer C, Mesonero Gismero F, Caballol B et al [Saiz Chumillas R]
  Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohort.
  Gastroenterol Hepatol . 2024; 47(10): 502197.
  FI: 2.2
• Tapiolas I, Manosa M, Troya J et al [Sicilia B]
  The ileorectal anastomosis after a total colectomy is a feasible and valid surgical alternative in the treatment of inflammatory bowel disease [Abstract P655]
  J Crohns Colitis. 2024; 18: I1239-I1239.
  FI: 8.3
• Vega P, Huguet JM, Gómez E et al [SIcilia B]
  IBD-PODCAST Spain: A Close Look at Current Daily Clinical Practice in IBD Management
  Dig Dis Sci . 2024; 69(3): 749-765.
  FI: 2.5
• Velamazán R, López-Guillén P, Martínez-Domínguez SJ et al [Chivato Martín-Falquina I]
  Symptomatic gallstone disease: Recurrence patterns and risk factors for relapse after first admission, the RELAPSTONE study
  United European Gastroenterol J . 2024; 12(3): 286-298.
  FI: 5.8
• Zabana Y, Rodriguez-Lago I, Sicilia B et al
  Incidence and risk factors of infection in patients with inflammatory bowel disease: longitudinal prospective INFEII registry of GETECCU [Abstract P817]
  J Crohns Colitis. 2024; 18: I1508-I1510.
  FI: 8.3

• Nº de orden del CEIC: 2810.
  Alfabetización de salud y autocuidado en pacientes con Insuficiencia Cardiaca y su relación con los determinantes de la salud y la equidad en Burgos (estudio ALFABETIC).
  Investigador principal: Azucena Santillán García.
  
• Nº de orden del CEIC: 2921.
  Estudio BOCADOS-IC: ensayo clínico aleatorizado prospectivo multcéntrico sobre el aBOrdaje nutriCional en ADultos seguidos en hOspitales eSpañoles por Insuficiencia Cardiaca.
  Investigador principal: José Ángel Pérez Rivera.
  En colaboración con: Sociedad Española de Cardiología.
  

Tesis

• Lara Aguilar Iglesias, Universidad de Valladolid (Cardiología)
  Utilidad de la evaluación geriátrica integral en pacientes ingresados por insuficiencia cardiaca aguda
  21-06-2024
  Sobresaliente Cum Laude
  Director:

Publicaciones

Factor de impacto total: 152.600.

• Aguilar-Iglesias L, Merino-Merino A, Sanchez-Corral E, Garcia-Sanchez MJ, Santos-Sanchez I, Dominguez-Calvo J, Saez-Maleta R, Perez-Rivera JA
  Prognostic effect of systematic geriatric assessment on patients with acute heart failure
  ESC Heart Fail. 2024; 11(2): 1194-1204.
  FI: 3.2
• Aguilar-Iglesias L, Merino-Merino A, Sanchez-Corral E et al
  Impact of geriatric syndromes on the prognosis of young patients admitted for acute heart failure [Abstract]
  ESC Heart Fail. 2024; 26:324-324.
  FI: 16.9
• Aguilar-Iglesias L, Perez-Asensio A, Vilches-Miguel L et al [Perez-Rivera JA]
  Impact of Frailty on Heart Failure Prognosis: Is Sex Relevant?
  Curr Heart Fail Rep. 2024; 21(2): 131-138.
  FI: 3.8
• Bastante T, Arzamendi D, Martín-Moreiras J et al [Luengo Mondéjar P]
  Spanish cardiac catheterization and coronary intervention registry. 33rd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2023)
  Rev Esp Cardiol (Engl Ed) . 2024; 77(11): 936-946.
  FI: 7.2
• Bazan V, Arana E, Rubio-Campal JM et al [García Fernández FJ]
  Spanish catheter ablation registry. 23rd official report of the Heart Rhythm Association of the Spanish Society of Cardiology (2023)
  Rev Esp Cardiol (Engl Ed). 2024; 77(12): 1026-1036.
  FI: 7.2
• Belhassen B, Conte G, Steinberg C et al [García-Fernández FJ]
  Mode and Characteristics of ArrhythmiaInitiation in Idiopathic Ventricular Fibrillation: A THESIS Substudy.
  JACC Clin Electrophysiol . 2024; 10(8): 1794-1809.
  FI: 8
• Corrado D, Anastasakis A, Basso C et al [Jiménez-Jáimez J]
  Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report
  Int J Cardiol . 2024: 395: 131447.
  FI: 3.5
• Domínguez F, Uribarri A, Larrañaga-Moreira JM et al [Fernández-González B]
  Diagnosis and treatment of myocarditis and inflammatory cardiomyopathy. Consensus document of the SEC-Working Group on Myocarditis.
  Rev Esp Cardiol (Engl Ed) . 2024; 77(8): 667-679.
  FI: 7.2
• Esteban Fernandez A, Gomez Otero I, Lopez Fernandez S et al [Sanchez Corral E]
  Particularities of foundational therapy in patients with newly diagnosed heart failure and reduced LVEF secondary to tachycardiomyopathy [Abstract]
  Eur J Heart Fail. 2024; 26: 7.
  FI: 16.9
• Esteban-Fernández A, Bonilla-Palomas JL, Ayesta-López A, Pérez-Rivera JÁ
  Justification and design of the BOCADOS-IC study: Nutritional management in adults followed in Spanish hospitals for heart failure.
  Rev Esp Geriatr Gerontol . 2024; 60(2): 101566.
  FI: 1.3
• Esteban-Fernández A, Gómez-Otero I, López-Fernández S et al [Pérez-Rivera JÁ]
  Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction
  Clin Res Cardiol . 2024; 113(8): 1171-1182.
  FI: 5
• García-Fernández FJ, Calvo Simal S, Cano Pérez Ó et al [Martín González J]
  Impact of the COVID-19 pandemic on implantation of cardiac implantable electronic devices and remote monitoring activations
  Rev Esp Cardiol (Engl Ed). 2024; 77(3): 243-253.
  FI: 7.2
• Garcia-Fernández FJ, Martín González J, Villagraz Tercedor L, Fernández Palacios G, Cantero D et al
  Feasibility, safety, and comfort of the '2BB' (2 cm below the bra) position of insertable cardiac monitors in women: the IN-WOMEN-ICM pilot study
  Europace . 2024; 26(4): euae080.
  FI: 7.9
• García-Sánchez E, Santamaría-Peláez M, Benito Figuerola E et al [ Carballo García MJ, Chico Hernando M, García García JM]
  Comparison of SF-36 and RAND-36 in Cardiovascular Diseases: A Reliability Study.
  J Clin Med . 2024 Oct 13;13(20):6106.
  FI: 3
• Jiménez-Méndez C, Díez-Villanueva P, Pérez-Rivera Á et al
  Different impact of chronic kidney disease in older patients with heart failure according to frailty [Abstract]
  Eur Heart J. 2024; 45.
  FI: 38.1
• Mayordomo S, Gómez M, Martín C.
  Aortic dissection
  Med Clin (Barc). 2024; 163(9): e90-e91.
  FI: 2.6
• Molina-Lerma M, Cózar-León R, García-Fernández FJ et al
  Spanish pacemaker registry. 21st official report of Heart Rhythm Association of the Spanish Society of Cardiology (2023)
  Rev Esp Cardiol (Engl Ed). 2024; 77(11): 947-956.
  FI: 7.2
• Roldán-Sevilla A, Gallego-Delgado M, Lista-Araujo MT, Torres-Pérez J, Merino-Merino AM, Gil-Polo C, Cantero-Lozano D, Lorenzo-Hernandez SM, Eiros-Bachiller
  Clinical and genetic features of AGel amyloidosis caused by novel gelsolin variant and its impact on cardiac function and conduction disorders
  Amyloid. 2024; 19: 5.21-3.
  FI: 5.2
• Sadaba Sagredo M, SubinasA, Romani S et al [Robles J]
  Discordance between fractional flow reserve and nonhyperemic index with a fiber-optic pressure wire. READI EPIC-14
  REC Interv Cardiol. 2024; 6: 158-165.
  FI: 1.2

PREMIOS

• 2º Premio a la Investigación del Colegio de Médicos de Burgos (Médicos Internos Residentes) en Burgos: Dra. Lara Aguilar Iglesias Prognostic effect of systematic geriatric assessment on patients with acute heart failure
• Premio al mejor Proyecto de Investigación-MIR. Fundación Burgos por la Investigación de la Salud en Burgos: Dra. Lara Aguilar Iglesias Fast Systematic Geriatric Assessment in Acute Heart Failure patients admitted in Cardiology

Publicaciones

Factor de impacto total: 16.400.

• Ferrando L, Palomo A, Otero M, Munoz N, Jorge D, Cruza I, Baudino M, Casaval L, Dominguez I, Polanco L, Alvarez MA
  A case of Laparoscopic Obturator Hernia [Abstract: znae122.14]
  Br J Surg. 2024; 111: 5.
  FI: 8.7
• González Prado C, Martín Acebes F, Manzanera Díaz M, Álvarez Rico MÁ
  Retroperitoneal mass: A diagnostic challenge
  Cir Esp (Engl Ed). 2024; 102(2): 117.
  FI: 1.3
• Ocaña J , García-Pérez JC , Fernández-Martínez D et al [Muñoz Plaza N]
  Outcomes of initially nonoperative management of diverticulitis with abscess formation in immunosuppressed patients. DIPLICAB study COLLABORATIVE group
  Colorectal Dis . 2024; 26(1): 120-129.
  FI: 3.4
• Reoyo JF, Alonso EA, Polanco L, Álvarez M
  Adenocarcinoma on retrorectal cystic hamartoma: An illustrative image for a very rare diagnosis
  Semin Oncol . 2024; 51(5-6): 154-155.
  FI: 3

Publicaciones

Factor de impacto total: 1.500.

• Pérez-Bertólez S, Godoy-Lenz J, Alonso V
  Traumatic rupture of testicle and epididymis
  An Pediatr (Engl Ed). 2024; 100(4): 305-306. .
  FI: 1.5

Publicaciones

Factor de impacto total: 3.000.

• Bueno A, Nevado-Sanchez E, Collazo C et al
  Functional Outcomes in Upper Limb Replantation-A Systematic Review
  J Clin Med . 2024; 13(5): 1289.
  FI: 3

Publicaciones

Factor de impacto total: 62.500.

• Díez JJ, Anda E, Pérez-Corral B et a [Delgado-Lucio AM]
  Prevalence of chronic postsurgical hypoparathyroidism not adequately controlled: an analysis of a nationwide cohort of 337 patients
  Front Endocrinol (Lausanne). 2024; 15:1464515.
  FI: 3.9
• Díez JJ, Anda E, Pérez-Corral B et al [Delgado-Lucio AM]
  Incident comorbidities in patients with chronic hypoparathyroidism after thyroidectomy: a multicenter nationwide study
  Front Endocrinol (Lausanne) . 2024: 15: 1348971.
  FI: 3.9
• García Almeida JM, Cornejo Pareja IM, Fernández Jiménez R et al [de la Maza Pereg L]
  Improving the nutritional care of oncology patients - Validation of a multidisciplinary protocol in the Spanish clinical setting
  Nutr Hosp . 2024; 41(4): 758-765.
  FI: 1.2
• Gómez-Peralta F, Pinés-Corrales PJ, Santos E et al
  Diabetes Management Based on the Phenotype and Stage of the Disease: An Expert Proposal from the AGORA Diabetes Collaborative Group
  J Clin Med . 2024; 13(16): 4839.
  FI: 3
• Pérez de Isla L, Díaz-Díaz JL, Romero MJ et al [Álvarez-Baños P]
  Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study
  Circ Cardiovasc Imaging . 2024; 17(1): e016206.
  FI: 6.5
• Perez de Isla L, Vallejo-Vaz AJ, Watts G et al [Álvarez-Baños P]
  Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study
  Lancet Diabetes Endocrinol . 2024; 12(9): 643-652.
  FI: 44

Tesis

• Luis Real López, Universidad de Jaén (Enfermería)
  Prevención de lesiones por presión adquiridas en hospital mediante el uso de metodología care bundle, en el Hospital Universitario de Burgos
  04-07-2024
  Sobresaliente Cum Laude
  Director:

Publicaciones

Factor de impacto total: 6.500.

• Alonso-Martínez L, Santos JC, Cunha M, Puente-Alcaraz J
  Validation of the Spanish Version of the Nurses' Global Assessment of Suicide Risk Scale (NGAR) in Nonclinical Settings
  Nurs Open . 2024; 11(10): e70057.
  FI: 2
• Cernuda Martínez JA, Suárez Mier MB, Martínez Ortega MDC et al [Villafranca Renes C]
  Risk factors and incidence of peripheral venous catheters-related phlebitis between 2017 and 2021: A multicentre study (Flebitis Zero Project)
  J Vasc Access . 2024; 25(6): 1835-1841.
  FI: 1.9
• Delgado-López PD, Martín-Alonso J, Herrero-Gutiérrez AI, Martín-Velasco V, Castilla-Díez JM, Montalvo-Afonso A, Diana-Martín R, Pérez-Cabo EM.
  Barbed versus conventional suture in elective posterior spine surgery
  Eur Spine J . 2024; 33(6): 2261-2268.
  FI: 2.6

PREMIOS

• II Concurso de Retos de Innovación en Salud de Castilla y León. Área IV - Futuro Saludable [Accésit] en León : D. Luis Real López Metodología Care Bundle para Prevención de Lesiones por Presión en Adultos Hospitalizados
• Mejor proyecto en Cuidados de Enfermería. Fundación Burgos por la Investigación de la Salud en Burgos: D. Luis Real López Uso de la metodología de paquete de cuidados (Care Bundle) aplicada a la prevención de lesiones por presión adquiridas en hospital en pacientes adultos: revisión exploratoria

Publicaciones

Factor de impacto total: 2.200.

• Quevedo García R, Arnaiz Díez S, Pérez Pevida E et al
  Orthopantomography Detection of Atheroma Plaques and Its Relationship with Periodontal Disease and Missing Teeth
  Radiol Res Pract. 2024; 2024: 8873720.
  FI: 2.2

• Nº de orden del CEIC: 2692.
  Estudio multicéntrico aleatrizado Fase III: linfadenectomía axilar versus radioterapia axilar en pacientes con ganglio centinela positivo tras terapia neoadyuvante. Protocolo ADARNAT.
  Investigador principal: Alba González Castro,Yolanda Ulpiana Pérez Martínez.
  

Publicaciones

Factor de impacto total: 8.200.

• Leon-Larios F, Alonso Llamazares MJ, Mausbach Reisen H, et al [Rey Novoa M]
  Impact of the hands-on clinical training program for subdermic implant on contraceptive counseling and users' choice in Spain: A 6-month follow-up study
  Contraception . 2024: 132: 110372.
  FI: 2.8
• Leon-Larios F, Silva-Reus I, Puente Martínez MJ et al [Renuncio Roba A]
  Influence of menstrual pain and symptoms on activities of daily living and work absenteeism: a cross-sectional study
  Reprod Health. 2024; 21(1): 25.
  FI: 3.6
• Salvador Sánchez L, Rodríguez Conesa N, Sánchez Ramón S, Rey Novoa M
  Addressing sexual violence in health services
  Aten Primaria . 2024; 56(11): 102837.
  FI: 1.8

• Nº de orden del CEIC: 3122.
  Viabilidad de la interrupción del tratamiento en pacientes con leucemia mieloide crónica previamente tratados con bosutinib.
  Investigador principal: María Victoria Cuevas Ruiz.
  En colaboración con: Fundación Progreso y Salud.
  

Publicaciones

Factor de impacto total: 477.900.

• Aiello TF, Salmanton-Garcia J, Marchesi F et al [ Labrador J,Gonzalez-Lopez TJ]
  Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry
  Haematologica. 2024; 109(8): 2693-2700.
  FI: 8.2
• Al-Samkari H, Schifferli A, Gonzalez-Lopez TJ
  The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostim
  Br J Haematol. 2024; 204(4): 1143-1145.
  FI: 5.1
• Alcoceba M, Stewart JP, García-Álvarez M et al [Díaz FJ]
  Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual disease
  Br J Haematol. 2024; 205(1): 109-121.
  FI: 5.1
• Bastos-Oreiro M, Gutierrez A, Cabero A et al [Diaz-Gálvez J]
  Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study
  Cancers (Basel) . 2024; 16(7): 1285.
  FI: 4.5
• Bobes A, Tormo M, Diaz-Beya M et al [Labrador J]
  Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: "Real-Life" Data Versus the RATIFY Study [Abstract AML-468]
  Clin Lymphoma Myeloma Leuk. 2024; 24: S315-S315.
  FI: 2.7
• Calvo-Villas JM, Núñez-Vázquez R, Benítez-Hidalgo O et al [García-Díaz C]
  Switching hemophilia A patients to rVIII-SingleChain: The Iberian experience
  Medicine (Baltimore) . 2024; 103(36): e39255.
  FI: 1.4
• Chatzikonstantinou T, Scarfò L, Minga E et al [Labrador J]
  Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL
  Hemasphere . 2024; 8(9): e70004.
  FI: 11.9
• Clark R, Davies S, Labrador J et al
  Safety and Immunogenicity of Respiratory Syncytial Virus Prefusion F Protein Vaccine when Co-administered with Adjuvanted Seasonal Quadrivalent Influenza Vaccine in Older Adults: A Phase 3 Randomized Trial
  Clin Infect Dis. 2024; 79(4): 1088-1098.
  FI: 8.2
• El-Ashwah S , Salmanton-García J , Bilgin YM et al [Labrador J]
  The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey
  Leuk Lymphoma . 2024; 65(2): 199-208.
  FI: 2.6
• Fattizzo B, Marchetti M, Michel M et al [González-López TJ]
  Diagnosis and management of Evans syndrome in adults: first consensus recommendations
  Lancet Haematol . 2024; 11(8): e617-e628.
  FI: 15.4
• González-López TJ.
  Editorial: Immune thrombocytopenia (ITP)-diagnosis and treatment
  Front Med (Lausanne) . 2024: 11: 1385113.
  FI: 3.1
• González-López TJ, Alperovich G, Burillo E et al
  Epidemiology, Treatment Patterns, and Cost Analysis of Immune Thrombocytopenia in Spain between 2014 and 2020: A Population-based Study
  TH Open . 2024; 8(3): e252-e265.
  FI: 0.1
• González-López TJ, Bárez A, Bernardo-Gutiérrez Á et al
  Real-life clinical practice in Spain in the setting of new drug availability for ITP treatment. A Delphi-based Spanish expert panel consensus
  Platelets . 2024; 35(1): 2336104.
  FI: 2.5
• Gonzalez-Lopez TJ, Bermejo N, Cardesa-Cabrera R et al [Díaz Gálvez FJ, Hermida G, García C]
  Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice.
  Blood . 2024; 144(6): 646-656.
  FI: 21.1
• González-López TJ, Jarque I, Siniscalchi C et al
  Editorial: Infectious diseases and hematology: diagnosis and management
  Front Med (Lausanne) . 2024: 11: 1385874.
  FI: 3.1
• Gonzalez-Lopez, TJ, Bermejo-Vega N, Cardesa-Cabrera R et al
  Early Treatment Use of Fostamatinib for Immune Thrombocytopenia (ITP): Efficacy and Safety As Second/Third ITP Treatment Lines in Clinical Practice in Spain [Abstract 2555]
  Blood. 2024; .
  FI: 21.1
• Hermida G, Alvarez-Nuño R, San Miguel-Izquierdo J, González-Quijada S, González-López TJ.
  Long Term Remission of Capillary Leak Syndrome Associated with Monoclonal Gammopathy with Progression to Multiple Myeloma After Autologous Stem Cell Transplantation: a Case Report and Review of the Literature
  Oncol Ther . 2024; 12(1): 183-188.
  FI: 3.2
• Hernández-Sánchez A, Villaverde-Ramiro Á, Arellano-Rodrigo E et al [Cuevas B]
  The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis
  Am J Hematol . 2024; 99(4): 755-758.
  FI: 10.1
• Hontecillas-Prieto L, García-Domínguez DJ, Palazón-Carrión N et al [Labrador J]
  CD8+NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma
  Front Immunol . 2024: 15: 1293931.
  FI: 5.7
• Kuter DJ, Gonzalez Lopez, TJ,Trautmann-Grill K et al
  A Phase 2 Study of Ianalumab in Patients with Primary Immune Thrombocytopenia Previously Treated with at Least Two Lines of Therapy: Interim Results from VAYHIT3 [Abstract 710]
  Blood. 2024; .
  FI: 21.1
• Labrador J, Martínez-Cuadrón D, Boluda B et al
  Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry.
  Cancer . 2024; 130(20): 3436-3451.
  FI: 6.1
• Lahmer T, Salmanton-García J, Marchesi F et al [ Labrador J, González-López TJ]
  Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
  Infection. 2024; 52(3): 1191-1194.
  FI: 5.4
• Lahmer T, Salmanton-García J, Marchesi F et al [Labrador J, González-López TJ]
  Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
  Infection. 2024; 52(3): 1125-1141.
  FI: 5.4
• Marcos-Peña S, Fernández-Pernia B, Provan D, González-López TJ
  Tapering and Sustained Remission of Thrombopoietin Receptor Agonists (TPO-RAs): Is it Time for Paediatric ITP?
  Adv Ther. 2024; 41(10): 3771-3777.
  FI: 3.4
• Martínez-Cuadrón D, Megías-Vericat JE, Gil C et al [Labrador J]
  Outcomes after intensive chemotherapy for secondary and myeloidrelated changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry
  Haematologica . 2024; 109(1): 115-128.
  FI: 8.2
• Martinez-Cuadron D, Rodriguez-Veiga R, Bergua Burgues JM et al [Labrador J]
  Correlation of ELN-Risk and Gene Mutations with Quizartinib Efficacy in Patients with FLT3-ITDā€“Negative Newly Diagnosed Acute Myeloid Leukemia in the Phase 2 Quiwi Pethema Trial [Abstrac 2895]
  Blood. 2024; .
  FI: 21.1
• Montesinos P, Rodriguez-Veiga R, Bergua Burgues JM et al [Labrador J]
  Final Results of Quiwi: A Double Blinded, Randomized Pethema Trial Comparing Standard Chemotherapy Plus Quizartinib Versus Placebo in Adult Patients with Newly Diagnosed FLT3-ITD Negative AML [Abstractt 1512]
  Blood. 2024; .
  FI: 21.1
• Mosquera Orgueira A, Perez Encinas M, Pérez Míguez C et al [Labrador J]
  Enhanced Validation of the FLT3-like Gene Expression Signature As a Predictive Biomarker for Quizartinib Response in FLT3-ITD Negative Acute Myeloid Leukemia: Expanded Cohort and Extended Follow-up from the Pethema Quiwi Trial [Abstract 1552]
  Blood. 2024; .
  FI: 21.1
• Mosquera-Orgueira A, Arellano-Rodrigo E, Garrote M et al [CuevasB]
  Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis
  Hemasphere . 2024; 8(3): e60.
  FI: 11.9
• Musto P, Salmanton-García J, Sgherza N et al Labrador J
  Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the epicovideha registry
  Hematol Oncol . 2024; 42(1): e3240.
  FI: 3.3
• Navarro Vicente I, Solana-Altabellam A, Sobas M et al [Labrador j]
  Clinical Features and Outcomes in 228 Patients Diagnosed with Blastic Plasmocytoid Dendritic Cell Neoplasm: A Pethema/PALG Study [Abstract 319]
  Blood. 2024; .
  FI: 21.1
• Navas-Acosta J, Hernandez-Sanchez A, Gonzalez T et al [Labrador J]
  Preferential Genetic Pathways Lead to Relapses in Adult B-Cell Acute Lymphoblastic Leukemia
  Cancers (Basel) . 2024; 16(24): 4200.
  FI: 4.5
• Ortega Pérez R, García-Gutiérrez V, Alvarez-Larran A et al [Cuevas B]
  Impact of Atrial Fibrillation on Patients with Myeloproliferative Neoplasms [Abstract 4549]
  Blood. 2024; .
  FI: 21.1
• Pastor-Galán I, Pereira A, Arellano-Rodrigo E et al [Cuevas B]
  Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis
  Leukemia. 2024; 38(11): 2483-2486.
  FI: 12.8
• Pérez Míguez C, Mosquera Orgueira A, Perez Encinas M et al [Labrador J]
  A Cutting-Edge Bioinformatics Tool for Neoantigen Identification in Unpaired RNA-Seq Samples of AML [Abstract 4986]
  Blood. 2024; .
  FI: 21.1
• Pérez-Lamas L, Segura Diaz A, García Delgado R et al [Cuevas B]
  Real-World Outcomes of Momelotinib As an Alternative Therapy to Other JAK Inhibitors in Myelofibrosis Patients with Anemia [Abstract 1790]
  Blood. 2024; .
  FI: 21.1
• Piñana JL, Vazquez L, Heras I et al [Labrador J]
  Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy
  Front Oncol. 2024; 14: 1389345.
  FI: 3.5
• Puertas B, Alejo E, Rey-Bua B et al [Serra F]
  Impact of Minimal Residual Disease in Apheresis Product (aMRD) Assessed by Multiparametric Flow Cytometry (MFC) in Transplant-Eligible Multiple Myeloma (MM) Patients [Abstract P-182]
  Clin Lymphoma Myeloma Leuk. 2024; 24: S143-S143.
  FI: 2.7
• Puertas B, Alejo E, Rey-Bua B et al [Serra F]
  Monoclonal Gammopathy of Uncertain Significance (MGUS) Like Profile in Transplant-Eligible Multiple Myeloma (MM) Patients: Clinic-Biological Characteristics and Prognosis Significance [Abstract P-183]
  Clin Lymphoma Myeloma Leuk. 2024; 24: S144-S144.
  FI: 2.7
• Rahhal A, Provan D, Ghanima W, González-López TJ et al
  A practical guide to the management of immune thrombocytopenia co-existing with acute coronary syndrome
  Front Med (Lausanne) . 2024: 11: 1348941.
  FI: 3.1
• Salmanton-García J, Marchesi F, Farina F et al [Labrador J, González-López TJ]
  Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022
  EClinicalMedicine . 2024: 71: 102553.
  FI: 9.6
• Sánchez R, Dorado S, Ruíz-Heredia Y et al [Cuevas B]
  Author Correction: Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA
  Sci Rep . 2024; 14(1): 7400.
  FI: 3.8
• Santaliestra M, Garrote M, Noya MS et al [Cuevas B ]
  Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia
  Leukemia . 2024; 38(12): 2636-2643.
  FI: 12.8
• Santaliestra M, Garrote M, Noya MS et al [Cuevas B ]
  Prognostic Value of Response to First-Line Hydroxyurea According to Ipset Stratification in Essential Thrombocythemia [Abstract 241]
  Blood. 2024; .
  FI: 21.1
• Segura-Díaz A, Stuckey R, Florido Y et al [Cuevas B]
  DNMT3A/TET2/ASXL1 Mutations are an Age-independent Thrombotic Risk Factor in Polycythemia Vera Patients: An Observational Study
  Thromb Haemost . 2024; 124(7): 669-675.
  FI: 5
• Sobas M, Knopinska Posluszny W, Piatkowska Jakubas B et al [Labrador J]
  Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience
  Ann Hematol . 2024; 103(2): 451-461.
  FI: 3.5
• Solana-Altabella A, Navarro Vicente I, Sobas M et al [Labrador J]
  Treatment Approaches for Blastic Plasmacytoid Dendritic Cell Neoplasm: Data from the Pethema and PALG Epidemiologic Registry [Abstract 320]
  Blood. 2024; .
  FI: 21.1
• Suárez EU, Boluda B, Lavilla E et al [ Labrador J]
  Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?
  Ann Hematol . 2024; 103(8): 2845-2851.
  FI: 3
• T C, Minga E, Karakatsoulis G et al [Labrador J]
  Survival Outcomes of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Treated in the Chemoimmunotherapy Vs BTK Inhibitor (BTKi) Eras: A European Research Initiative on CLL (ERIC) Study [Abstrac 4619]
  Blood. 2024; .
  FI: 21.1

PREMIOS

• 1º Mejor Comunicación. Congreso Anual de la Sociedad Castellano Leonesa de Hematología y Hemoterapia en Zamora: Dra. Uxue Lucas Alberdi Más allá de los síntomas en paciente con Gammapatía Monoclonal de Significado Incierto
• 3º Mejor Comunicación. Congreso Anual de la Sociedad Castellano Leonesa de Hematología y Hemoterapia en Zamora: Dra. Jhoana Carolina Delgado Torres Explorando lo inusual: tumoración de cuero cabelludo en paciente con Leucemia Mieloide Crónica.
• Segundo Premio a la Investigación. Fundación Burgos por la Investigación de la Salud en Burgos: Dra. Beatriz Cuevas Ruiz Application of IPSET-Thrombosis in 1366 patients prospectively followed from the Spanish Registry of Essential Thrombocythemia

Publicaciones

Factor de impacto total: 36.800.

• Bueso Navarro M, Zabalegui Pérez A, Blandino Ortiz A et al
  Current situation and characteristics of centers specialized in management of aneurysmal subarachnoid hemorrhage in Spain
  Med Intensiva (Engl Ed). 2024; 48(7): 426-428.
  FI: 2.7
• Delgado-López PD, Martín-Alonso J, Herrero-Gutiérrez AI, Martín-Velasco V, Castilla-Díez JM, Montalvo-Afonso A, Diana-Martín R, Pérez-Cabo EM.
  Barbed versus conventional suture in elective posterior spine surgery
  Eur Spine J . 2024; 33(6): 2261-2268.
  FI: 2.6
• Garnacho-Montero J, Gordillo-Escobar E, Trenado et al [Fisac L]
  A Nationwide, Prospective Study of Tracheal Intubation in Critically Ill Adults in Spain: Management, Associated Complications, and Outcomes
  Crit Care Med . 2024; 52(5): 786-797.
  FI: 7.7
• Maldonado N, López-Hernández I, López-Cortés LE et al [Del Valle Ortíz M]
  Association of microbiological factors with mortality in Escherichia coli bacteraemia presenting with sepsis/septic shock: a prospective cohort study
  Clin Microbiol Infect . 2024; 30(8): 1035-1041.
  FI: 10.9
• Mantecón-Vallejo MD, Mesquida A, Del Valle-Ortiz M, Buzón-Martín L, Ossa-Echeverri S, Fisac-Cuadrado L, Megías-Lobón G, Ortega-Lafont MP et al
  Clonal spread of fluconazole-resistant C. parapsilosis in patients admitted to a referral hospital located in Burgos, Spain, during the COVID-19 pandemic
  Mycoses. 2024; 67(1):e13685.
  FI: 4.1
• Montalvo-Afonso A, Castilla-Díez JM, Martín-Velasco V, Martín-Alonso J, Diana-Martín R, Delgado-López PD
  Perioperative risk factors for major complications after bone replacement in decompressive craniectomy
  Neurocirugia (Astur : Engl Ed). 2024; 35(3): 145-151.
  FI: 0.7
• Nanwani-Nanwani K, Gero Escapa M, Serrano Lazaro A
  The Patient Blood Management Coordinator, shall we position ourselves?
  Med Intensiva (Engl Ed) . 2023; 47(11): 676-677.
  FI: 2.7
• Rodríguez A , Martín Loeches I , Gerard Moreno G et al [Del Valle Ortiz M]
  Association of obesity on the outcome of critically ill patients affected by COVID-19
  Med Intensiva (Engl Ed). 2024; 48(3): 142-154.
  FI: 2.7
• Rodríguez A, Gómez J, Franquet Á et al [Del Valle Ortíz M]
  Applicability of an unsupervised cluster model developed on first wave COVID-19 patients in second/third wave critically ill patients
  Med Intensiva (Engl Ed). 2024; 48(6):326-340.
  FI: 2.7

• Nº de orden del CEIC: 2956.
  Estudio retrospectivo y prospectivo multicéntrico que evalúa la eficacia y seguridad de Cabotegravir y Rilpivirina como tratamiento LONG ACTING en vida real. Tras su implementación en España. Cohorte RELATIVITY.
  Investigador principal: Luis Buzón Martín.
  

Publicaciones

Factor de impacto total: 44.100.

• Aguareles J, Villares Fernández P, Forné C et al [Navarro-San Francisco C, Buzón-Martín LM]
  Outcomes and clinical characteristics of the compassionate use of plitidepsin in COVID-19 patients with solid tumours, haematological malignancies or anti-CD20 antibody treatment
  Infect Dis (Lond) . 2024; 56(7): 575-580.
  FI: 4
• Buzon-Martin L, Navarro-San Francisco C, Fernandez-Regueras M, Sanchez-Gomez L.
  Integrase strand transfer inhibitor resistance mediated by R263K plus E157Q in a patient with HIV infection treated with bictegravir/tenofovir alafenamide/emtricitabine: case report and review of the literature
  J Antimicrob Chemother . 2024; 79(5): 1153-1156.
  FI: 3.9
• De la Rosa-Riestra S, López-Hernández I, Pérez-Rodríguez MT et al [Sanchez Gómez L]
  A comprehensive, predictive mortality score for patients with bloodstream infections (PROBAC): a prospective, multicentre cohort study
  J Antimicrob Chemother. 2024; 79(8): 1794-1800.
  FI: 3.9
• Escrihuela-Vidal F, Palacios-Baena ZR, Agirre JG et al [Sánchez Gómez L]
  Early Antibiotic De-escalation in Patients With Severe Infections Due to Bloodstream Infection by Enterobacterales: A Post Hoc Analysis of a Prospective Multicentre Cohort
  Int J Antimicrob Agents . 2024; 64(5): 107317.
  FI: 4.9
• Guedes M, Gathara D, López-Hernández I et al [Aleman A]
  Differences in clinical outcomes of bloodstream infections caused by Klebsiella aerogenes, Klebsiella pneumoniae and Enterobacter cloacae: a multicentre cohort study
  Ann Clin Microbiol Antimicrob . 2024; 23(1): 42.
  FI: 4.6
• Hermida G, Alvarez-Nuño R, San Miguel-Izquierdo J, González-Quijada S, González-López TJ.
  Long Term Remission of Capillary Leak Syndrome Associated with Monoclonal Gammopathy with Progression to Multiple Myeloma After Autologous Stem Cell Transplantation: a Case Report and Review of the Literature
  Oncol Ther . 2024; 12(1): 183-188.
  FI: 3.2
• Mantecón-Vallejo MD, Mesquida A, Del Valle-Ortiz M, Buzón-Martín L, Ossa-Echeverri S, Fisac-Cuadrado L, Megías-Lobón G, Ortega-Lafont MP et al
  Clonal spread of fluconazole-resistant C. parapsilosis in patients admitted to a referral hospital located in Burgos, Spain, during the COVID-19 pandemic
  Mycoses. 2024; 67(1):e13685.
  FI: 4.1
• Perpiñá-Clérigues C, Mellado S, Galiana-Roselló C et al [Fernández-Regueras M]
  Novel insight into the lipid network of plasma extracellular vesicles reveal sex-based differences in the lipidomic profile of alcohol use disorder patients
  Biol Sex Differ . 2024; 15(1): 10.
  FI: 4.9
• Scharloo F, Cogliati Dezza F, López-Hernández I et al [Morán Rodríguez MÁ]
  Clinical characteristics, predisposing factors and outcomes for Enterococcus faecalis versus Enterococcus faecium bloodstream infections: a prospective multicentre cohort study
  Eur J Clin Microbiol Infect Dis . 2024 Oct;43(10):2011-2022.
  FI: 3.7
• Troya J, Pousada G, Micán R et al [Buzón L]
  Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48-96 weeks of RETROBIC Study
  J Antimicrob Chemother. 2024; 79(3): 595-607.
  FI: 3.9
• Vázquez-Sánchez F, Gómez-Menéndez AI, López-Veloso M et al [Calvo-Simal S, García-López B]
  A Proposal for Neurography Referral in Patients with Carpal Tunnel Syndrome Based on Clinical Symptoms and Demographic Variables of 797 Patients
  Diagnostics (Basel) . 2024; 14(3): 297.
  FI: 3

Publicaciones

Factor de impacto total: 25.800.

• Castillo Simon A, Lisei Coscia D, Nevares Herrero M, Salvat Davila C,Gomez Hidalgo J, Lanchas Alfonso I, Miguel Martinez M, Duque Gallo J
  [18f]FDG-PET in Refractory Epilepsy: epileptic foci localization and comparison with Magnetic Resonance Imaging [Abstract EP-0554]
  Eur J Nucl Med Mol Imaging. 2024; 51: S652-S653.
  FI: 8.6
• Mitjavila Casanovas M, Lopez J, Jimenez-Fonseca P et al [Nevares Herrero M]
  Prediction of patient progression-free survival with 177Lu-DOTATATE in clinical practice: NEPTUNESEPTRALU model for patient selection [Abstract OP-257]
  Eur J Nucl Med Mol Imaging. 2024; 51: S652-S653.
  FI: 8.6
• Mitjavila Casanovas M, Pubul V, Garcia-Burillo A et al [Nevares M]
  Neurodevelopmental Impairments Prediction in Premature Infants Based on Clinical Data and Machine Learning Techniques [Abstract OP-260]
  Eur J Nucl Med Mol Imaging. 2024; 51: S126-S126.
  FI: 8.6

Publicaciones

Factor de impacto total: 43.900.

• De la Rosa-Riestra S, López-Hernández I, Pérez-Rodríguez MT et al [Sánchez Gómez L]
  A comprehensive, predictive mortality score for patients with bloodstream infections (PROBAC): a prospective, multicentre cohort study
  J Antimicrob Chemother . 2024; 79(8): 1794-1800.
  FI: 3.9
• Guinea J, Alcoceba E, Padilla E et al [Mantecón-Vallejo MÁ]
  Fluconazole-resistant Candida parapsilosis: fast detection of the Y132F ERG11p substitution, and a proposed microsatellite genotyping scheme.
  Clin Microbiol Infect . 2024; 30(11): 1447-1452.
  FI: 10.9
• Maldonado N, López-Hernández I, García-Montaner A et al [Labayru-Echeverría C]
  Whole-genome characterisation of Escherichia coli isolates from patients with bacteraemia presenting with sepsis or septic shock in Spain: a multicentre cross-sectional study
  Lancet Microbe. 2024; 5(4): e390-e399.
  FI: 20.9
• Mantecón-Vallejo MD, Mesquida A, Del Valle-Ortiz M, Buzón-Martín L, Ossa-Echeverri S, Fisac-Cuadrado L, Megías-Lobón G, Ortega-Lafont MP et al
  Clonal spread of fluconazole-resistant C. parapsilosis in patients admitted to a referral hospital located in Burgos, Spain, during the COVID-19 pandemic
  Mycoses. 2024; 67(1):e13685.
  FI: 4.1
• Mesquida A, Alcoceba E, Padilla E et al [Mantecón-Vallejo MLÁ]
  Fluconazole-resistant Candida parapsilosis genotypes from hospitals located in five Spanish cities and one in Italy: Description of azole-resistance profiles associated with the Y132F ERG11p substitution
  Mycoses . 2024; 67(3): e13706.
  FI: 4.1

Publicaciones

Factor de impacto total: 17.500.

• Blasco M, Quiroga B, García-Aznar JM et al [ Izquierdo MJ, Sanchez-Ospina D]
  Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study.
  Am J Kidney Dis . 2024; 84(6): 719-730.e1.
  FI: 9.4
• Camino Ramos S, Martín Rosique A, Terán Redondo M, Patricio Jacome Tapia X, Gabriel Yepez León F, Teresa Yerovi León E, Camarero Temiño V, Abaigar Luquin P, Agúndez Gomez I.
  Kidney transplant with refractory hypertension in a case of mid aortic syndrome
  Nefrologia (Engl Ed) . 2024; 44(2): 276-277.
  FI: 2
• Caravaca-Fontán F, Stevens K, Padrón M et al [Yerovi E]
  Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritis
  Nephrol Dial Transplant. 2024; 39(2): 328-340.
  FI: 6.1

Publicaciones

Factor de impacto total: 23.200.

• Aguado Suquia J, Carballosa de Miguel P, Naya Prieto A et al
  Muscle weakness, myositis and scleroderma induced by durvalumab
  Respirol Case Rep . 2024; 12(12): e70084.
  FI: 0.8
• Gutiérrez Herrero G, Núñez-Rodríguez S, Collazo C et al
  Impact of the COVID-19 Pandemic on the Diagnosis of Malignant Neoplasia of the Bronchus and Lung in the Burgos Region .
  Healthcare (Basel) . 2024; 12(16): 1677.
  FI: 2.4
• Gutierrez-Herrero G, Núñez-Rodríguez S, Collazo C et al [Castellanos-Romero L]
  Retrospective Study of Lung Cancer: Evolution in 16 Years in the Burgos Region
  J Clin Med. 2024;13(6):1601.
  FI: 3
• Pinilla L, Dodani K, Benitez I et al [Muñoz C]
  Molecular insights into hypoxic burden physiopathology in OSA: a proteomic perspective [Abstract]
  Eur Respir J. 2024; 64.
  FI: 17

Publicaciones

Factor de impacto total: 8.300.

• Delgado-López PD, Martín-Alonso J, Herrero-Gutiérrez AI, Martín-Velasco V, Castilla-Díez JM, Montalvo-Afonso A, Diana-Martín R, Pérez-Cabo EM.
  Barbed versus conventional suture in elective posterior spine surgery
  Eur Spine J . 2024; 33(6): 2261-2268.
  FI: 2.6
• Delgado-López PD, Montalvo-Afonso A, Martín-Alonso J, Martín-Velasco V, Diana-Martín R, Castilla-Díez JM
  Predicting histological grade in symptomatic meningioma by an objective estimation of the tumoral surface irregularity.
  Neurocirugia (Astur : Engl Ed). 2024; 35(3):113-121.
  FI: 0.7
• López-Gómez M, Morales M, Fuerte R et al [Delgado-López PD]
  Prevalence of Helicobacter pylori infection among patients with esophageal carcinoma
  World J Gastroenterol. 2024; 30(29): 3479-3487.
  FI: 4.3
• Montalvo-Afonso A, Castilla-Díez JM, Martín-Velasco V, Martín-Alonso J, Diana-Martín R, Delgado-López PD
  Perioperative risk factors for major complications after bone replacement in decompressive craniectomy
  Neurocirugia (Astur : Engl Ed). 2024; 35(3): 145-151.
  FI: 0.7

PREMIOS

• Premio a la Investigación del Colegio de Médicos de Burgos (Medicina Hospitalaria) en Burgos: Dr. Pedro David Delgado López Barbed versus conventional suture in elective posterior spine surgery

Publicaciones

Factor de impacto total: 8.200.

• Roldán-Sevilla A, Gallego-Delgado M, Lista-Araujo MT, Torres-Pérez J, Merino-Merino AM, Gil-Polo C, Cantero-Lozano D, Lorenzo-Hernandez SM, Eiros-Bachiller
  Clinical and genetic features of AGel amyloidosis caused by novel gelsolin variant and its impact on cardiac function and conduction disorders
  Amyloid. 2024; 19: 5.21-3.
  FI: 5.2
• Vázquez-Sánchez F, Gómez-Menéndez AI, López-Veloso M et al [Calvo-Simal S, García-López B]
  A Proposal for Neurography Referral in Patients with Carpal Tunnel Syndrome Based on Clinical Symptoms and Demographic Variables of 797 Patients
  Diagnostics (Basel) . 2024; 14(3): 297.
  FI: 3

PREMIOS

• Premio Pepita Arnaiz del Río- Economia de la Salud. Fundación Burgos por la Investigación de la Salud en Burgos: Dr. Fernando Vazquez Sánchez Análisis de rentabilidad de la neurografía e intervención quirúrgica en casos de Síndrome de túnel carpiano con síntomas atípicos
• Premio Ciudad de Burgos. Conocimiento e Innovación en Burgos: Dr. Fernando Vazquez Sánchez Evaluación de fortalezas y puntos débiles en procedimientos diagnósticos en Neurofisiología: Epilepsia, Mielopatía cervicoartrósica y Síndrome del túnel carpiano en el Hospital Universitario de Burgos. Propuestas de mejora

• Nº de orden del CEIC: 2393.
  Estudio en fase III, aleatorizado, con doble enmascaramiento, controlado con placebo, con grupos paralelos y multicéntrico para evaluar la eficacia y la seguridad de pridopidina en pacientes con enfermedad de Huntington en etapa temprana..
  Investigador principal: Esther Cubo Delgado.
  Código de protocolo: 2020-002822-10.
  En colaboración con: Prilenia Therapeutics.
  
• Nº de orden del CEIC: 3049.
  Estudio transversal para evaluar la eficacia y seguridad de ofatumumab (Kesimpta®) en pacientes con esclerosis múltiple recurrente en la práctica clínica española: estudio CRONOS-MS.
  Investigador principal: Laura Aguado García.
  En colaboración con: Novartis Farmaceutica S.A..
  

Publicaciones

Factor de impacto total: 122.000.

• Aguirre C, Alonso-Torres A, Agüera E et al [Iglesias F]
  Real-World Experience with Diroximel Fumarate in Patients with Multiple Sclerosis: A Prospective Multicenter Study.
  Clin Drug Investig . 2024; 44(11): 829-838.
  FI: 2.9
• Amo-Salas J, Olivares-Gil A, García-Bustillo Á et al [Cubo E]
  Computer Vision for Parkinson's Disease Evaluation: A Survey on Finger Tapping
  Healthcare (Basel) . 2024; 12(4): 439.
  FI: 2.4
• Aragon Gawinska K, Fernandez Garcia M, Nascimiento Osorio A et al [(Gil C]
  Natural history of spinal muscular atrophy patients with 3 and 4 copies of SMN2 gene - data from the national Spanish registry (CUIDAME) [Abstract 201P]
  Neurom Disorders. 2024; 43 .
  FI: 2.7
• Cilia R, Dekker M, Cubo E et al.
  Delivery of Allied Health Therapies to People with Parkinson's Disease in Africa
  J Parkinsons Dis. 2024; 14(s1): S227-S239.
  FI: 5.2
• Echavarria Iniguez A, Guerrero Peral AL, Diaz de Teheran J et al [Iglesias Diez F]
  MADRE MIA: Monoclonal Antibody Duration of REsponse in MIgraine After treatment interruption: A prospective multicentric study on 2164 patients [AbstractAL017]
  J Headache Pain. 2024; 25: 1.
  FI: 7.3
• Fahed VS, Doheny EP, Collazo C et al [Cubo E]
  Language-Independent Acoustic Biomarkers for Quantifying Speech Impairment in Huntington's Disease
  Am J Speech Lang Pathol. 2024; 33(3): 1390-1405.
  FI: 2.3
• Gámez-Leyva G, Cubo E.
  Freezing of gait: pharmacological and surgical options.
  Curr Opin Neurol . 2024; 37(4): 394-399.
  FI: 4.1
• García-Azorín D, García-Ruiz C, Sierra-Mencía Á et al [Echavarría Íñiguez A]
  Acute and Preventive Treatment of COVID-19-Related Headache: A Series of 100 Patients
  Life (Basel). 2024; 14(7): 910.
  FI: 3.2
• Gonzalez Martinez A, Romero del Rincon C, Quintas Gutierrez S et al [Iglesias Diez F]
  RE-START STUDY: Multicenter study to assess response after reintroduction of anti-CGRP antibodies in patients with migraine [AbstractAL013]
  J Headache Pain. 2024; 25: 1.
  FI: 7.3
• Gonzalez Martinez A, Sánchez-Rodríguez C, Pagan J et al [Gil Luque S]
  External validation of the predictive model of response to anti-CGRP monoclonal antibodies in patients with migraine [ Abstract P296]
  J Headache Pain. 2024; 25: 1.
  FI: 7.3
• Kim JJ, Vitale D, Otani DV et al [Cubo E]
  Multi-ancestry genome-wide association meta-analysis of Parkinson's disease
  Nat Genet. 2024; 56(1): 27-36.
  FI: 30.8
• Navarro-Pérez MP, González-Quintanilla V, Muñoz-Vendrell A et al [Madrigal E, Iglesias F]
  Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study
  Front Neurol. 2024; 15: 1417831.
  FI: 2.7
• Oreja-Guevara C, Aguado Garcia L, Martin Martinez J et al
  Real world experience with siponimod in Active Secondary Progressive Multiple Sclerosis: Results of the RESYZE study [Abstract P862/1631]
  Mult Scler J. 2024; 30: 668-669.
  FI: 4.8
• Oreja-Guevara C, Meca-Lallana JE, Díaz-Díaz J et al [Herrera Varo N]
  Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: DISCOVER study
  Mult Scler Relat Disord . 2024: 90: 105787.
  FI: 2.9
• Ribeiro-Constante J, Tristán-Noguero A, Martínez Calvo FF et al [ Iglesias Santa Polonia FF]
  Developmental outcome of electroencephalographic findings in SYNGAP1 encephalopathy
  Front Cell Dev Biol. 2024; 12: 1321282.
  FI: 4.6
• Rivadeneyra-Posadas J, Simón-Vicente L, Castillo-Alvira D, Raya-González J, Soto-Celix M, Rodríguez-Fernández A, García-Bustillo A, Saiz-Rodríguez M, Vázquez-Sánchez F, Aguado-Garcia L, Gámez Leyva-Hernández G, Cubo E
  How to estimate body composition in Huntington's disease. A cross-sectional, observational study using multiple frequencies bioimpedance
  Rev Neurol. 2024; 78(1): 17-25.
  FI: 1.2
• Roldán-Sevilla A, Gallego-Delgado M, Lista-Araujo MT, Torres-Pérez J, Merino-Merino AM, Gil-Polo C, Cantero-Lozano D, Lorenzo-Hernandez SM, Eiros-Bachiller
  Clinical and genetic features of AGel amyloidosis caused by novel gelsolin variant and its impact on cardiac function and conduction disorders
  Amyloid. 2024; 19: 5.21-3.
  FI: 5.2
• Romero Del Rincón C, Gonzalez-Martinez A, Quintas S et al [Iglesias Díez F]
  RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine
  Eur J Neurol . 2024; 31(4): e16203.
  FI: 4.5
• Sanchez-Rodriguez C, Gago-Viega A, Pagán J et al [Gil Luque S]
  Evaluation of the accuracy of the predictive algorithm of response to anti-CGRP monoclonal antibodies in patients with migraine older than 65 years: external validation study [Abstract P058]
  J Headache Pain. 2024; 25: 1.
  FI: 7.3
• Santos-García D, de Deus T, Cores C et al [Cubo E]
  Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study
  Mov Disord Clin Pract . 2024; 11(7): 830-849.
  FI: 2.6
• Santos-García D, López-Manzanares L, Muro I et al [Cubo E]
  Use of the MNCD Classification to Monitor Clinical Stage and Response to Levodopa-Entacapone-Carbidopa Intestinal Gel Infusion in Advanced Parkinson's Disease
  Brain Sci . 2024; 14(12): 1244.
  FI: 2.7
• Simón-Vicente L, Rodríguez-Cano S, Delgado-Benito V et al [Cubo Delgado E]
  Cybersickness. A systematic literature review of adverse effects related to virtual reality
  Neurologia (Engl Ed). 2024; 39(8): 701-709.
  FI: 2.9
• Simón-Vicente L, Rodríguez-Fernández A, Rivadeneyra-Posadas J et al [Calvo S, Mariscal N, García-Bustillo Á, Aguado L, Cubo E]
  Validation of ActiGraph and Fitbit in the assessment of energy expenditure in Huntington's disease
  Gait Posture . 2024: 109: 89-94.
  FI: 2.2
• Trejo-Gabriel-Galán JM
  Euthanasia and assisted suicide in neurological diseases: a systematic review
  Neurologia (Engl Ed). 2024; 39(2): 170-177. .
  FI: 2.9

PREMIOS

• II Concurso de Retos de Innovación en Salud de Castilla y León. Área I - Innovación en Productos y Procesos [Accésit] en León : Dra. Esther Cubo Creación de Plataformas de Almacenamiento y Análisis Inteligente de Datos

Publicaciones

Factor de impacto total: 7.900.

• Jiménez Benito J, Macías Molinero L, Gajate Paniagua N, López Peña MJ, Pérez-Salvador García E.
  The never-ending and inexhaustible search of wisdom in our professional work as ophthalmologists
  Arch Soc Esp Oftalmol (Engl Ed) . 2024; 99(4): 143-144.
  FI: 0.5
• Mansour M, Lopez-Guajardo L, Belotto S et al [Pérez-Salvador E]
  Recovery course of persistent posterior subretinal fluid after successful repair of rhegmatogenous retinal detachment
  Eur J Ophthalmol . 2024; 34(4): 1217-1227.
  FI: 1.7
• Monasterio Bel J, Pérez-Salvador García E, Alcuaz Alcalaya A, Tello Fernández A.
  Ultravit high-speed vitrectomy, is higher always better? Hydrodynamic cavitation must be considered.
  Arch Soc Esp Oftalmol (Engl Ed) . 2024; 99(6): 267-268.
  FI: 0.5
• Roldán-Sevilla A, Gallego-Delgado M, Lista-Araujo MT, Torres-Pérez J, Merino-Merino AM, Gil-Polo C, Cantero-Lozano D, Lorenzo-Hernandez SM, Eiros-Bachiller
  Clinical and genetic features of AGel amyloidosis caused by novel gelsolin variant and its impact on cardiac function and conduction disorders
  Amyloid. 2024; 19: 5.21-3.
  FI: 5.2

• Nº de orden del CEIC: 1547.
  PALLAS (PALbociclib Adjuvant Study): Ensayo en fase III aleatorizado de palbociclib con tratamiento endocrino adyuvante estándar frente a monoterapia con tratamiento endocrino adyuvante estándar en cáncer de mama primario con receptores hormonales positivos (RH+) HER2-negativo.
  Investigador principal: Blanca Ascensión Hernando Fernández de Aránguiz.
  Código de protocolo: AFT-05, ABCSG 42, BIG 14-03.
  En colaboración con: GEICAM (Grupo Español de Investigación en Cáncer de Mama).
  
• Nº de orden del CEIC: 1643.
  Estudio observacional prospectivo para Identificar pacientes con CPNM avanzado/metastásico y translocación de ALK y conocer su manejo terapéutico (IDEALK).
  Investigador principal: Guillermo Crespo Herrero.
  Código de protocolo: PFI-ALK-2015-01/A8081057 .
  En colaboración con: Pfizer S.A..
  
• Nº de orden del CEIC: 1701.
  Validación del Consorcio de la base de datos internacional de cáncer renal metastásico (IMDC) como clasificación pronóstica para terapias dirigidas (inhibidores de la ITC/Mtor) en segunda línea después del tratamiento con pazopanib primera línea. SPAZO-2.
  Investigador principal: Guillermo Crespo Herrero.
  Código de protocolo: SOG-PAZ-2016-01.
  En colaboración con: Grupo Español de Oncología Genitourinaria (SOGUG) .
  
• Nº de orden del CEIC: 1741.
  Estudio prospectivo de la utilidad de la biopsia líquida como factor predictor y pronóstico en pacientes con carcinoma urotelial metastásico en progresión tras quimioterapia basada en platino.
  Investigador principal: Guillermo Crespo Herrero.
  Código de protocolo: SOG-PLA-2016-01.
  En colaboración con: SOGUG ( Grupo Español de Oncología Genitourinaria).
  
• Nº de orden del CEIC: 1805.
  Estudio de fase IIIB, abierto, multicéntrico, para evaluar la seguridad y la eficacia de Ribociclib (LEE011) en combinación con Letrozol en el tratamiento de hombres y mujeres pre/postmenopáusicas con cáncer de mama avanzado (CMA) con receptor hormonal positivo (HR+) y HER2 negativo (HER2-) que no hayan recibido tratamiento hormonal para la enfermedad avanzada.
  Investigador principal: Blanca Ascensión Hernando Fernández de Aránguiz.
  Código de protocolo: 2016-003467-19.
  En colaboración con: Novartis Farmaceutica S.A..
  
• Nº de orden del CEIC: 1978.
  Estudio observacional descriptivo sobre las características y del melanoma avanzado y metastásico en España..
  Investigador principal: Guillermo Crespo Herrero.
  Código de protocolo: GEM-IPI-2018-01.
  En colaboración con: Grupo Español Multidisciplinar de Melanoma.
  
• Nº de orden del CEIC: 2036.
  Estudio no intervencional, multicéntrico y de varias cohortes para investigar los resultados y la seguridad del tratamiento con atezolizumab en las condiciones reales de la práctiva clínica habitual. Estudio Atezo Practice.
  Investigador principal: Guillermo Crespo Herrero.
  Código de protocolo: MO40653.
  En colaboración con: Roche Farma S.A.
  
• Nº de orden del CEIC: 2063.
  Ensayo clínico fase III doble ciego, randomizado, controlado con placebo, para evaluar la eficacia y seguridad de atezolizumab o placebo en combinación con doxorubicina + ciclofosfamida como tratamiento neoadyuvante, seguido de paclitaxel + transtuzumab + pertuzumab, en pacientes con cáncer de mama precoz HER2-positivo.
  Investigador principal: Blanca Ascensión Hernando Fernández de Aránguiz.
  Código de protocolo: 2018-001881-40.
  En colaboración con: F. Hoffmann-La Roche Ltd..
  
• Nº de orden del CEIC: 2083.
  Registro de tumores torácicos.
  Investigador principal: .
  Código de protocolo: GECP 16/01 (RTT).
  En colaboración con: Grupo Español de Cáncer de Pulmón.
  
• Nº de orden del CEIC: 2096.
  Ensayo clínico fase III, multicéntrico, aleatorizado y abierto, para evaluar la eficacia y seguridad de ribociclib con terapia endocrina, como tratamiento adyuvante en pacientes con cáncer de mama precoz, receptores hormonales positivos, HER2 negativo (nuevo ensayo en adyuvancia con ribociclib - [LEE011]: NATALEE).
  Investigador principal: Blanca Ascensión Hernando Fernández de Aránguiz.
  Código de protocolo: 2018-002998-21.
  En colaboración con: Novo Nordisk España .
  
• Nº de orden del CEIC: 2103.
  Secuenciación múltiple de última generación en tumores sólidos: utilidad clínica en un Hospital de tercer nivel.
  Investigador principal: Enrique Lastra Aras.
  
• Nº de orden del CEIC: 2152.
  Estudio en fase III, multicéntrico, aleatorizado y abierto para comparar atezolizumab (anticuerpo ANTI-PD-L1) en combinación con quimioterapia adyuvante basada en antraciclina/taxano frente a solo quimioterapia en pacientes con cáncer de mama triple negativo operable.
  Investigador principal: Blanca Ascensión Hernando Fernández de Aránguiz.
  Código de protocolo: 2016-003695-47.
  En colaboración con: F. Hoffmann-La Roche Ltd..
  
• Nº de orden del CEIC: 2200.
  Estudio de la eficacia y seguridad del tratamiento con cabozantinib en pacientes con carcinoma de células renales (CCR) avanzado dentro del programa español de uso compasivo y en condiciones de práctica clínica real.
  Investigador principal: Guillermo Crespo Herrero.
  Código de protocolo: SOGUG-2017-A-IEC(REN)-7.
  
• Nº de orden del CEIC: 2242.
  Estudio prospectivo de cohorte de datos de la vida real en el tratamiento del cáncer colorrectal metastásico: perspectiva del médico y el paciente (PROMETCO).
  Investigador principal: Ana Mª López Muñoz.
  Código de protocolo: SAM-ONC-2018-01 .
  En colaboración con: Servier International.
  
• Nº de orden del CEIC: 2297.
  Estudio posautorización de seguridad para evaluar los riesgos del síndrome mielodisplásico/la leucemia mieloide aguda y las segundas neoplasias malignas primarias en pacientes adultos con cáncer epitelial de ovario, de las trompas de Falopio o peritoneal de tipo primario, sensible al platino, recidivante y seroso de alto grado que reciben tratamiento de mantenimiento con Zejula (niraparib).
  Investigador principal: Blanca Ascensión Hernando Fernández de Aránguiz.
  En colaboración con: Tesaro Inc.
  
• Nº de orden del CEIC: 2301.
  Estudio de fase II, aleatorizado, abierto, internacional y multicéntrico, para comparar la eficacia de la quimioterapia estándar frente a letrozol más abemaciclib como terapia neoadjuvante en pacientes con cáncer de mama con RH-positivo/HER2-negativo de riesgo alto/intermedio. "CARABELA".
  Investigador principal: Blanca Ascensión Hernando Fernández de Aránguiz.
  Código de protocolo: 2019-002123-15.
  En colaboración con: GEICAM (Grupo Español de Investigación en Cáncer de Mama).
  
• Nº de orden del CEIC: 2366.
  Estudio Fase 3 aleatorizado de la combinación de Amivantamab y Lazertinib frente a Osimertinib como tratamiento de primera línea en pacientes con cáncer de púlmon no microcítico localmente avanzado o metastásico con mutación de EGFR. MARIPOSA.
  Investigador principal: Carlos García Girón.
  Código de protocolo: 2020-000743-31.
  En colaboración con: Janssen Research & Development, LLC.
  
• Nº de orden del CEIC: 2439.
  Estudio observacional retrospectivo prospectivo en pacientes con tumores genitourinarios que presentan infección COVID-19 (SOGUG-COVID-19).
  Investigador principal: Guillermo Crespo Herrero.
  En colaboración con: SOGUG ( Grupo Español de Oncología Genitourinaria).
  
• Nº de orden del CEIC: 2543.
  Encorafenib plus binimetinib in patients with locally advanced, unresectable or metastatic BRAFV600-mutated melanoma treated in real life in Spain: a multi-centric, retrospective and non-interventional study.
  Investigador principal: Guillermo Crespo Herrero.
  En colaboración con: Grupo Español Multidisciplinar de Melanoma.
  
• Nº de orden del CEIC: 2581.
  Estudio BURAN sobre buparlisib (AN2025) en combinación con paclitaxel frente a paclitaxel en monoterapia, para pacientes con carcinoma de células escamosas de cabeza y cuello recurrente o metástasico.
  Investigador principal: Cristina Bayona Antón.
  Código de protocolo: 2019-000790-23.
  
• Nº de orden del CEIC: 2582.
  Estudio observacional para describir las características genotípicas y las mutaciones de resistencia en el NSCLC ALK+.
  Investigador principal: Cristina Bayona Antón.
  En colaboración con: ONCOSUR (Grupo de Trabajo Oncológico de Centros Hospitalarios del sur de Madrid).
  
• Nº de orden del CEIC: 2614.
  HERODOTUS: Head and Neck cancERs international cOviD-19 collabOraTion.
  Investigador principal: Cristina Bayona Antón.
  En colaboración con: Hepanorte.
  
• Nº de orden del CEIC: 2626.
  Análisis de la estrategia terapéutica del cáncer de ovario BRCA mutado.
  Investigador principal: Blanca Ascensión Hernando Fernández de Aránguiz.
  
• Nº de orden del CEIC: 2628.
  Estudio observacional, multicéntrico, internacional para comprender el efecto de la pandemia de la COVID 19 en el tratamiento de pacientes con carcinoma pulmonar no microcítico (CPNM) irresecable en estadio III..
  Investigador principal: Cristina Bayona Antón.
  En colaboración con: AstraZeneca GmbH.
  
• Nº de orden del CEIC: 2657.
  Estudio Fase ll, aleatorizado, para discontinuación debida a Diarrea en los 3 primeros ciclos de tratamiento en pacientes con Cáncer de Mama Precoz HER2 positivo (HER2+), Receptor Hormonal positivo (RH+), tratados con Neratinib más Loperamida versus Neratinib con escalada inicial de dosis más Loperamida (según necesidad) versus Neratinib más Loperamida más Colesevelam. "Estudio DIANER''.
  Investigador principal: Blanca Ascensión Hernando Fernández de Aránguiz.
  
• Nº de orden del CEIC: 2663.
  Estudio de fase 3 aleatorizado, multicéntrico, doble ciego y controlado con placebo de bemarituzumab más quimioterapia frente a placebo más quimioterapia en sujetos con cáncer gástrico o de la unión gastroesofágica avanzado no tratado previamente con sobreexpresión de FGFR2b (FORTITUDE-101).
  Investigador principal: Ana Mª López Muñoz.
  En colaboración con: Amgen Inc..
  
• Nº de orden del CEIC: 2664.
  Estudio observacional retrospectivo sobre la eficacia y la seguridad de lorlatinib en pacientes con cáncer de pulmón de células no pequeñas metastásico ALK o ROS1 tratados dentro del programa de uso compasivo en España. Estudio LORLAPULM.
  Investigador principal: Cristina Bayona Antón.
  En colaboración con: Gebro Pharma S.A..
  
• Nº de orden del CEIC: 2811.
  Comparación de diferentes técnicas para probar la mutación BRAF V600 en sangre en pacientes con melanoma.
  Investigador principal: Guillermo Crespo Herrero.
  En colaboración con: Grupo Español Multidisciplinar de Melanoma.
  
• Nº de orden del CEIC: 2827.
  Infraestructura de medicina de precisión asociada a la ciencia y la tecnología- IMPaCT.
  Investigador principal: Enrique Lastra Aras.
  
• Nº de orden del CEIC: 2850.
  Estudio RE-SEARCH: pautas de dosificación con regorafenib en la práctica clínica en España: un estudio retrospectivo.
  Investigador principal: Ana María López Muñoz.
  En colaboración con: Bayer Hispania S.L..
  
• Nº de orden del CEIC: 2852.
  Estudio RASTRO: mutaciones HRAS en Tumores de Región ORL. Estudio de prevalencia de mutaciones HRAS en carcinoma epidermoide de cabeza y cuello de pacientes con enfermedad recurrente y/o metastásica.
  Investigador principal: Inmaculada Rodriguez Ledesma.
  
• Nº de orden del CEIC: 2892.
  Base de Datos Española de Cáncer Hereditario (SPAINCARE).
  Investigador principal: Enrique Lastra Aras.
  En colaboración con: Fundació Privada Institud d´Investigación Oncológica.
  
• Nº de orden del CEIC: 2907.
  Proyecto CRECE (Consorcio REgistro de Cáncer hEreditario).
  Investigador principal: Enrique Lastra Aras.
  
• Nº de orden del CEIC: 2927.
  EMBER-4: Estudio de fase 3, aleatorizado, abierto, en el que se compara la administración adyuvante de imlunestrant versus terapia endocrina adyuvante estándar en pacientes que recibieron previamente de 2 a 5 años de terapia endocrina adyuvante para el cáncer de mama temprano ER+, HER2- con un mayor riesgo de recurrencia.
  Investigador principal: María García González.
  Código de protocolo: 2022-501007-28-00.
  En colaboración con: Lilly.
  
• Nº de orden del CEIC: 2950.
  A multi-center, multi-country prospective observational study of patients initiating T-DXd in the first or second treatment line for HER2+, and HER2-low unresectable and/or metastatic breast cancer. DESTINY BREAST - RESPOND.
  Investigador principal: Blanca Ascensión Hernando Fernández de Aránguiz.
  En colaboración con: AstraZeneca GmbH.
  
• Nº de orden del CEIC: 2960.
  Recopilación retrosprectiva de datos para el cribado dinamico precoz del cáncer colorrectal mediante nuevos biomarcadores proteinicos que reflejan los mecanismos biológicos de iniciación. Colorectal Clinical Stady. DIOPTRA.
  Investigador principal: Enrique Lastra Aras.
  
• Nº de orden del CEIC: 2962.
  Estudio de fase iii, aleatorizado, doble ciego y controlado con placebo para evaluar atezolizumab y bevacizumab, con o sin tiragolumab, en pacientes con carcinoma hepatocelular localmente avanzado o metastásico no tratado.
  Investigador principal: Ana Mª López Muñoz.
  Código de protocolo: 2023-503422-39-00.
  En colaboración con: F. Hoffmann-La Roche Ltd..
  
• Nº de orden del CEIC: 2982.
  Estudio observacional, internacional, retrospectivo de revisión de historias clínicas, para describir las características, patrones de tratamiento y resultados clínicos en los pacientes tratados con selpercatinib dentro de un Programa de Acceso Temprano en España y Portugal (Estudio SELPIBER).
  Investigador principal: Guillermo Crespo Herrero.
  En colaboración con: Lilly.
  
• Nº de orden del CEIC: 3011.
  Caracterización molecular de tumores de ovario con mutación en BRCA e identificación de mecanismos de resistencia y respuesta a Olaparib. RESPOLA.
  Investigador principal: Blanca Ascensión Hernando Fernández de Aránguiz.
  En colaboración con: Fundación para la Investigación Biomédica del Hospital Clínico San Carlos.
  
• Nº de orden del CEIC: 3014.
  Avances en Oncogenómica mediante paneles moleculares: Transformando el tratamiento en medicina de precisión.
  Investigador principal: Enrique Lastra Aras.
  
• Nº de orden del CEIC: 3018.
  Datos reales sobre el uso Avelumab en pacientes con cáncer urotelial localmente avanzado o metastásico - AVEBLADDER.
  Investigador principal: Guillermo Crespo Herrero.
  En colaboración con: GoNorte.
  
• Nº de orden del CEIC: 3119.
  Estudio SOGUG-PRINCIS. Proyecto de Investigación Clinica de Interés Social: Estudio observacionalde efectividad de medicamentos financiados por el Sistema Nacional de Salud para tumores genitourinarios.
  Investigador principal: Guillermo Crespo Herrero.
  En colaboración con: SOGUG ( Grupo Español de Oncología Genitourinaria).
  

Publicaciones

Factor de impacto total: 246.800.

• Arranz Ledo M, Lastra Aras E, Abella Santos L et al
  Usefulness of a predictive model for Polygenic Hereditary Cancer detection [Abstract EP13.032]
  Eur J Hum Genet. 2024; 32: 257-257.
  FI: 3.7
• Basterretxea Badiola L, Laínez Milagro N, Cacho Lavín D et al [Lopez Peraita S]
  RENO Study: Clinical characteristics, treatment patterns and survival results in patients with metastatic renal cell carcinoma in Northern Spain
  Semin Oncol . 2024; 51(3-4): 77-86.
  FI: 3
• Berciano-Guerrero MA, Perez-Ruiz E, Munoz Couselo E et al [Crespo G]
  Real-world effectiveness and safety of dabrafenib-trametinib as first-line of treatment for BRAF mutated metastatic melanoma: Results of the study GEM1801 [Abstract e21515]
  J Clin Oncol. 2024; 42: 16.
  FI: 42.1
• Contreras-Toledo D, Jiménez-Fonseca P, López CL et al [López Muñoz AM]
  Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?
  Br J Cancer . 2024; 130(5): 777-787.
  FI: 6.4
• Guerrero A, Martin M, Perez ME et al [Hernando B]
  Evaluating Ki67 and Oncotype DX Breast Recurrence Score during neoadjuvant treatment with letrozole/abemaciclib or chemotherapy in patients with highly proliferative HR+/HER2-breast cancer participating in the GEICAM CARABELA trial [ Abstract 576]
  J Clin Oncol. 2024; 42: 16.
  FI: 42.1
• Gutiérrez Pérez C, Blanco Abad C, Hontoria Bautista G et al [Rodríguez Ledesma I , Espinosa Cabria N, Ramos Reguera I, Lopez Muñoz AM]
  KRAS mutations in pancreatic cancer: could we talk about a risk factor for the development of thromboembolic phenomena?
  Rev Esp Enferm Dig . 2024; 116(4): 236-237.
  FI: 2
• Gutiérrez Pérez C, Rodríguez Ledesma I, Blanco Abad C, López Muñoz AM, Chivato Martín-Falquina I, Durán Domínguez M, Lastra Aras E
  Stage IV perihilar cholangiocarcinoma with loss of expression of MSH2 and MSH6: hereditary cancer syndrome?
  Rev Esp Enferm Dig . 2024; 116(4): 234-235.
  FI: 2
• Gutiérrez Pérez C, Rodríguez Ledesma I, Blanco Abad C, López Muñoz AM, Chivato Martín-Falquina I, Durán Domínguez M, Lastra Aras E.
  Stage IV mixed adenoneuroendocrine carcinoma of sigmoid colon in complete response after immunotherapy. Closer to curing neuroendocrine neoplasms?
  Gastroenterol Hepatol . 2024; 47(3): 262-263.
  FI: 2.2
• Gutierrez Perez C, Rodriguez Ledesma I, Pumares Gonzalez M et al
  Single-center analysis on a real-world cohort of patients with metastatic urothelial carcinoma studied by NGS: Molecular landscape and efficacy of targeted therapies [Abstract]
  J Clin Oncol. 2024; 42: 661-661.
  FI: 42.1
• Infante M, Arranz-Ledo M, Lastra E et al
  Profiling of the genetic features of patients with breast, ovarian, colorectal and extracolonic cancers: Association to CHEK2 and PALB2 germline mutations
  Clin Chim Acta. 2024; 552: 117695.
  FI: 5
• Juan Fita MJ, Fernandez Calvo O, Anido Herranz U et al [Crespo G]
  SOGUG-AVELUMAB_RWD: Comprehensive analysis of real-word data to evaluate the effectiveness and safety of avelumab maintenance therapy in patients with stage IV urothelial carcinoma conducted in Spain [Abstract e16561]
  J Clin Oncol. 2024; 42: 16.
  FI: 42.1
• López C, Calvo M, Cámara JC et al [Lopez AM]
  SEOM-GEMCAD-TTD clinical guidelines for the management of hepatocarcinoma patients (2023)
  Clin Transl Oncol . 2024; 26(11): 2800-2811.
  FI: 2.8
• Martínez-Jañez N, Ezquerra MB, Manso Sanchez LM et al [Hernando Fernandez de Araguiz B]
  First-line therapy with palbociclib in patients with advanced HR+/HER2- breast cancer: The real-life study PALBOSPAIN
  Breast Cancer Res Treat . 2024; 206(2): 317-328.
  FI: 3
• Rubio MJ, Manzano A, de Sande LM et al [Hernando B]
  Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study
  BMC Cancer . 2024; 24(1): 803.
  FI: 3.4
• Sotelo M, Pelaez M, Basterretxea L et al [Rodriguez Ledesma I]
  Real-world data (RWD) with avelumab in patients (pts) with locally advanced or metastatic urothelial cancer (la-mUC): The AVEBLADDER study [Abstract e16559]
  J Clin Oncol. 2024; 42: 16.
  FI: 42.1
• Valladares-Ayerbes M, Safont MJ, González Flores E et al [López-Muñoz AM[
  Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study
  Clin Transl Oncol . 2024; 26(10): 2640-2651.
  FI: 2.8

Publicaciones

Factor de impacto total: 0.100.

• Cordero-Civantos C, Alvarez-Gómez L, Gomez-Gregoris I et al
  Structural central causes of vertigo in childhood
  REVISTA ORL. 2024; 15: 149-154.
  FI: 0.1

• Nº de orden del CEIC: 3038.
  Estudio descriptivo sobre los pacientes con epilepsia atendidos en el servicio de Pediatria del Hospital Universitario de Burgos.
  Investigador principal: .
  
• Nº de orden del CEIC: 3111.
  INtervención Basada en la Evidencia para la Reducción de la Neumonía Asociada a la Ventilación Mecánica en Unidades Neonatales (INBERNAV-Neo).
  Investigador principal: Sara Martínez Díaz.
  
• Nº de orden del CEIC: 3118.
  Registro multicéntrico de técnicas de depuración 2023-2025.
  Investigador principal: María García González.
  

Tesis

• Maria Montesclaros Hortigüela Saeta, Universidad de Valladolid (Pediatría)
  Seguimiento neurológico en una cohorte de pacientes con asfixia perinatal
  17-05-2024
  Sobresaliente Cum Laude
  Director:
• José Manuel Merino Arribas, Universidad de Burgos (Pediatría)
  El desarrollo de las vacunas en la mejora de la salud infantil
  18-12-2024
  
  Director:

Publicaciones

Factor de impacto total: 86.800.

• Alarcon A, de Vries LS, Parodi A et al [Arnaez J]
  Neuroimaging in infants with congenital cytomegalovirus infection and its correlation with outcome: emphasis on white matter abnormalities
  Arch Dis Child Fetal Neonatal Ed. 2024; 109(2): 151-158.
  FI: 4.4
• Alvarez Molinero M, Gomez Andres D, Garcia Uzquiano R et al [Navarro Abia V]
  Prevalence of neurodevelopmental anomalies in patients with Spinal Muscular Atrophy Type I registered in CUIDAME [Abstract 117P]
  Neurom Disorders. 2024; 43 .
  FI: 2.7
• Arnaez, J
  In memoriam Neonatal neurology at the SCCALP, heir to the Garcia-Alix School
  Boletin de Pediatria. 2024; 64: 103-104.
  FI: 0.1
• Bermúdez-Barrezueta L, Mayordomo-Colunga J, Miñambres-Rodríguez M et al [Valencia-Ramos J]
  Implications of sedation during the use of noninvasive ventilation in children with acute respiratory failure (SEDANIV Study)
  Crit Care. 2024; 28(1): 235.
  FI: 8.8
• Diz-de Almeida S, Cruz R, Luchessi AD et al [Valencia-Ramos J]
  Novel risk loci for COVID-19 hospitalization among admixed American populations.
  Elife . 2024: 13: RP93666.
  FI: 6.4
• Exposito Escudero J, Costa Comellas L, Garcia Romero M et al [Navarro Abia V]
  Treatment with gene therapy in patients with spinal muscular atrophy. current experience in CuidAME registry [Abstract 128P]
  Neurom Disorders. 2024; 43 .
  FI: 2.7
• Garcia-Alix A, Arnaez J, Arca G et al
  Hypoxic-ischaemic encephalopathy code: a systematic review for resource-limited settings
  An Pediatr (Engl Ed) . 2024; 100(4): 275-286.
  FI: 1.5
• Horsch S, Schwarz S, Arnaez J et al
  Cerebral Doppler imaging in neonates: A guide for clinical application and diagnosis
  Dev Med Child Neurol. 2024; 66(12): 1570-1589.
  FI: 3.8
• Hortigüela MM, Martínez-Biarge M, Conejo D, Vega-Del-Val C, Arnaez J
  Motor, cognitive and behavioural outcomes after neonatal hypoxic-ischaemic encephalopathy
  An Pediatr (Engl Ed). 2024; 100(2): 104-114.
  FI: 1.5
• Iglesias Rodriguez M, Navarro Abia V
  Joubert Syndrome. A review of the literature
  Boletin de Pediatria. 2024; 64: 117-124.
  FI: 0.1
• Iglesias-Rodríguez M, Navarro-Abia V, Barbadillo-Mariscal B, Gil-Calderón FJ, Gonzalo-San Esteban A, Mañaricua-Arnaiz A, Tejero-Pastor L, Conejo-Moreno D
  Characteristics of patients with drug-resistant epilepsy in a tertiary hospital
  Rev Neurol. 2024; 79(10): 273-277.
  FI: 0.8
• López-Carrasco A, Vieco-Martí I, Granados-Aparici S et al [ Portugal R]
  Vitronectin Levels in the Plasma of Neuroblastoma Patients and Culture Media of 3D Models: A Prognostic Circulating Biomarker?
  Int J Mol Sci . 2024; 25(16): 8733.
  FI: 4.9
• Marcos-Peña S, Fernández-Pernia B, Provan D, González-López TJ
  Tapering and Sustained Remission of Thrombopoietin Receptor Agonists (TPO-RAs): Is it Time for Paediatric ITP?
  Adv Ther. 2024; 41(10): 3771-3777.
  FI: 3.4
• Nascimento Osorio A, Garcia Uzquiano R, Puig C et al [Navarro V]
  CuidAME: The Spanish longitudinal Registry of SMA patients. A global view in 2024 [Abstract 183P]
  Neurom Disorders. 2024; 43 .
  FI: 2.7
• Panizo E, Vazquez-Gomez F, Perez-Somarriba, M et al [Portugal R]
  Re-Irradiation for Progressive Diffuse Intrinsic Pontine Glioma (DIPG): the Spanish Experience [Abstract DIPG-63]
  Neuro Oncol. 2024; 26: supp 4.
  FI: 16.4
• Pérez Porra S , Granda E , Benito H et al
  Prevalence of invasive bacterial infection in febrile infants ?90 days with a COVID-19 positive test: a systematic review and meta-analysis
  Emerg Med J . 2024; 41(4): 228-235.
  FI: 3.1
• Pérez-Jurado LA, Cáceres A, Balagué-Dobón L et al [Valencia J]
  Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2
  Commun Biol . 2024; 7(1): 202.
  FI: 5.2
• Perez-Torres Lobato M, Navarro Marchena L , De Noriega I et al [Portugal R]
  Palliative care for children with central nervous system tumors: results of a Spanish multicenter study
  Clin Transl Oncol. 2024; 26(3): 786-795.
  FI: 3.4
• Pujol-Muncunill G, Navas-López VM, Ledder O et al [Fernandez de Valderrama A]
  STEP-CD study: ustekinumab use in paediatric Crohn's disease-a multicentre retrospective study from paediatric IBD Porto group of ESPGHAN
  Eur J Pediatr . 2024; 183(8): 3253-3262.
  FI: 3
• Sáez-Llorens X, Norero X, Mussi-Pinhata MM et al [Merino Arribas JM]
  Safety and immunogenicity of a ChAd155-vectored respiratory syncytial virus vaccine in infants 6-7 months of age: a phase 1/2 randomized trial
  J Infect Dis . 2024; 229(1): 95-107.
  FI: 5
• Terroba-Seara S, Oulego-Erroz I, Palanca-Arias D et al [Bustamante-Hervás C, Vega-Del-Val C]
  Association between early echocardiography screening of low systemic blood flow and intraventricular hemorrhage in preterm infants: a multicenter cohort study
  J Perinatol . 2024; 44(10): 1496-1503.
  FI: 2.4
• Vega-Del-Val C, Arnaez J, Ochoa-Sangrador C et al
  Incidence of encephalopathy and comorbidity in infants with perinatal asphyxia: a comparative prospective cohort study
  Front Pediatr. 2024; 12: 1363576.
  FI: 2.1
• Velasco Puyó P, Tagarro A, Garcia-Obregon S et al [Portugal Rodríguez R]
  Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities
  Pediatr Blood Cancer . 2024; 71(8): e31120.
  FI: 2.4

PREMIOS

• Mejor Publicación Científica del Colegio de Médicos de Burgos (Fundación Mutual Médica) en Burgos: Dr. Juan Arnáez Solís Biomarkers of Oxidative Stress in Healthy Infants within the First Three Days after Birth
• 1º Premio II Concurso de Retos de Innovación en Salud de Castilla y León. Área II - Diagnóstico de Vanguardia en León : Dr. Juan Valencia NIPT (Neonatal/Infant Pain Tool)
• Primer Premio a la Investigación. Fundación Burgos por la Investigación de la Salud en Burgos: Dr. Juan Arnáez Solís CSF Neopterin and beta-2-microglobulin as inflammation biomarkers in newborns with Hypoxic-Ischemic Encephalopathy

Publicaciones

Factor de impacto total: 5.900.

• Bernal-Jiménez A, García-Soto XR, Calvo-Simal S et al.
  Evolution of Child and Youth Mental Health in the Context of the COVID-19 Pandemic: A Longitudinal Analysis
  Children (Basel) . 2024;11(6): 660.
  FI: 2
• Franco-Rubio L, Puente-Martínez A, Ubillos-Landa S
  Factors associated with recovery during schizophrenia and related disorders: A review of meta-analysis
  Schizophr Res . 2024: 267: 201-212.
  FI: 3.6
• Vegas Miguel MI, Mateos-Agut M
  Role of the mother and role of the father in Spanish adolescents and their relationship with the development of aggressiveness
  Revista sobre la Infancia y Adolescencia. 2024; 27: 63.
  FI: 0.3

Publicaciones

Factor de impacto total: 11.200.

• Castillo Simon A, Lisei Coscia D, Nevares Herrero M, Salvat Davila C,Gomez Hidalgo J, Lanchas Alfonso I, Miguel Martinez M, Duque Gallo J
  [18f]FDG-PET in Refractory Epilepsy: epileptic foci localization and comparison with Magnetic Resonance Imaging [Abstract EP-0554]
  Eur J Nucl Med Mol Imaging. 2024; 51: S652-S653.
  FI: 8.6
• Mayordomo S, Gómez M, Martín C.
  Aortic dissection
  Med Clin (Barc). 2024; 163(9): e90-e91.
  FI: 2.6

• Nº de orden del CEIC: 2692.
  Estudio multicéntrico aleatrizado Fase III: linfadenectomía axilar versus radioterapia axilar en pacientes con ganglio centinela positivo tras terapia neoadyuvante. Protocolo ADARNAT.
  Investigador principal: Alba González Castro,Yolanda Ulpiana Pérez Martínez.
  

Publicaciones

Factor de impacto total: 2.500.

• Ríos-León M, Cuñado-González Á, Domínguez-Fernández S et al
  Effectiveness of motor imagery in complex regional pain syndrome: A systematic review with meta-analysis
  Pain Pract. 2024; 24(5): 760-771.
  FI: 2.5

Publicaciones

Factor de impacto total: 3.600.

• Martinez-Vidal MP, Fernandez-Carballido C, Otero-Varela L et al [Álvarez-Lario B]
  Long-Term Survival of Subcutaneous Biosimilar Tumor Necrosis Factor Inhibitors Compared to Originators: Results From a Multicenter Prospective Registry
  J Rheumatol. 2024 Sep 1;51(9):877-883.
  FI: 3.6

Publicaciones

Factor de impacto total: 11.000.

• Aguado HJ, Castillon-Bernal P, Teixidor-Serra J et al [Criado-Albillos G, Cabello-Benavides HG, Millan-Cid M, Cunchillos-Pascual J]
  Optimizing periprosthetic fracture management and in-hospital outcome: insights from the PIPPAS multicentric study of 1387 cases in Spain
  J Orthop Traumatol. 2024; 25(1): 13.
  FI: 3
• Andrés-Peiró JV, Nomdedéu J, Aguado HJ et al [Criado-Albillos G, Cabello-Benavides HG, Cunchillos-Pascual J]
  Predictors of outcomes after internal fixation of periprosthetic femoral hip fractures Subgroup analysis of the peri-implant and peri-prosthetic fractures Spanish registry (PIPPAS)
  Injury . 2024; 55(10): 111715.
  FI: 2.2
• Ramos Pascua LR, Casas Ramos P, De la Cruz Gutiérrez L et al [Mora Fernández MI]
  External Hemipelvectomy in Soft Tissue Sarcomas: Are They Still Needed?
  Cancers (Basel) . 2024; 16(22): 3828.
  FI: 4.5
• Torre-Puente R, Rotinen-Diaz M, Fernández-Gutierrez L et al
  Frontal Plane Correction of Hallux Valgus Deformity With a Minimally Invasive Third Generation Tecnique: Short-Term Radiographic Outcomes of a Prospective Case Series
  J Foot Ankle Surg . 2024; 63(3): 404-410.
  FI: 1.3

Publicaciones

Factor de impacto total: 30.370.

• Apellaniz-Ruiz M, Barrachina J, Castro-Sanchez P et al [Saiz-Rodríguez M]
  Status of the implementation of pharmacogenetics in clinical practice in Spain: from regional to national initiatives.
  Drug Metab Pers Ther . 2024; 39(4): 183-199.
  FI: 0.27
• Bernal-Jiménez A, García-Soto XR, Calvo-Simal S et al.
  Evolution of Child and Youth Mental Health in the Context of the COVID-19 Pandemic: A Longitudinal Analysis
  Children (Basel) . 2024;11(6): 660.
  FI: 2
• Casajus A, Zubiaur P, Alday E et al [Saiz Rodriguez M]
  Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain
  Clin Transl Sci . 2024; 17(1): e13698.
  FI: 3.1
• Clark R, Davies S, Labrador J et al
  Safety and Immunogenicity of Respiratory Syncytial Virus Prefusion F Protein Vaccine when Co-administered with Adjuvanted Seasonal Quadrivalent Influenza Vaccine in Older Adults: A Phase 3 Randomized Trial
  Clin Infect Dis. 2024; 79(4): 1088-1098.
  FI: 8.2
• García-Fernández FJ, Calvo Simal S, Cano Pérez Ó et al [Martín González J]
  Impact of the COVID-19 pandemic on implantation of cardiac implantable electronic devices and remote monitoring activations
  Rev Esp Cardiol (Engl Ed). 2024; 77(3): 243-253.
  FI: 7.2
• Gonzalez Marcos E, Garrido Cano M, Gonzalez-Bernal JJ et al
  Mental pathology in the field of personality and psychotic disorders, systematic review of its relationship with the commission of homicide and violent acts
  J Investig Psychol Offender Profil. 2024; 21: e1639.
  FI: 0.8
• Rivadeneyra-Posadas J, Simón-Vicente L, Castillo-Alvira D, Raya-González J, Soto-Celix M, Rodríguez-Fernández A, García-Bustillo A, Saiz-Rodríguez M, Vázquez-Sánchez F, Aguado-Garcia L, Gámez Leyva-Hernández G, Cubo E
  How to estimate body composition in Huntington's disease. A cross-sectional, observational study using multiple frequencies bioimpedance
  Rev Neurol. 2024; 78(1): 17-25.
  FI: 1.2
• Simón-Vicente L, Rodríguez-Fernández A, Rivadeneyra-Posadas J et al [Calvo S, Mariscal N, García-Bustillo Á, Aguado L, Cubo E]
  Validation of ActiGraph and Fitbit in the assessment of energy expenditure in Huntington's disease
  Gait Posture . 2024: 109: 89-94.
  FI: 2.2
• Stewart S, Seco-Meseguer E, Diago-Sempere E et al [Saiz-Rodriguez M]
  Phase IV adaptive randomised clinical trials evaluating efficacy and cost-efficacy of pre-emptive pharmacogenetic genotyping strategies in the Spanish National Health System: iPHARMGx Master Protocol and PREVESTATGx nested clinical trial
  BMJ Open . 2024; 14(11): e089823.
  FI: 2.4
• Vázquez-Sánchez F, Gómez-Menéndez AI, López-Veloso M et al [Calvo-Simal S, García-López B]
  A Proposal for Neurography Referral in Patients with Carpal Tunnel Syndrome Based on Clinical Symptoms and Demographic Variables of 797 Patients
  Diagnostics (Basel) . 2024; 14(3): 297.
  FI: 3

PREMIOS

• 1º Premio II Concurso de Retos de Innovación en Salud de Castilla y León. Área III - Avances Terapéuticos en León : Dra. María Rodríguez Díaz Desarrollo de Geles Inyectables para el Tratamiento de la Osteoartritis
• Tercer Premio a la Investigación. Fundación Burgos por la Investigación de la Salud en Burgos: D. Antonio Sanz Solas Bortezomib pharmacogenetic biomarkers for the treatment of Multiple Myeloma: review and future perspectives

Publicaciones

Factor de impacto total: 32.600.

• Espinosa B, Llorens P, Jacob J et al [López-Díez MP]
  Epidemiologic and clinical characteristics and course of acute heart failure and cardiogenic shock diagnosed in emergency departments
  Emergencias. 2024; 36(6): 425-437.
  FI: 5.4
• Fernández Alonso C, Fuentes Ferrer ME, García-Lamberechts EJ et al [Hernández González R]
  Impact of dementia on 30-, 180-, and 365-day mortality during the first pandemic wave in older adults seen in spanish emergency departments diagnosed with or without COVID-19
  Aging Ment Health . 2024; 28(8): 1110-1118.
  FI: 2.8
• Gorlicki J, Masip J, Gil V et al [ López-Díez MP]
  Effect of early initiation of noninvasive ventilation in patients transported by emergency medical service for acute heart failure.
  Eur J Emerg Med. 2024; 31(5): 339-346.
  FI: 3.1
• Jacob J, Fuentes E, Del Castillo JG et al [López-Diez MP]
  Use of diagnostic tests in elderly patients consulting the emergency department. Analysis of the emergency department and elder needs cohort (EDEN-8).
  Australas Emerg Care . 2024; 27(4): 268-275.
  FI: 2.1
• Miró Ò, Aguiló S, Alquézar-Arbé A et al [Castro Jiménez V]
  Overnight stay in Spanish emergency departments and mortality in older patients.
  Intern Emerg Med . 2024; 19(6): 1653-1665.
  FI: 3.2
• Moyano García R, Piñera-Salmerón P, Jacob J et al [López Díez MP]
  Clinical course in older patients diagnosed with syncope treated in Spanish emergency departments: results from the Emergency Department and Elder Needs-17 study
  Emergencias. 2024; 36(4): 281-289.
  FI: 5.4
• Richard Espiga F, Almendro Delia M, Caballero Martínez F et al
  Delayed diagnosis and missed opportunities in the early detection of atrial fibrillation: a cross-sectional study.
  Rev Clin Esp (Barc). 2024; 224(9): 560-568.
  FI: 2.3
• Romero-Carrete CJ, Alquézar-Arbé A, Herrera Mateo S et al [López-Díez MP]
  Timing of previous heart failure hospitalization as a prognostic factor for emergency department heart failure patients
  Intern Emerg Med. 2024; 19(4): 1089-1098.
  FI: 3.2
• Ruiz-Ramos J, Alquézar-Arbé A, Juanes-Borrego A et al [González-Ferreira L]
  Association of Benzodiazepine Prescription With Short-Term Prognosis in Elderly Patients Attended in Emergency Department: Results From the EDEN PROJECT.
  Pharmacoepidemiol Drug Saf . 2024; 33(11): e70044.
  FI: 2.4
• Supervía A, Caballero-Bermejo AF, Puiguriguer J et al [Callado F]
  Seven- and thirty-day mortality in digoxin poisoning: Results from the DIGITOX study
  Am J Emerg Med . 2024: 81: 92-98.
  FI: 2.7

PREMIOS

• Mejor Tesis Doctoral del Colegio de Médicos de Burgos (Fundación Caja Rural Cajaviva) en Burgos: Dr. Pilar López Diez Análisis de la heterogeneidad en el manejo clínico y los resultados obtenidos en pacientes con Insuficiencia Cardiaca Aguda atendidos en los servicios de urgencias hospitalarios españoles

Publicaciones

Factor de impacto total: 3.000.

• Borau A, Salinas J, Allué M et al [Adot JM]
  Consensus update on the therapeutic approach to patients with neurogenic detrusor overactivity
  Actas Urol Esp (Engl Ed) . 2024; 48(9): 674-682.
  FI: 1.2
• Vírseda-Chamorro M, Salinas-Casado J, Adot-Zurbano JM et al
  Can We Differentiate Between Organic and Functional Bladder Outlet Obstruction in Males With Parkinson's Disease?
  Neurourol Urodyn . 2025 Jan;44(1):171-177.
  FI: 1.8

Investigador principal	CEIC	Financiador / Promotor	Título
Laura Aguado García	3049	Novartis Farmaceutica S.A.	Estudio transversal para evaluar la eficacia y seguridad de ofatumumab (Kesimpta®) en pacientes con esclerosis múltiple recurrente en la práctica clínica española: estudio CRONOS-MS
Cristina Bayona Antón	2582	ONCOSUR (Grupo de Trabajo Oncológico de Centros Hospitalarios del sur de Madrid)	Estudio observacional para describir las características genotípicas y las mutaciones de resistencia en el NSCLC ALK+
	2614	Hepanorte	HERODOTUS: Head and Neck cancERs international cOviD-19 collabOraTion
	2628	AstraZeneca GmbH	Estudio observacional, multicéntrico, internacional para comprender el efecto de la pandemia de la COVID 19 en el tratamiento de pacientes con carcinoma pulmonar no microcítico (CPNM) irresecable en estadio III.
	2664	Gebro Pharma S.A.	Estudio observacional retrospectivo sobre la eficacia y la seguridad de lorlatinib en pacientes con cáncer de pulmón de células no pequeñas metastásico ALK o ROS1 tratados dentro del programa de uso compasivo en España. Estudio LORLAPULM
Luis Buzón Martín	2956		Estudio retrospectivo y prospectivo multicéntrico que evalúa la eficacia y seguridad de Cabotegravir y Rilpivirina como tratamiento LONG ACTING en vida real. Tras su implementación en España. Cohorte RELATIVITY
Guillermo Crespo Herrero	1978	Grupo Español Multidisciplinar de Melanoma	Estudio observacional descriptivo sobre las características y del melanoma avanzado y metastásico en España.
	2036	Roche Farma S.A	Estudio no intervencional, multicéntrico y de varias cohortes para investigar los resultados y la seguridad del tratamiento con atezolizumab en las condiciones reales de la práctiva clínica habitual. Estudio Atezo Practice
	2200		Estudio de la eficacia y seguridad del tratamiento con cabozantinib en pacientes con carcinoma de células renales (CCR) avanzado dentro del programa español de uso compasivo y en condiciones de práctica clínica real
	2439	SOGUG ( Grupo Español de Oncología Genitourinaria)	Estudio observacional retrospectivo prospectivo en pacientes con tumores genitourinarios que presentan infección COVID-19 (SOGUG-COVID-19)
	2543	Grupo Español Multidisciplinar de Melanoma	Encorafenib plus binimetinib in patients with locally advanced, unresectable or metastatic BRAFV600-mutated melanoma treated in real life in Spain: a multi-centric, retrospective and non-interventional study
	2811	Grupo Español Multidisciplinar de Melanoma	Comparación de diferentes técnicas para probar la mutación BRAF V600 en sangre en pacientes con melanoma
	2982	Lilly	Estudio observacional, internacional, retrospectivo de revisión de historias clínicas, para describir las características, patrones de tratamiento y resultados clínicos en los pacientes tratados con selpercatinib dentro de un Programa de Acceso Temprano en España y Portugal (Estudio SELPIBER)
	3018	GoNorte	Datos reales sobre el uso Avelumab en pacientes con cáncer urotelial localmente avanzado o metastásico - AVEBLADDER
	3119	SOGUG ( Grupo Español de Oncología Genitourinaria)	Estudio SOGUG-PRINCIS. Proyecto de Investigación Clinica de Interés Social: Estudio observacionalde efectividad de medicamentos financiados por el Sistema Nacional de Salud para tumores genitourinarios
María Victoria Cuevas Ruiz	3122	Fundación Progreso y Salud	Viabilidad de la interrupción del tratamiento en pacientes con leucemia mieloide crónica previamente tratados con bosutinib
María García González	3118		Registro multicéntrico de técnicas de depuración 2023-2025
Judith Gomez Camarero	3121		Evaluación de los cirterios de respuesta a segunda línea en pacientes con colangitis biliar primaria
Alba González Castro	2692		Estudio multicéntrico aleatrizado Fase III: linfadenectomía axilar versus radioterapia axilar en pacientes con ganglio centinela positivo tras terapia neoadyuvante. Protocolo ADARNAT
Gonzalo González Gete	3117		Registro propectivo y multicéntrico español de indicadores de calidad y eventos adversos de la Colangiopancreatografía retrógada endoscópica. REGISTRO-CPRE
Blanca Ascensión Hernando Fernández de Aránguiz	2297	Tesaro Inc	Estudio posautorización de seguridad para evaluar los riesgos del síndrome mielodisplásico/la leucemia mieloide aguda y las segundas neoplasias malignas primarias en pacientes adultos con cáncer epitelial de ovario, de las trompas de Falopio o peritoneal de tipo primario, sensible al platino, recidivante y seroso de alto grado que reciben tratamiento de mantenimiento con Zejula (niraparib)
	2626		Análisis de la estrategia terapéutica del cáncer de ovario BRCA mutado
	2657		Estudio Fase ll, aleatorizado, para discontinuación debida a Diarrea en los 3 primeros ciclos de tratamiento en pacientes con Cáncer de Mama Precoz HER2 positivo (HER2+), Receptor Hormonal positivo (RH+), tratados con Neratinib más Loperamida versus Neratinib con escalada inicial de dosis más Loperamida (según necesidad) versus Neratinib más Loperamida más Colesevelam. "Estudio DIANER''
	2950	AstraZeneca GmbH	A multi-center, multi-country prospective observational study of patients initiating T-DXd in the first or second treatment line for HER2+, and HER2-low unresectable and/or metastatic breast cancer. DESTINY BREAST - RESPOND
	3011	Fundación para la Investigación Biomédica del Hospital Clínico San Carlos	Caracterización molecular de tumores de ovario con mutación en BRCA e identificación de mecanismos de resistencia y respuesta a Olaparib. RESPOLA
Enrique Lastra Aras	2103		Secuenciación múltiple de última generación en tumores sólidos: utilidad clínica en un Hospital de tercer nivel
	2827		Infraestructura de medicina de precisión asociada a la ciencia y la tecnología- IMPaCT
	2892	Fundació Privada Institud d´Investigación Oncológica	Base de Datos Española de Cáncer Hereditario (SPAINCARE)
	2907		Proyecto CRECE (Consorcio REgistro de Cáncer hEreditario)
	2960		Recopilación retrosprectiva de datos para el cribado dinamico precoz del cáncer colorrectal mediante nuevos biomarcadores proteinicos que reflejan los mecanismos biológicos de iniciación. Colorectal Clinical Stady. DIOPTRA
	3014		Avances en Oncogenómica mediante paneles moleculares: Transformando el tratamiento en medicina de precisión
Ana Mª López Muñoz	2242	Servier International	Estudio prospectivo de cohorte de datos de la vida real en el tratamiento del cáncer colorrectal metastásico: perspectiva del médico y el paciente (PROMETCO)
Ana María López Muñoz	2850	Bayer Hispania S.L.	Estudio RE-SEARCH: pautas de dosificación con regorafenib en la práctica clínica en España: un estudio retrospectivo
Sara Martínez Díaz	3111		INtervención Basada en la Evidencia para la Reducción de la Neumonía Asociada a la Ventilación Mecánica en Unidades Neonatales (INBERNAV-Neo)
Yolanda Ulpiana Pérez Martínez	2692		Estudio multicéntrico aleatrizado Fase III: linfadenectomía axilar versus radioterapia axilar en pacientes con ganglio centinela positivo tras terapia neoadyuvante. Protocolo ADARNAT
José Ángel Pérez Rivera	2921	Sociedad Española de Cardiología	Estudio BOCADOS-IC: ensayo clínico aleatorizado prospectivo multcéntrico sobre el aBOrdaje nutriCional en ADultos seguidos en hOspitales eSpañoles por Insuficiencia Cardiaca
Inmaculada Rodriguez Ledesma	2852		Estudio RASTRO: mutaciones HRAS en Tumores de Región ORL. Estudio de prevalencia de mutaciones HRAS en carcinoma epidermoide de cabeza y cuello de pacientes con enfermedad recurrente y/o metastásica
Azucena Santillán García	2810		Alfabetización de salud y autocuidado en pacientes con Insuficiencia Cardiaca y su relación con los determinantes de la salud y la equidad en Burgos (estudio ALFABETIC)

Investigador principal	CEIC	Financiador / Promotor	Título
Cristina Bayona Antón	2581		Estudio BURAN sobre buparlisib (AN2025) en combinación con paclitaxel frente a paclitaxel en monoterapia, para pacientes con carcinoma de células escamosas de cabeza y cuello recurrente o metástasico
Guillermo Crespo Herrero	1643	Pfizer S.A.	Estudio observacional prospectivo para Identificar pacientes con CPNM avanzado/metastásico y translocación de ALK y conocer su manejo terapéutico (IDEALK)
	1701	Grupo Español de Oncología Genitourinaria (SOGUG)	Validación del Consorcio de la base de datos internacional de cáncer renal metastásico (IMDC) como clasificación pronóstica para terapias dirigidas (inhibidores de la ITC/Mtor) en segunda línea después del tratamiento con pazopanib primera línea. SPAZO-2
	1741	SOGUG ( Grupo Español de Oncología Genitourinaria)	Estudio prospectivo de la utilidad de la biopsia líquida como factor predictor y pronóstico en pacientes con carcinoma urotelial metastásico en progresión tras quimioterapia basada en platino
Esther Cubo Delgado	2393	Prilenia Therapeutics	Estudio en fase III, aleatorizado, con doble enmascaramiento, controlado con placebo, con grupos paralelos y multicéntrico para evaluar la eficacia y la seguridad de pridopidina en pacientes con enfermedad de Huntington en etapa temprana.
María García González	2927	Lilly	EMBER-4: Estudio de fase 3, aleatorizado, abierto, en el que se compara la administración adyuvante de imlunestrant versus terapia endocrina adyuvante estándar en pacientes que recibieron previamente de 2 a 5 años de terapia endocrina adyuvante para el cáncer de mama temprano ER+, HER2- con un mayor riesgo de recurrencia
Carlos García Girón	2366	Janssen Research & Development, LLC	Estudio Fase 3 aleatorizado de la combinación de Amivantamab y Lazertinib frente a Osimertinib como tratamiento de primera línea en pacientes con cáncer de púlmon no microcítico localmente avanzado o metastásico con mutación de EGFR. MARIPOSA
Blanca Ascensión Hernando Fernández de Aránguiz	1547	GEICAM (Grupo Español de Investigación en Cáncer de Mama)	PALLAS (PALbociclib Adjuvant Study): Ensayo en fase III aleatorizado de palbociclib con tratamiento endocrino adyuvante estándar frente a monoterapia con tratamiento endocrino adyuvante estándar en cáncer de mama primario con receptores hormonales positivos (RH+) HER2-negativo
	1805	Novartis Farmaceutica S.A.	Estudio de fase IIIB, abierto, multicéntrico, para evaluar la seguridad y la eficacia de Ribociclib (LEE011) en combinación con Letrozol en el tratamiento de hombres y mujeres pre/postmenopáusicas con cáncer de mama avanzado (CMA) con receptor hormonal positivo (HR+) y HER2 negativo (HER2-) que no hayan recibido tratamiento hormonal para la enfermedad avanzada
	2063	F. Hoffmann-La Roche Ltd.	Ensayo clínico fase III doble ciego, randomizado, controlado con placebo, para evaluar la eficacia y seguridad de atezolizumab o placebo en combinación con doxorubicina + ciclofosfamida como tratamiento neoadyuvante, seguido de paclitaxel + transtuzumab + pertuzumab, en pacientes con cáncer de mama precoz HER2-positivo
	2096	Novo Nordisk España	Ensayo clínico fase III, multicéntrico, aleatorizado y abierto, para evaluar la eficacia y seguridad de ribociclib con terapia endocrina, como tratamiento adyuvante en pacientes con cáncer de mama precoz, receptores hormonales positivos, HER2 negativo (nuevo ensayo en adyuvancia con ribociclib - [LEE011]: NATALEE)
	2152	F. Hoffmann-La Roche Ltd.	Estudio en fase III, multicéntrico, aleatorizado y abierto para comparar atezolizumab (anticuerpo ANTI-PD-L1) en combinación con quimioterapia adyuvante basada en antraciclina/taxano frente a solo quimioterapia en pacientes con cáncer de mama triple negativo operable
	2301	GEICAM (Grupo Español de Investigación en Cáncer de Mama)	Estudio de fase II, aleatorizado, abierto, internacional y multicéntrico, para comparar la eficacia de la quimioterapia estándar frente a letrozol más abemaciclib como terapia neoadjuvante en pacientes con cáncer de mama con RH-positivo/HER2-negativo de riesgo alto/intermedio. "CARABELA"
Ana Mª López Muñoz	2663	Amgen Inc.	Estudio de fase 3 aleatorizado, multicéntrico, doble ciego y controlado con placebo de bemarituzumab más quimioterapia frente a placebo más quimioterapia en sujetos con cáncer gástrico o de la unión gastroesofágica avanzado no tratado previamente con sobreexpresión de FGFR2b (FORTITUDE-101)
	2962	F. Hoffmann-La Roche Ltd.	Estudio de fase iii, aleatorizado, doble ciego y controlado con placebo para evaluar atezolizumab y bevacizumab, con o sin tiragolumab, en pacientes con carcinoma hepatocelular localmente avanzado o metastásico no tratado

Relación por orden alfabético del primer autor

Autores	Titulo	Revista	Factor de impacto	Servicio(s)
Aguirre C, Alonso-Torres A, Agüera E et al [Iglesias F]	Real-World Experience with Diroximel Fumarate in Patients with Multiple Sclerosis: A Prospective Multicenter Study.	Clin Drug Investig . 2024; 44(11): 829-838	2.9	Neurología
Aguado Suquia J, Carballosa de Miguel P, Naya Prieto A et al	Muscle weakness, myositis and scleroderma induced by durvalumab	Respirol Case Rep . 2024; 12(12): e70084	0.8	Neumología
Aguilar-Iglesias L, Merino-Merino A, Sanchez-Corral E et al	Impact of geriatric syndromes on the prognosis of young patients admitted for acute heart failure [Abstract]	ESC Heart Fail. 2024; 26:324-324	16.9	Análisis Clinicos, Cardiología
Franco-Rubio L, Puente-Martínez A, Ubillos-Landa S	Factors associated with recovery during schizophrenia and related disorders: A review of meta-analysis	Schizophr Res . 2024: 267: 201-212	3.6	Psiquiatría
González-López TJ, Alperovich G, Burillo E et al	Epidemiology, Treatment Patterns, and Cost Analysis of Immune Thrombocytopenia in Spain between 2014 and 2020: A Population-based Study	TH Open . 2024; 8(3): e252-e265	0.1	Hematología y Hemoterapia
González-López TJ, Bárez A, Bernardo-Gutiérrez Á et al	Real-life clinical practice in Spain in the setting of new drug availability for ITP treatment. A Delphi-based Spanish expert panel consensus	Platelets . 2024; 35(1): 2336104	2.5	Hematología y Hemoterapia
Gonzalez-Lopez TJ, Bermejo N, Cardesa-Cabrera R et al [Díaz Gálvez FJ, Hermida G, García C]	Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice.	Blood . 2024; 144(6): 646-656	21.1	Hematología y Hemoterapia
González-López TJ, Jarque I, Siniscalchi C et al	Editorial: Infectious diseases and hematology: diagnosis and management	Front Med (Lausanne) . 2024: 11: 1385874	3.1	Hematología y Hemoterapia
Gonzalez-Lopez, TJ, Bermejo-Vega N, Cardesa-Cabrera R et al	Early Treatment Use of Fostamatinib for Immune Thrombocytopenia (ITP): Efficacy and Safety As Second/Third ITP Treatment Lines in Clinical Practice in Spain [Abstract 2555]	Blood. 2024;	21.1	Hematología y Hemoterapia
Gutiérrez Herrero G, Núñez-Rodríguez S, Collazo C et al	Impact of the COVID-19 Pandemic on the Diagnosis of Malignant Neoplasia of the Bronchus and Lung in the Burgos Region .	Healthcare (Basel) . 2024; 12(16): 1677	2.4	Neumología
Labrador J, Martínez-Cuadrón D, Boluda B et al	Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry.	Cancer . 2024; 130(20): 3436-3451	6.1	Hematología y Hemoterapia
Richard Espiga F, Almendro Delia M, Caballero Martínez F et al	Delayed diagnosis and missed opportunities in the early detection of atrial fibrillation: a cross-sectional study.	Rev Clin Esp (Barc). 2024; 224(9): 560-568	2.3	Urgencias
Sánchez-Ospina D, Mas-Fontao S, Gracia-Iguacel C et al	Displacing the Burden: A Review of Protein-Bound Uremic Toxin Clearance Strategies in Chronic Kidney Disease	J Clin Med . 2024; 13(5): 1428	3	Análisis Clinicos
Vega-Del-Val C, Arnaez J, Ochoa-Sangrador C et al	Incidence of encephalopathy and comorbidity in infants with perinatal asphyxia: a comparative prospective cohort study	Front Pediatr. 2024; 12: 1363576.	2.1	Pediatría
Aguado HJ, Castillon-Bernal P, Teixidor-Serra J et al [Criado-Albillos G, Cabello-Benavides HG, Millan-Cid M, Cunchillos-Pascual J]	Optimizing periprosthetic fracture management and in-hospital outcome: insights from the PIPPAS multicentric study of 1387 cases in Spain	J Orthop Traumatol. 2024; 25(1): 13	3	Traumatología
Aguareles J, Villares Fernández P, Forné C et al [Navarro-San Francisco C, Buzón-Martín LM]	Outcomes and clinical characteristics of the compassionate use of plitidepsin in COVID-19 patients with solid tumours, haematological malignancies or anti-CD20 antibody treatment	Infect Dis (Lond) . 2024; 56(7): 575-580	4	Medicina Interna
Aguas M, Del Hoyo J, Vicente R et al [Sicilia B]	Telemonitoring with TECCU of active Inflammatory Bowel Disease is Not Inferior to Standard Care: Short-term Results of a Multicentre Randomized Controlled Trial of GETECCU.	J Med Internet Res . 2024; 26: e60966	5.8	Aparato Digestivo
Aguilar-Iglesias L, Merino-Merino A, Sanchez-Corral E, Garcia-Sanchez MJ, Santos-Sanchez I, Dominguez-Calvo J, Saez-Maleta R, Perez-Rivera JA	Prognostic effect of systematic geriatric assessment on patients with acute heart failure	ESC Heart Fail. 2024; 11(2): 1194-1204	3.2	Análisis Clinicos, Cardiología
Aguilar-Iglesias L, Perez-Asensio A, Vilches-Miguel L et al [Perez-Rivera JA]	Impact of Frailty on Heart Failure Prognosis: Is Sex Relevant?	Curr Heart Fail Rep. 2024; 21(2): 131-138	3.8	Cardiología
Aiello TF, Salmanton-Garcia J, Marchesi F et al [ Labrador J,Gonzalez-Lopez TJ]	Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry	Haematologica. 2024; 109(8): 2693-2700	8.2	Hematología y Hemoterapia
Al-Samkari H, Schifferli A, Gonzalez-Lopez TJ	The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostim	Br J Haematol. 2024; 204(4): 1143-1145	5.1	Hematología y Hemoterapia
Alarcon A, de Vries LS, Parodi A et al [Arnaez J]	Neuroimaging in infants with congenital cytomegalovirus infection and its correlation with outcome: emphasis on white matter abnormalities	Arch Dis Child Fetal Neonatal Ed. 2024; 109(2): 151-158	4.4	Pediatría
Alcoceba M, Stewart JP, García-Álvarez M et al [Díaz FJ]	Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual disease	Br J Haematol. 2024; 205(1): 109-121.	5.1	Hematología y Hemoterapia
Alonso-Martínez L, Santos JC, Cunha M, Puente-Alcaraz J	Validation of the Spanish Version of the Nurses' Global Assessment of Suicide Risk Scale (NGAR) in Nonclinical Settings	Nurs Open . 2024; 11(10): e70057	2	Enfermería
Alvarez Molinero M, Gomez Andres D, Garcia Uzquiano R et al [Navarro Abia V]	Prevalence of neurodevelopmental anomalies in patients with Spinal Muscular Atrophy Type I registered in CUIDAME [Abstract 117P]	Neurom Disorders. 2024; 43 .	2.7	Pediatría
Amo-Salas J, Olivares-Gil A, García-Bustillo Á et al [Cubo E]	Computer Vision for Parkinson's Disease Evaluation: A Survey on Finger Tapping	Healthcare (Basel) . 2024; 12(4): 439	2.4	Neurología
Ampuero J, Aller R, Gallego-Durán R et al [Gómez-Camarero J]	The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis	J Gastroenterol . 2024; 59(7): 586-597	6.9	Aparato Digestivo
Ampuero J, Lucena A, Berenguer M et al [Gómez-Camarero J]	Predictive factors for decompensating events in cirrhotic patients with primary biliary cholangitis under different lines of therapy	Hepatology . 2024; 80(4): 791-806	13	Aparato Digestivo
Andrés L, García S , Hontoria S et al	Enteric infection by Mycobacterium avium. Infección entérica por Mycobacterium avium.	Gastroenterol Hepatol . 2024; 47(6): 625-626	2.2	Aparato Digestivo
Andres Pascual L, Arias Garcia L, Saiz Chumillas RM, Chivato Martin-Falquina I, Sicilia Aladren B	Switching from intravenous vedolizumab to subcutaneous maintains clinical remission even in intensified patients with Inflammatory Bowel Disease. One year follow-up [Abstract P555]	J Crohns Colitis. 2024; 18: I1083-I1084	8.3	Aparato Digestivo
Andrés-Peiró JV, Nomdedéu J, Aguado HJ et al [Criado-Albillos G, Cabello-Benavides HG, Cunchillos-Pascual J]	Predictors of outcomes after internal fixation of periprosthetic femoral hip fractures Subgroup analysis of the peri-implant and peri-prosthetic fractures Spanish registry (PIPPAS)	Injury . 2024; 55(10): 111715	2.2	Traumatología
Apellaniz-Ruiz M, Barrachina J, Castro-Sanchez P et al [Saiz-Rodríguez M]	Status of the implementation of pharmacogenetics in clinical practice in Spain: from regional to national initiatives.	Drug Metab Pers Ther . 2024; 39(4): 183-199	0.27	Unidad A. Investigación
Aragon Gawinska K, Fernandez Garcia M, Nascimiento Osorio A et al [(Gil C]	Natural history of spinal muscular atrophy patients with 3 and 4 copies of SMN2 gene - data from the national Spanish registry (CUIDAME) [Abstract 201P]	Neurom Disorders. 2024; 43	2.7	Neurología
Arnaez, J	In memoriam Neonatal neurology at the SCCALP, heir to the Garcia-Alix School	Boletin de Pediatria. 2024; 64: 103-104	0.1	Pediatría
Arranz Ledo M, Lastra Aras E, Abella Santos L et al	Usefulness of a predictive model for Polygenic Hereditary Cancer detection [Abstract EP13.032]	Eur J Hum Genet. 2024; 32: 257-257	3.7	Oncología Médica
Barreira-Díaz A, Riveiro-Barciela M, Fernández-Bonilla EM et al [Gómez-Camarero J]	Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study	Ann Hepatol . 2024; 29(3): 101489	3.7	Aparato Digestivo
Barrio Azaceta M, Sala Llinas M, Horta D et al [Gomez-Camarero J]	Diabetes mellitus (DM) is associated with worse outcomes in patients with primary biliary cholangitis (PBC) regardless of the presence of liver steatosis: results from the ColHai registry [AbstractTHU-154-YI]	J Hepatol. 2024; 80: S717-S718.	26.8	Aparato Digestivo
Bastante T, Arzamendi D, Martín-Moreiras J et al [Luengo Mondéjar P]	Spanish cardiac catheterization and coronary intervention registry. 33rd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2023)	Rev Esp Cardiol (Engl Ed) . 2024; 77(11): 936-946	7.2	Cardiología
Basterretxea Badiola L, Laínez Milagro N, Cacho Lavín D et al [Lopez Peraita S]	RENO Study: Clinical characteristics, treatment patterns and survival results in patients with metastatic renal cell carcinoma in Northern Spain	Semin Oncol . 2024; 51(3-4): 77-86	3	Oncología Médica
Bastos-Oreiro M, Gutierrez A, Cabero A et al [Diaz-Gálvez J]	Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study	Cancers (Basel) . 2024; 16(7): 1285	4.5	Hematología y Hemoterapia
Bazan V, Arana E, Rubio-Campal JM et al [García Fernández FJ]	Spanish catheter ablation registry. 23rd official report of the Heart Rhythm Association of the Spanish Society of Cardiology (2023)	Rev Esp Cardiol (Engl Ed). 2024; 77(12): 1026-1036	7.2	Cardiología
Belhassen B, Conte G, Steinberg C et al [García-Fernández FJ]	Mode and Characteristics of ArrhythmiaInitiation in Idiopathic Ventricular Fibrillation: A THESIS Substudy.	JACC Clin Electrophysiol . 2024; 10(8): 1794-1809	8	Cardiología
Berciano-Guerrero MA, Perez-Ruiz E, Munoz Couselo E et al [Crespo G]	Real-world effectiveness and safety of dabrafenib-trametinib as first-line of treatment for BRAF mutated metastatic melanoma: Results of the study GEM1801 [Abstract e21515]	J Clin Oncol. 2024; 42: 16.	42.1	Oncología Médica
Berengue M, García-Villarreal L, Olveira A et al [Gomez-Camarero J]	Transaminase Pattern Over Time Is Not Associated with a More Aggressive Hepatic Evolution: Results from the AEEH Wilson Registry [AbstractWED-172]	J Hepatol. 2024; 80: S717-S718	26.8	Aparato Digestivo
Bermúdez-Barrezueta L, Mayordomo-Colunga J, Miñambres-Rodríguez M et al [Valencia-Ramos J]	Implications of sedation during the use of noninvasive ventilation in children with acute respiratory failure (SEDANIV Study)	Crit Care. 2024; 28(1): 235	8.8	Pediatría
Bernal-Jiménez A, García-Soto XR, Calvo-Simal S et al.	Evolution of Child and Youth Mental Health in the Context of the COVID-19 Pandemic: A Longitudinal Analysis	Children (Basel) . 2024;11(6): 660	2	Unidad A. Investigación, Psiquiatría
Blasco M, Quiroga B, García-Aznar JM et al [ Izquierdo MJ, Sanchez-Ospina D]	Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study.	Am J Kidney Dis . 2024; 84(6): 719-730.e1	9.4	Nefrología, Análisis Clinicos
Bobes A, Tormo M, Diaz-Beya M et al [Labrador J]	Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: "Real-Life" Data Versus the RATIFY Study [Abstract AML-468]	Clin Lymphoma Myeloma Leuk. 2024; 24: S315-S315	2.7	Hematología y Hemoterapia
Borau A, Salinas J, Allué M et al [Adot JM]	Consensus update on the therapeutic approach to patients with neurogenic detrusor overactivity	Actas Urol Esp (Engl Ed) . 2024; 48(9): 674-682	1.2	Urología
Bueno A, Nevado-Sanchez E, Collazo C et al	Functional Outcomes in Upper Limb Replantation-A Systematic Review	J Clin Med . 2024; 13(5): 1289	3	Cirugía Plástica
Bueso Navarro M, Zabalegui Pérez A, Blandino Ortiz A et al	Current situation and characteristics of centers specialized in management of aneurysmal subarachnoid hemorrhage in Spain	Med Intensiva (Engl Ed). 2024; 48(7): 426-428	2.7	Medicina Intensiva
Buzon-Martin L, Navarro-San Francisco C, Fernandez-Regueras M, Sanchez-Gomez L.	Integrase strand transfer inhibitor resistance mediated by R263K plus E157Q in a patient with HIV infection treated with bictegravir/tenofovir alafenamide/emtricitabine: case report and review of the literature	J Antimicrob Chemother . 2024; 79(5): 1153-1156	3.9	Medicina Interna
Calafat M, Torres P, Tosca-Cuquerella J et al [Arias L]	Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry	Therap Adv Gastroenterol . 2024: 17: 17562848231221713	3.9	Aparato Digestivo
Calvo-Villas JM, Núñez-Vázquez R, Benítez-Hidalgo O et al [García-Díaz C]	Switching hemophilia A patients to rVIII-SingleChain: The Iberian experience	Medicine (Baltimore) . 2024; 103(36): e39255	1.4	Hematología y Hemoterapia
Camino Ramos S, Martín Rosique A, Terán Redondo M, Patricio Jacome Tapia X, Gabriel Yepez León F, Teresa Yerovi León E, Camarero Temiño V, Abaigar Luquin P, Agúndez Gomez I.	Kidney transplant with refractory hypertension in a case of mid aortic syndrome	Nefrologia (Engl Ed) . 2024; 44(2): 276-277	2	Nefrología, Angiología y Cirugía Vascular
Caravaca-Fontán F, Stevens K, Padrón M et al [Yerovi E]	Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritis	Nephrol Dial Transplant. 2024; 39(2): 328-340.	6.1	Nefrología
Casajus A, Zubiaur P, Alday E et al [Saiz Rodriguez M]	Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain	Clin Transl Sci . 2024; 17(1): e13698	3.1	Unidad A. Investigación
Casanova MJ, Caballol B, García MJ et al [ Sicilia B]	Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU.	Dig Liver Dis . 2024; 56(11): 1845-1853	4	Aparato Digestivo
Casas Deza D, Julián Gomara AB, Caudevilla Biota E et al [Sicilia B]	A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study).	Gastroenterol Hepatol . 2024; 47(7): 821-833.	2.2	Aparato Digestivo
Casas Deza D, Julián Gomara AB, Caudevilla Biota E et al [Sicilia B]	Impact of mesalazine on the response to COVID-19 vaccination in patients with inflammatory bowel disease: Results of a prospective multicentre study of GETECCU (VACOVEII study)	Gastroenterol Hepatol . 2024; 47(7): 750-758.	2.2	Aparato Digestivo
Casas Deza D, Polo Cuadro C, de Francisco R et al [Sicilia B]	Initial Management of Intra-abdominal Abscesses and Preventive Strategies for Abscess Recurrence in Penetrating Crohn's Disease: A National, Multicentre Study Based on ENEIDA Registry	J Crohns Colitis . 2024; 18(4): 578-588	8	Aparato Digestivo
Castillo Simon A, Lisei Coscia D, Nevares Herrero M, Salvat Davila C,Gomez Hidalgo J, Lanchas Alfonso I, Miguel Martinez M, Duque Gallo J	[18f]FDG-PET in Refractory Epilepsy: epileptic foci localization and comparison with Magnetic Resonance Imaging [Abstract EP-0554]	Eur J Nucl Med Mol Imaging. 2024; 51: S652-S653	8.6	Radiodiagnóstico, Medicina Nuclear
Cernuda Martínez JA, Suárez Mier MB, Martínez Ortega MDC et al [Villafranca Renes C]	Risk factors and incidence of peripheral venous catheters-related phlebitis between 2017 and 2021: A multicentre study (Flebitis Zero Project)	J Vasc Access . 2024; 25(6): 1835-1841	1.9	Enfermería
Chaparro M, Hermida S, Acosta D et al [Sicilia B]	Short and long-term effectiveness and safety of ustekinumab in Ulcerative Colitis in real life: the ULISES study [Abstract DOP74]	J Crohns Colitis. 2024; 18: I207-I209	8.3	Aparato Digestivo
Chaparro M, Garcia Donday M, Nunez Ortiz A et al [Arias L]	Prevalence and factors associated with Inflammatory Bowel Disease (IBD) activity during pregnancy: updated data from the DUMBO Registry [Abstract DOP80]	J Crohns Colitis. 2024; 18: I221-I224.	8.3	Aparato Digestivo
Chaparro M, Garre A, Nunez Ortiz A et al [Arias L]	Long-term outcomes of newly diagnosed Inflammatory Bowel Disease (IBD) patients: results from the nationwide EpidemIBD study of GETECCU [Abstract P1170]	J Crohns Colitis. 2024; 18: I2071-I2074	8.3	Aparato Digestivo
Chaparro M, Hermida S, Acosta D et al [Sicilia B]	Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study	Aliment Pharmacol Ther. 2024; 60(10): 1325-1338	6.6	Aparato Digestivo
Chatzikonstantinou T, Scarfò L, Minga E et al [Labrador J]	Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL	Hemasphere . 2024; 8(9): e70004	11.9	Hematología y Hemoterapia
Cilia R, Dekker M, Cubo E et al.	Delivery of Allied Health Therapies to People with Parkinson's Disease in Africa	J Parkinsons Dis. 2024; 14(s1): S227-S239	5.2	Neurología
Clark R, Davies S, Labrador J et al	Safety and Immunogenicity of Respiratory Syncytial Virus Prefusion F Protein Vaccine when Co-administered with Adjuvanted Seasonal Quadrivalent Influenza Vaccine in Older Adults: A Phase 3 Randomized Trial	Clin Infect Dis. 2024; 79(4): 1088-1098	8.2	Unidad A. Investigación
Clark R, Davies S, Labrador J et al	Safety and Immunogenicity of Respiratory Syncytial Virus Prefusion F Protein Vaccine when Co-administered with Adjuvanted Seasonal Quadrivalent Influenza Vaccine in Older Adults: A Phase 3 Randomized Trial	Clin Infect Dis. 2024; 79(4): 1088-1098	8.2	Hematología y Hemoterapia
Contreras-Toledo D, Jiménez-Fonseca P, López CL et al [López Muñoz AM]	Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?	Br J Cancer . 2024; 130(5): 777-787	6.4	Oncología Médica
Cordero-Civantos C, Alvarez-Gómez L, Gomez-Gregoris I et al	Structural central causes of vertigo in childhood	REVISTA ORL. 2024; 15: 149-154	0.1	ORL
Corrado D, Anastasakis A, Basso C et al [Jiménez-Jáimez J]	Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report	Int J Cardiol . 2024: 395: 131447	3.5	Cardiología
De la Rosa-Riestra S, López-Hernández I, Pérez-Rodríguez MT et al [Sánchez Gómez L]	A comprehensive, predictive mortality score for patients with bloodstream infections (PROBAC): a prospective, multicentre cohort study	J Antimicrob Chemother . 2024; 79(8): 1794-1800	3.9	Microbiología
De la Rosa-Riestra S, López-Hernández I, Pérez-Rodríguez MT et al [Sanchez Gómez L]	A comprehensive, predictive mortality score for patients with bloodstream infections (PROBAC): a prospective, multicentre cohort study	J Antimicrob Chemother. 2024; 79(8): 1794-1800	3.9	Medicina Interna
Delgado-López PD, Martín-Alonso J, Herrero-Gutiérrez AI, Martín-Velasco V, Castilla-Díez JM, Montalvo-Afonso A, Diana-Martín R, Pérez-Cabo EM.	Barbed versus conventional suture in elective posterior spine surgery	Eur Spine J . 2024; 33(6): 2261-2268	2.6	Medicina Intensiva, Enfermería, Neurocirugía
Delgado-López PD, Montalvo-Afonso A, Martín-Alonso J, Martín-Velasco V, Diana-Martín R, Castilla-Díez JM	Predicting histological grade in symptomatic meningioma by an objective estimation of the tumoral surface irregularity.	Neurocirugia (Astur : Engl Ed). 2024; 35(3):113-121	0.7	Neurocirugía
Díaz-Calvillo P, Gómez-Jiménez C, Sabushimike D et al	Expanding the Spectrum of Skin Neoplasms in Muir-Torre Syndrome: Beyond Sebaceous Tumours	Am J Dermatopathol . 2024; 46(3): 189-191	1.1	Anatomía Patológica
Diaz-Gonzalez A, Ferreiro E, Gomez-Dominguez E et al [Gomez-Camarero J]	Prophylaxis for tuberculosis and pneumocystis jirovecii does not seem necessary in patients with autoimmune hepatitis treated with corticosteroid therapy: spanish multicentre study [Abstract THU-118]	J Hepatol. 2024; 80: S318-S319	26.8	Aparato Digestivo
Diaz-Gonzalez A, Ferreiro E, Gomez-Dominguez E et al [Gomez-Camarero J]	Incidence of fungal and other opportunistic infections in patients with autoimmune hepatitis: a spanish multicentre study [AbstractTHU-155]	J Hepatol. 2024; 80: S330-S331	26.8	Aparato Digestivo
Díez JJ, Anda E, Pérez-Corral B et a [Delgado-Lucio AM]	Prevalence of chronic postsurgical hypoparathyroidism not adequately controlled: an analysis of a nationwide cohort of 337 patients	Front Endocrinol (Lausanne). 2024; 15:1464515	3.9	Endocrinologia y Nutricion
Díez JJ, Anda E, Pérez-Corral B et al [Delgado-Lucio AM]	Incident comorbidities in patients with chronic hypoparathyroidism after thyroidectomy: a multicenter nationwide study	Front Endocrinol (Lausanne) . 2024: 15: 1348971	3.9	Endocrinologia y Nutricion
Diz-de Almeida S, Cruz R, Luchessi AD et al [Valencia-Ramos J]	Novel risk loci for COVID-19 hospitalization among admixed American populations.	Elife . 2024: 13: RP93666.	6.4	Pediatría
Domínguez F, Uribarri A, Larrañaga-Moreira JM et al [Fernández-González B]	Diagnosis and treatment of myocarditis and inflammatory cardiomyopathy. Consensus document of the SEC-Working Group on Myocarditis.	Rev Esp Cardiol (Engl Ed) . 2024; 77(8): 667-679	7.2	Cardiología
Echavarria Iniguez A, Guerrero Peral AL, Diaz de Teheran J et al [Iglesias Diez F]	MADRE MIA: Monoclonal Antibody Duration of REsponse in MIgraine After treatment interruption: A prospective multicentric study on 2164 patients [AbstractAL017]	J Headache Pain. 2024; 25: 1.	7.3	Neurología
El-Ashwah S , Salmanton-García J , Bilgin YM et al [Labrador J]	The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey	Leuk Lymphoma . 2024; 65(2): 199-208	2.6	Hematología y Hemoterapia
Escrihuela-Vidal F, Palacios-Baena ZR, Agirre JG et al [Sánchez Gómez L]	Early Antibiotic De-escalation in Patients With Severe Infections Due to Bloodstream Infection by Enterobacterales: A Post Hoc Analysis of a Prospective Multicentre Cohort	Int J Antimicrob Agents . 2024; 64(5): 107317	4.9	Medicina Interna
Espinosa B, Llorens P, Jacob J et al [López-Díez MP]	Epidemiologic and clinical characteristics and course of acute heart failure and cardiogenic shock diagnosed in emergency departments	Emergencias. 2024; 36(6): 425-437	5.4	Urgencias
Esteban Fernandez A, Gomez Otero I, Lopez Fernandez S et al [Sanchez Corral E]	Particularities of foundational therapy in patients with newly diagnosed heart failure and reduced LVEF secondary to tachycardiomyopathy [Abstract]	Eur J Heart Fail. 2024; 26: 7	16.9	Cardiología
Esteban-Fernández A, Bonilla-Palomas JL, Ayesta-López A, Pérez-Rivera JÁ	Justification and design of the BOCADOS-IC study: Nutritional management in adults followed in Spanish hospitals for heart failure.	Rev Esp Geriatr Gerontol . 2024; 60(2): 101566.	1.3	Cardiología
Esteban-Fernández A, Gómez-Otero I, López-Fernández S et al [Pérez-Rivera JÁ]	Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction	Clin Res Cardiol . 2024; 113(8): 1171-1182	5	Cardiología
Exposito Escudero J, Costa Comellas L, Garcia Romero M et al [Navarro Abia V]	Treatment with gene therapy in patients with spinal muscular atrophy. current experience in CuidAME registry [Abstract 128P]	Neurom Disorders. 2024; 43	2.7	Pediatría
Fahed VS, Doheny EP, Collazo C et al [Cubo E]	Language-Independent Acoustic Biomarkers for Quantifying Speech Impairment in Huntington's Disease	Am J Speech Lang Pathol. 2024; 33(3): 1390-1405	2.3	Neurología
Fattizzo B, Marchetti M, Michel M et al [González-López TJ]	Diagnosis and management of Evans syndrome in adults: first consensus recommendations	Lancet Haematol . 2024; 11(8): e617-e628	15.4	Hematología y Hemoterapia
Fernández Alonso C, Fuentes Ferrer ME, García-Lamberechts EJ et al [Hernández González R]	Impact of dementia on 30-, 180-, and 365-day mortality during the first pandemic wave in older adults seen in spanish emergency departments diagnosed with or without COVID-19	Aging Ment Health . 2024; 28(8): 1110-1118	2.8	Urgencias
Fernández de Alba I, Brigido C, Carretero P	Eosinophilia highly probable induced by carbapenems: A case report.	Rev Med Chil . 2024; 152(1): 124-127	0.5	Alergología e Inmunología
Fernandez-Gordon Sanchez F, Rodriguez-Tajes S, Londono MC et al [Gomez-Camarero J]	Optimization of treatment in patients with primary biliary cholangitis: Gamma-glutamyl transferase levels as an early prognostic marker for ursodeoxycholic acid response. Results from the ColHai registry [ AbstractTHU-189]	J Hepatol. 2024; 80: S344-S344S.	26.8	Aparato Digestivo
Ferrando L, Palomo A, Otero M, Munoz N, Jorge D, Cruza I, Baudino M, Casaval L, Dominguez I, Polanco L, Alvarez MA	A case of Laparoscopic Obturator Hernia [Abstract: znae122.14]	Br J Surg. 2024; 111: 5	8.7	Cirugía General
Ferreiro-Iglesias R, Porto Silva S, Marín S et al [Arias L, Sicilia B]	Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry	Aliment Pharmacol Ther. 2024; 60(5): 604-612	6.6	Aparato Digestivo
Fuente-Garrido R, González-Pérez G, Moradillo-Renuncio N, Agúndez-Gómez	Answer to: "Population screening for abdominal aortic aneurysms. Pilot study in Salamanca"	Angiologia. 2024; 76: 350-351	0.1	Angiología y Cirugía Vascular
Fuentes-Valenzuela E, Baston-Rey I,Garcia-Alonso FJ et al [Saiz Chumillas, RM]	Effectiveness and safety of rectal tacrolimus in patients with ulcerative colitis. TACRO-TOPIC study. A multicenter study from the young group of GETECCU [Abstract P949]	J Crohns Colitis. 2024; 18: I1715-I1716	8.3	Aparato Digestivo
Gámez-Leyva G, Cubo E.	Freezing of gait: pharmacological and surgical options.	Curr Opin Neurol . 2024; 37(4): 394-399	4.1	Neurología
García MJ, Rivero M, Fernández-Clotet A et al [Sicilia B, Arias L]	Comparative Study Of The Effectiveness Of Vedolizumab Versus Ustekinumab After Anti-Tnf Failure In Crohn's Disease (Versus-Cd): Data From Eneida Registry.	J Crohns Colitis . 2024; 18(1): 65-74	8	Aparato Digestivo
García Almeida JM, Cornejo Pareja IM, Fernández Jiménez R et al [de la Maza Pereg L]	Improving the nutritional care of oncology patients - Validation of a multidisciplinary protocol in the Spanish clinical setting	Nutr Hosp . 2024; 41(4): 758-765	1.2	Endocrinologia y Nutricion
Garcia-Alix A, Arnaez J, Arca G et al	Hypoxic-ischaemic encephalopathy code: a systematic review for resource-limited settings	An Pediatr (Engl Ed) . 2024; 100(4): 275-286.	1.5	Pediatría
García-Azorín D, García-Ruiz C, Sierra-Mencía Á et al [Echavarría Íñiguez A]	Acute and Preventive Treatment of COVID-19-Related Headache: A Series of 100 Patients	Life (Basel). 2024; 14(7): 910	3.2	Neurología
García-Fernández FJ, Calvo Simal S, Cano Pérez Ó et al [Martín González J]	Impact of the COVID-19 pandemic on implantation of cardiac implantable electronic devices and remote monitoring activations	Rev Esp Cardiol (Engl Ed). 2024; 77(3): 243-253	7.2	Cardiología, Unidad A. Investigación
Garcia-Fernández FJ, Martín González J, Villagraz Tercedor L, Fernández Palacios G, Cantero D et al	Feasibility, safety, and comfort of the '2BB' (2 cm below the bra) position of insertable cardiac monitors in women: the IN-WOMEN-ICM pilot study	Europace . 2024; 26(4): euae080	7.9	Cardiología
García-Sánchez E, Santamaría-Peláez M, Benito Figuerola E et al [ Carballo García MJ, Chico Hernando M, García García JM]	Comparison of SF-36 and RAND-36 in Cardiovascular Diseases: A Reliability Study.	J Clin Med . 2024 Oct 13;13(20):6106	3	Cardiología
Gargallo-Puyuelo CJ, Ricart E, Iglesias E et al [Sicilia B]	Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA	Clin Gastroenterol Hepatol . 2024; 22(11): 2280-2290	11.6	Aparato Digestivo
Garnacho-Montero J, Gordillo-Escobar E, Trenado et al [Fisac L]	A Nationwide, Prospective Study of Tracheal Intubation in Critically Ill Adults in Spain: Management, Associated Complications, and Outcomes	Crit Care Med . 2024; 52(5): 786-797	7.7	Medicina Intensiva
Giordano A, Perez Martinez I, Gisbert, JP et al [Arias L]	Impact of Crohn's Disease Location on Biologic Therapy Persistence and the Risk of Intestinal Surgery: Insights from the ENEIDA Registry (the DISCOLOC Study) [Abstract P987]	J Crohns Colitis. 2024; 18: I1781-I1782	8.3	Aparato Digestivo
Gómez-Labrador C, Ricart E, Iborra M et al [Arias L]	Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA	Pharmaceutics . 2024; 16(5): 629.	4.9	Aparato Digestivo
Gómez-Peralta F, Pinés-Corrales PJ, Santos E et al	Diabetes Management Based on the Phenotype and Stage of the Disease: An Expert Proposal from the AGORA Diabetes Collaborative Group	J Clin Med . 2024; 13(16): 4839	3	Endocrinologia y Nutricion
Gonzalez Marcos E, Garrido Cano M, Gonzalez-Bernal JJ et al	Mental pathology in the field of personality and psychotic disorders, systematic review of its relationship with the commission of homicide and violent acts	J Investig Psychol Offender Profil. 2024; 21: e1639	0.8	Unidad A. Investigación
Gonzalez Martinez A, Romero del Rincon C, Quintas Gutierrez S et al [Iglesias Diez F]	RE-START STUDY: Multicenter study to assess response after reintroduction of anti-CGRP antibodies in patients with migraine [AbstractAL013]	J Headache Pain. 2024; 25: 1	7.3	Neurología
Gonzalez Martinez A, Sánchez-Rodríguez C, Pagan J et al [Gil Luque S]	External validation of the predictive model of response to anti-CGRP monoclonal antibodies in patients with migraine [ Abstract P296]	J Headache Pain. 2024; 25: 1.	7.3	Neurología
González Prado C, Martín Acebes F, Manzanera Díaz M, Álvarez Rico MÁ	Retroperitoneal mass: A diagnostic challenge	Cir Esp (Engl Ed). 2024; 102(2): 117	1.3	Cirugía General
González-López TJ.	Editorial: Immune thrombocytopenia (ITP)-diagnosis and treatment	Front Med (Lausanne) . 2024: 11: 1385113	3.1	Hematología y Hemoterapia
González-Muñoza C, Calafat M, Gisbert JP et al [Sicilia B]	Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA project	Postgrad Med J . 2024; 100(1189): 836-844	3.6	Aparato Digestivo
Gorlicki J, Masip J, Gil V et al [ López-Díez MP]	Effect of early initiation of noninvasive ventilation in patients transported by emergency medical service for acute heart failure.	Eur J Emerg Med. 2024; 31(5): 339-346	3.1	Urgencias
Gratacos-Gines J, Del Barrio M, Ruz-Zafra P et al [Badia-Aranda E]	The interaction between metabolic syndrome and alcohol consumption after an episode of alcohol-associated hepatitis is associated with increased mortality: results from de spanish registry of alcohol-associated liver disease (REHALC) [Abstract SAT-267]	J Hepatol. 2024; 80: S142-S143	26.8	Aparato Digestivo
Gratacos-Gines J, Ruz-Zafra P, Celada-Sendino M et al [Badia-Aranda E]	Hepatorenal syndrome markedly impacts prognosis of patients with alcohol-associated hepatitis. Results from the spanish registry of alcohol-associated liver disease (REHALC) [AbstractSAT-257]	J Hepatol. 2024; 80: 139-S140	26.8	Aparato Digestivo
Gratacós-Ginès J, Ruz-Zafra P, Celada-Sendino M et al [Badia-Aranda E]	Recurrent alcohol-associated hepatitis is common and is associated with increased mortality	Hepatology . 2024; 80(3): 621-632	13	Aparato Digestivo
Guardiola Capon J, Iborra M, Padró A et al [Sicilia B]	Effect of the HLA-DQA1*05 allele on the efficacy of ustekinumab in patients with Crohn's Disease. Multicenter study based on the ENEIDA registry of GETECCU [Abstract OP37]	J Crohns Colitis. 2024; 18: I67-I67	8.3	Aparato Digestivo
Guedes M, Gathara D, López-Hernández I et al [Aleman A]	Differences in clinical outcomes of bloodstream infections caused by Klebsiella aerogenes, Klebsiella pneumoniae and Enterobacter cloacae: a multicentre cohort study	Ann Clin Microbiol Antimicrob . 2024; 23(1): 42	4.6	Medicina Interna
Guerra I, Barros F, Chaparro M et al [Sicilia B]	Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry	Dig Dis. 2024; 42(3): 257-264	2	Aparato Digestivo
Guerrero A, Martin M, Perez ME et al [Hernando B]	Evaluating Ki67 and Oncotype DX Breast Recurrence Score during neoadjuvant treatment with letrozole/abemaciclib or chemotherapy in patients with highly proliferative HR+/HER2-breast cancer participating in the GEICAM CARABELA trial [ Abstract 576]	J Clin Oncol. 2024; 42: 16.	42.1	Oncología Médica
Guinea J, Alcoceba E, Padilla E et al [Mantecón-Vallejo MÁ]	Fluconazole-resistant Candida parapsilosis: fast detection of the Y132F ERG11p substitution, and a proposed microsatellite genotyping scheme.	Clin Microbiol Infect . 2024; 30(11): 1447-1452	10.9	Microbiología
Gutiérrez Pérez C, Blanco Abad C, Hontoria Bautista G et al [Rodríguez Ledesma I , Espinosa Cabria N, Ramos Reguera I, Lopez Muñoz AM]	KRAS mutations in pancreatic cancer: could we talk about a risk factor for the development of thromboembolic phenomena?	Rev Esp Enferm Dig . 2024; 116(4): 236-237	2	Oncología Médica
Gutiérrez Pérez C, Rodríguez Ledesma I, Blanco Abad C, López Muñoz AM, Chivato Martín-Falquina I, Durán Domínguez M, Lastra Aras E	Stage IV perihilar cholangiocarcinoma with loss of expression of MSH2 and MSH6: hereditary cancer syndrome?	Rev Esp Enferm Dig . 2024; 116(4): 234-235	2	Aparato Digestivo, Oncología Médica
Gutiérrez Pérez C, Rodríguez Ledesma I, Blanco Abad C, López Muñoz AM, Chivato Martín-Falquina I, Durán Domínguez M, Lastra Aras E.	Stage IV mixed adenoneuroendocrine carcinoma of sigmoid colon in complete response after immunotherapy. Closer to curing neuroendocrine neoplasms?	Gastroenterol Hepatol . 2024; 47(3): 262-263	2.2	Aparato Digestivo, Oncología Médica
Gutierrez Perez C, Rodriguez Ledesma I, Pumares Gonzalez M et al	Single-center analysis on a real-world cohort of patients with metastatic urothelial carcinoma studied by NGS: Molecular landscape and efficacy of targeted therapies [Abstract]	J Clin Oncol. 2024; 42: 661-661	42.1	Anatomía Patológica, Oncología Médica
Gutierrez-Herrero G, Núñez-Rodríguez S, Collazo C et al [Castellanos-Romero L]	Retrospective Study of Lung Cancer: Evolution in 16 Years in the Burgos Region	J Clin Med. 2024;13(6):1601	3	Neumología
Hermida G, Alvarez-Nuño R, San Miguel-Izquierdo J, González-Quijada S, González-López TJ.	Long Term Remission of Capillary Leak Syndrome Associated with Monoclonal Gammopathy with Progression to Multiple Myeloma After Autologous Stem Cell Transplantation: a Case Report and Review of the Literature	Oncol Ther . 2024; 12(1): 183-188	3.2	Hematología y Hemoterapia, Medicina Interna
Hernandez S, Conde E, Molero A et al [Garcia-Toro E, Saiz-Lopez P]	Efficient Identification of Patients With NTRK Fusions Using a Supervised Tumor-Agnostic Approach	Arch Pathol Lab Med . 2024; 148(3): 318-326	3.7	Anatomía Patológica
Hernández-Sánchez A, Villaverde-Ramiro Á, Arellano-Rodrigo E et al [Cuevas B]	The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis	Am J Hematol . 2024; 99(4): 755-758	10.1	Hematología y Hemoterapia
Hontecillas-Prieto L, García-Domínguez DJ, Palazón-Carrión N et al [Labrador J]	CD8+NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma	Front Immunol . 2024: 15: 1293931	5.7	Hematología y Hemoterapia
Horsch S, Schwarz S, Arnaez J et al	Cerebral Doppler imaging in neonates: A guide for clinical application and diagnosis	Dev Med Child Neurol. 2024; 66(12): 1570-1589	3.8	Pediatría
Hortigüela MM, Martínez-Biarge M, Conejo D, Vega-Del-Val C, Arnaez J	Motor, cognitive and behavioural outcomes after neonatal hypoxic-ischaemic encephalopathy	An Pediatr (Engl Ed). 2024; 100(2): 104-114.	1.5	Pediatría
Iborra M, Caballol B, Garrido A et al [Arias García L]	Subcutaneous infliximab cut-off points in a large cohort of Spanish patients with inflammatory bowel disease and factors associated with long-term outcomes [Abstract P516]	J Crohns Colitis. 2024; 18: I1013-I1014	8.3	Aparato Digestivo
Iglesias Rodriguez M, Navarro Abia V	Joubert Syndrome. A review of the literature	Boletin de Pediatria. 2024; 64: 117-124	0.1	Pediatría
Iglesias-Rodríguez M, Navarro-Abia V, Barbadillo-Mariscal B, Gil-Calderón FJ, Gonzalo-San Esteban A, Mañaricua-Arnaiz A, Tejero-Pastor L, Conejo-Moreno D	Characteristics of patients with drug-resistant epilepsy in a tertiary hospital	Rev Neurol. 2024; 79(10): 273-277	0.8	Pediatría
Infante M, Arranz-Ledo M, Lastra E et al	Profiling of the genetic features of patients with breast, ovarian, colorectal and extracolonic cancers: Association to CHEK2 and PALB2 germline mutations	Clin Chim Acta. 2024; 552: 117695	5	Oncología Médica
Jacob J, Fuentes E, Del Castillo JG et al [López-Diez MP]	Use of diagnostic tests in elderly patients consulting the emergency department. Analysis of the emergency department and elder needs cohort (EDEN-8).	Australas Emerg Care . 2024; 27(4): 268-275	2.1	Urgencias
Jiménez Benito J, Macías Molinero L, Gajate Paniagua N, López Peña MJ, Pérez-Salvador García E.	The never-ending and inexhaustible search of wisdom in our professional work as ophthalmologists	Arch Soc Esp Oftalmol (Engl Ed) . 2024; 99(4): 143-144	0.5	Oftalmología
Jiménez-Méndez C, Díez-Villanueva P, Pérez-Rivera Á et al	Different impact of chronic kidney disease in older patients with heart failure according to frailty [Abstract]	Eur Heart J. 2024; 45	38.1	Cardiología
Juan Fita MJ, Fernandez Calvo O, Anido Herranz U et al [Crespo G]	SOGUG-AVELUMAB_RWD: Comprehensive analysis of real-word data to evaluate the effectiveness and safety of avelumab maintenance therapy in patients with stage IV urothelial carcinoma conducted in Spain [Abstract e16561]	J Clin Oncol. 2024; 42: 16	42.1	Oncología Médica
Kim JJ, Vitale D, Otani DV et al [Cubo E]	Multi-ancestry genome-wide association meta-analysis of Parkinson's disease	Nat Genet. 2024; 56(1): 27-36	30.8	Neurología
Kuter DJ, Gonzalez Lopez, TJ,Trautmann-Grill K et al	A Phase 2 Study of Ianalumab in Patients with Primary Immune Thrombocytopenia Previously Treated with at Least Two Lines of Therapy: Interim Results from VAYHIT3 [Abstract 710]	Blood. 2024;	21.1	Hematología y Hemoterapia
Lahmer T, Salmanton-García J, Marchesi F et al [ Labrador J, González-López TJ]	Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.	Infection. 2024; 52(3): 1191-1194	5.4	Hematología y Hemoterapia
Lahmer T, Salmanton-García J, Marchesi F et al [Labrador J, González-López TJ]	Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey	Infection. 2024; 52(3): 1125-1141	5.4	Hematología y Hemoterapia
Leon-Larios F, Alonso Llamazares MJ, Mausbach Reisen H, et al [Rey Novoa M]	Impact of the hands-on clinical training program for subdermic implant on contraceptive counseling and users' choice in Spain: A 6-month follow-up study	Contraception . 2024: 132: 110372	2.8	Ginecología
Leon-Larios F, Silva-Reus I, Puente Martínez MJ et al [Renuncio Roba A]	Influence of menstrual pain and symptoms on activities of daily living and work absenteeism: a cross-sectional study	Reprod Health. 2024; 21(1): 25	3.6	Ginecología
López C, Calvo M, Cámara JC et al [Lopez AM]	SEOM-GEMCAD-TTD clinical guidelines for the management of hepatocarcinoma patients (2023)	Clin Transl Oncol . 2024; 26(11): 2800-2811	2.8	Oncología Médica
López-Carrasco A, Vieco-Martí I, Granados-Aparici S et al [ Portugal R]	Vitronectin Levels in the Plasma of Neuroblastoma Patients and Culture Media of 3D Models: A Prognostic Circulating Biomarker?	Int J Mol Sci . 2024; 25(16): 8733	4.9	Pediatría
López-Gómez M, Morales M, Fuerte R et al [Delgado-López PD]	Prevalence of Helicobacter pylori infection among patients with esophageal carcinoma	World J Gastroenterol. 2024; 30(29): 3479-3487	4.3	Neurocirugía
Maldonado N, López-Hernández I, García-Montaner A et al [Labayru-Echeverría C]	Whole-genome characterisation of Escherichia coli isolates from patients with bacteraemia presenting with sepsis or septic shock in Spain: a multicentre cross-sectional study	Lancet Microbe. 2024; 5(4): e390-e399	20.9	Microbiología
Maldonado N, López-Hernández I, López-Cortés LE et al [Del Valle Ortíz M]	Association of microbiological factors with mortality in Escherichia coli bacteraemia presenting with sepsis/septic shock: a prospective cohort study	Clin Microbiol Infect . 2024; 30(8): 1035-1041	10.9	Medicina Intensiva
Mansour M, Lopez-Guajardo L, Belotto S et al [Pérez-Salvador E]	Recovery course of persistent posterior subretinal fluid after successful repair of rhegmatogenous retinal detachment	Eur J Ophthalmol . 2024; 34(4): 1217-1227	1.7	Oftalmología
Mantecón-Vallejo MD, Mesquida A, Del Valle-Ortiz M, Buzón-Martín L, Ossa-Echeverri S, Fisac-Cuadrado L, Megías-Lobón G, Ortega-Lafont MP et al	Clonal spread of fluconazole-resistant C. parapsilosis in patients admitted to a referral hospital located in Burgos, Spain, during the COVID-19 pandemic	Mycoses. 2024; 67(1):e13685	4.1	Medicina Interna, Microbiología, Medicina Intensiva
Marcos-Peña S, Fernández-Pernia B, Provan D, González-López TJ	Tapering and Sustained Remission of Thrombopoietin Receptor Agonists (TPO-RAs): Is it Time for Paediatric ITP?	Adv Ther. 2024; 41(10): 3771-3777.	3.4	Hematología y Hemoterapia, Pediatría
Martín-Cardona A, Horta D, Flórez-Díez P et al [Sicilia B]	Safety and effectiveness of direct-acting antiviral drugs in the treatment of hepatitis C in patients with inflammatory bowel disease	Dig Liver Dis . 2024; 56(3): 468-476	4	Aparato Digestivo
Martínez-Cuadrón D, Megías-Vericat JE, Gil C et al [Labrador J]	Outcomes after intensive chemotherapy for secondary and myeloidrelated changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry	Haematologica . 2024; 109(1): 115-128	8.2	Hematología y Hemoterapia
Martinez-Cuadron D, Rodriguez-Veiga R, Bergua Burgues JM et al [Labrador J]	Correlation of ELN-Risk and Gene Mutations with Quizartinib Efficacy in Patients with FLT3-ITDā€“Negative Newly Diagnosed Acute Myeloid Leukemia in the Phase 2 Quiwi Pethema Trial [Abstrac 2895]	Blood. 2024;	21.1	Hematología y Hemoterapia
Martínez-Jañez N, Ezquerra MB, Manso Sanchez LM et al [Hernando Fernandez de Araguiz B]	First-line therapy with palbociclib in patients with advanced HR+/HER2- breast cancer: The real-life study PALBOSPAIN	Breast Cancer Res Treat . 2024; 206(2): 317-328	3	Oncología Médica
Martinez-Vidal MP, Fernandez-Carballido C, Otero-Varela L et al [Álvarez-Lario B]	Long-Term Survival of Subcutaneous Biosimilar Tumor Necrosis Factor Inhibitors Compared to Originators: Results From a Multicenter Prospective Registry	J Rheumatol. 2024 Sep 1;51(9):877-883	3.6	Reumatología
Mayordomo S, Gómez M, Martín C.	Aortic dissection	Med Clin (Barc). 2024; 163(9): e90-e91	2.6	Cardiología, Radiodiagnóstico
Mesonero F, Zabana Y, Fernández-Clotet A et al [Sáiz-Chumillas RM]	Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU.	Dig Liver Dis . 2024	4	Aparato Digestivo
Mesquida A, Alcoceba E, Padilla E et al [Mantecón-Vallejo MLÁ]	Fluconazole-resistant Candida parapsilosis genotypes from hospitals located in five Spanish cities and one in Italy: Description of azole-resistance profiles associated with the Y132F ERG11p substitution	Mycoses . 2024; 67(3): e13706.	4.1	Microbiología
Miró Ò, Aguiló S, Alquézar-Arbé A et al [Castro Jiménez V]	Overnight stay in Spanish emergency departments and mortality in older patients.	Intern Emerg Med . 2024; 19(6): 1653-1665	3.2	Urgencias
Mitjavila Casanovas M, Lopez J, Jimenez-Fonseca P et al [Nevares Herrero M]	Prediction of patient progression-free survival with 177Lu-DOTATATE in clinical practice: NEPTUNESEPTRALU model for patient selection [Abstract OP-257]	Eur J Nucl Med Mol Imaging. 2024; 51: S652-S653.	8.6	Medicina Nuclear
Mitjavila Casanovas M, Pubul V, Garcia-Burillo A et al [Nevares M]	Neurodevelopmental Impairments Prediction in Premature Infants Based on Clinical Data and Machine Learning Techniques [Abstract OP-260]	Eur J Nucl Med Mol Imaging. 2024; 51: S126-S126	8.6	Medicina Nuclear
Molina-Lerma M, Cózar-León R, García-Fernández FJ et al	Spanish pacemaker registry. 21st official report of Heart Rhythm Association of the Spanish Society of Cardiology (2023)	Rev Esp Cardiol (Engl Ed). 2024; 77(11): 947-956	7.2	Cardiología
Monasterio Bel J, Pérez-Salvador García E, Alcuaz Alcalaya A, Tello Fernández A.	Ultravit high-speed vitrectomy, is higher always better? Hydrodynamic cavitation must be considered.	Arch Soc Esp Oftalmol (Engl Ed) . 2024; 99(6): 267-268	0.5	Oftalmología
Montalvo-Afonso A, Castilla-Díez JM, Martín-Velasco V, Martín-Alonso J, Diana-Martín R, Delgado-López PD	Perioperative risk factors for major complications after bone replacement in decompressive craniectomy	Neurocirugia (Astur : Engl Ed). 2024; 35(3): 145-151	0.7	Neurocirugía
Montalvo-Afonso A, Castilla-Díez JM, Martín-Velasco V, Martín-Alonso J, Diana-Martín R, Delgado-López PD	Perioperative risk factors for major complications after bone replacement in decompressive craniectomy	Neurocirugia (Astur : Engl Ed). 2024; 35(3): 145-151	0.7	Medicina Intensiva
Montesinos P, Rodriguez-Veiga R, Bergua Burgues JM et al [Labrador J]	Final Results of Quiwi: A Double Blinded, Randomized Pethema Trial Comparing Standard Chemotherapy Plus Quizartinib Versus Placebo in Adult Patients with Newly Diagnosed FLT3-ITD Negative AML [Abstractt 1512]	Blood. 2024;	21.1	Hematología y Hemoterapia
Mosquera Orgueira A, Perez Encinas M, Pérez Míguez C et al [Labrador J]	Enhanced Validation of the FLT3-like Gene Expression Signature As a Predictive Biomarker for Quizartinib Response in FLT3-ITD Negative Acute Myeloid Leukemia: Expanded Cohort and Extended Follow-up from the Pethema Quiwi Trial [Abstract 1552]	Blood. 2024;	21.1	Hematología y Hemoterapia
Mosquera-Orgueira A, Arellano-Rodrigo E, Garrote M et al [CuevasB]	Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis	Hemasphere . 2024; 8(3): e60	11.9	Hematología y Hemoterapia
Moyano García R, Piñera-Salmerón P, Jacob J et al [López Díez MP]	Clinical course in older patients diagnosed with syncope treated in Spanish emergency departments: results from the Emergency Department and Elder Needs-17 study	Emergencias. 2024; 36(4): 281-289	5.4	Urgencias
Musto P, Salmanton-García J, Sgherza N et al Labrador J	Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the epicovideha registry	Hematol Oncol . 2024; 42(1): e3240	3.3	Hematología y Hemoterapia
Nanwani-Nanwani K, Gero Escapa M, Serrano Lazaro A	The Patient Blood Management Coordinator, shall we position ourselves?	Med Intensiva (Engl Ed) . 2023; 47(11): 676-677	2.7	Medicina Intensiva
Nascimento Osorio A, Garcia Uzquiano R, Puig C et al [Navarro V]	CuidAME: The Spanish longitudinal Registry of SMA patients. A global view in 2024 [Abstract 183P]	Neurom Disorders. 2024; 43	2.7	Pediatría
Navarro Vicente I, Solana-Altabellam A, Sobas M et al [Labrador j]	Clinical Features and Outcomes in 228 Patients Diagnosed with Blastic Plasmocytoid Dendritic Cell Neoplasm: A Pethema/PALG Study [Abstract 319]	Blood. 2024;	21.1	Hematología y Hemoterapia
Navarro-Pérez MP, González-Quintanilla V, Muñoz-Vendrell A et al [Madrigal E, Iglesias F]	Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study	Front Neurol. 2024; 15: 1417831	2.7	Neurología
Navas-Acosta J, Hernandez-Sanchez A, Gonzalez T et al [Labrador J]	Preferential Genetic Pathways Lead to Relapses in Adult B-Cell Acute Lymphoblastic Leukemia	Cancers (Basel) . 2024; 16(24): 4200	4.5	Hematología y Hemoterapia
Ocaña J , García-Pérez JC , Fernández-Martínez D et al [Muñoz Plaza N]	Outcomes of initially nonoperative management of diverticulitis with abscess formation in immunosuppressed patients. DIPLICAB study COLLABORATIVE group	Colorectal Dis . 2024; 26(1): 120-129	3.4	Cirugía General
Oreja-Guevara C, Aguado Garcia L, Martin Martinez J et al	Real world experience with siponimod in Active Secondary Progressive Multiple Sclerosis: Results of the RESYZE study [Abstract P862/1631]	Mult Scler J. 2024; 30: 668-669	4.8	Neurología
Oreja-Guevara C, Meca-Lallana JE, Díaz-Díaz J et al [Herrera Varo N]	Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: DISCOVER study	Mult Scler Relat Disord . 2024: 90: 105787	2.9	Neurología
Ortega Pérez R, García-Gutiérrez V, Alvarez-Larran A et al [Cuevas B]	Impact of Atrial Fibrillation on Patients with Myeloproliferative Neoplasms [Abstract 4549]	Blood. 2024;	21.1	Hematología y Hemoterapia
Pabón-Carrasco M, Keco-Huerga A, Castro-Fernández M et al Gomez-Camarero, J	Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management	United European Gastroenterol J . 2024; 12(1): 122-138	6	Aparato Digestivo
Palomino Perez LM, Velasco Rodriguez-Belvis M, Brenes Ruiz Y et al [Arias L]	Unveiling the impact on in utero exposure to biologic treatments for inflammatory bowel disease (IBD) on children's psychomotor development: Insights from the DUMBO registry of GETECCU [Abstract P676]	J Crohns Colitis. 2024; 18: I1272-I1274	8.3	Aparato Digestivo
Pandiella S, García-Belenguer P, Baena MC et al	Negative pressure pulmonary edema in an unexpected condition: sedation interventional procedure in prone position in patient with severe obstructive sleep apnea-hypopnea syndrome	Minerva Anestesiol. 2024; 90: 943-944	2.9	Anestesiologia y Reanimación
Panizo E, Vazquez-Gomez F, Perez-Somarriba, M et al [Portugal R]	Re-Irradiation for Progressive Diffuse Intrinsic Pontine Glioma (DIPG): the Spanish Experience [Abstract DIPG-63]	Neuro Oncol. 2024; 26: supp 4	16.4	Pediatría
Pastor-Galán I, Pereira A, Arellano-Rodrigo E et al [Cuevas B]	Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis	Leukemia. 2024; 38(11): 2483-2486	12.8	Hematología y Hemoterapia
Pérez de Isla L, Díaz-Díaz JL, Romero MJ et al [Álvarez-Baños P]	Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study	Circ Cardiovasc Imaging . 2024; 17(1): e016206	6.5	Endocrinologia y Nutricion
Perez de Isla L, Vallejo-Vaz AJ, Watts G et al [Álvarez-Baños P]	Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study	Lancet Diabetes Endocrinol . 2024; 12(9): 643-652	44	Endocrinologia y Nutricion
Pérez Míguez C, Mosquera Orgueira A, Perez Encinas M et al [Labrador J]	A Cutting-Edge Bioinformatics Tool for Neoantigen Identification in Unpaired RNA-Seq Samples of AML [Abstract 4986]	Blood. 2024;	21.1	Hematología y Hemoterapia
Pérez Porra S , Granda E , Benito H et al	Prevalence of invasive bacterial infection in febrile infants ?90 days with a COVID-19 positive test: a systematic review and meta-analysis	Emerg Med J . 2024; 41(4): 228-235	3.1	Pediatría
Pérez-Bertólez S, Godoy-Lenz J, Alonso V	Traumatic rupture of testicle and epididymis	An Pediatr (Engl Ed). 2024; 100(4): 305-306.	1.5	Cirugía Infantil
Pérez-Jurado LA, Cáceres A, Balagué-Dobón L et al [Valencia J]	Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2	Commun Biol . 2024; 7(1): 202	5.2	Pediatría
Pérez-Lamas L, Segura Diaz A, García Delgado R et al [Cuevas B]	Real-World Outcomes of Momelotinib As an Alternative Therapy to Other JAK Inhibitors in Myelofibrosis Patients with Anemia [Abstract 1790]	Blood. 2024;	21.1	Hematología y Hemoterapia
Perez-Torres Lobato M, Navarro Marchena L , De Noriega I et al [Portugal R]	Palliative care for children with central nervous system tumors: results of a Spanish multicenter study	Clin Transl Oncol. 2024; 26(3): 786-795.	3.4	Pediatría
Perpiñá-Clérigues C, Mellado S, Galiana-Roselló C et al [Fernández-Regueras M]	Novel insight into the lipid network of plasma extracellular vesicles reveal sex-based differences in the lipidomic profile of alcohol use disorder patients	Biol Sex Differ . 2024; 15(1): 10.	4.9	Medicina Interna
Piñana JL, Vazquez L, Heras I et al [Labrador J]	Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy	Front Oncol. 2024; 14: 1389345	3.5	Hematología y Hemoterapia
Pinilla L, Dodani K, Benitez I et al [Muñoz C]	Molecular insights into hypoxic burden physiopathology in OSA: a proteomic perspective [Abstract]	Eur Respir J. 2024; 64	17	Neumología
Puertas B, Alejo E, Rey-Bua B et al [Serra F]	Monoclonal Gammopathy of Uncertain Significance (MGUS) Like Profile in Transplant-Eligible Multiple Myeloma (MM) Patients: Clinic-Biological Characteristics and Prognosis Significance [Abstract P-183]	Clin Lymphoma Myeloma Leuk. 2024; 24: S144-S144	2.7	Hematología y Hemoterapia
Puertas B, Alejo E, Rey-Bua B et al [Serra F]	Impact of Minimal Residual Disease in Apheresis Product (aMRD) Assessed by Multiparametric Flow Cytometry (MFC) in Transplant-Eligible Multiple Myeloma (MM) Patients [Abstract P-182]	Clin Lymphoma Myeloma Leuk. 2024; 24: S143-S143	2.7	Hematología y Hemoterapia
Pujol-Muncunill G, Navas-López VM, Ledder O et al [Fernandez de Valderrama A]	STEP-CD study: ustekinumab use in paediatric Crohn's disease-a multicentre retrospective study from paediatric IBD Porto group of ESPGHAN	Eur J Pediatr . 2024; 183(8): 3253-3262	3	Pediatría
Quevedo García R, Arnaiz Díez S, Pérez Pevida E et al	Orthopantomography Detection of Atheroma Plaques and Its Relationship with Periodontal Disease and Missing Teeth	Radiol Res Pract. 2024; 2024: 8873720	2.2	Farmacia
Rahhal A, Provan D, Ghanima W, González-López TJ et al	A practical guide to the management of immune thrombocytopenia co-existing with acute coronary syndrome	Front Med (Lausanne) . 2024: 11: 1348941	3.1	Hematología y Hemoterapia
Ramos Pascua LR, Casas Ramos P, De la Cruz Gutiérrez L et al [Mora Fernández MI]	External Hemipelvectomy in Soft Tissue Sarcomas: Are They Still Needed?	Cancers (Basel) . 2024; 16(22): 3828	4.5	Traumatología
Reoyo JF, Alonso EA, Polanco L, Álvarez M	Adenocarcinoma on retrorectal cystic hamartoma: An illustrative image for a very rare diagnosis	Semin Oncol . 2024; 51(5-6): 154-155	3	Cirugía General
Ribeiro-Constante J, Tristán-Noguero A, Martínez Calvo FF et al [ Iglesias Santa Polonia FF]	Developmental outcome of electroencephalographic findings in SYNGAP1 encephalopathy	Front Cell Dev Biol. 2024; 12: 1321282	4.6	Neurología
Ríos-León M, Cuñado-González Á, Domínguez-Fernández S et al	Effectiveness of motor imagery in complex regional pain syndrome: A systematic review with meta-analysis	Pain Pract. 2024; 24(5): 760-771	2.5	Rehabilitación
Rivadeneyra-Posadas J, Simón-Vicente L, Castillo-Alvira D, Raya-González J, Soto-Celix M, Rodríguez-Fernández A, García-Bustillo A, Saiz-Rodríguez M, Vázquez-Sánchez F, Aguado-Garcia L, Gámez Leyva-Hernández G, Cubo E	How to estimate body composition in Huntington's disease. A cross-sectional, observational study using multiple frequencies bioimpedance	Rev Neurol. 2024; 78(1): 17-25	1.2	Neurología, Unidad A. Investigación
Rodríguez A , Martín Loeches I , Gerard Moreno G et al [Del Valle Ortiz M]	Association of obesity on the outcome of critically ill patients affected by COVID-19	Med Intensiva (Engl Ed). 2024; 48(3): 142-154	2.7	Medicina Intensiva
Rodríguez A, Gómez J, Franquet Á et al [Del Valle Ortíz M]	Applicability of an unsupervised cluster model developed on first wave COVID-19 patients in second/third wave critically ill patients	Med Intensiva (Engl Ed). 2024; 48(6):326-340	2.7	Medicina Intensiva
Rodríguez Pérez R , Del Pozuelo S, Pulido E et al [Brígido C, Carretero P]	Chemiluminescence-based IgE dot-blot assay to diagnose a case of anaphylaxis caused by Prontosan	J Investig Allergol Clin Immunol . 2024; 34(2): 141-142.	6.7	Alergología e Inmunología
Rodriguez-Lago I, Vela M, Ordás I et al [SiciliaB]	Characteristics and management of pyoderma gangrenosum and erythema nodosum in patients with inflammatory bowel disease: PIONOSO multicenter study [Abstract P1115]	J Crohns Colitis. 2024; 18: I1987-I1988	8.3	Aparato Digestivo
Roldán-Sevilla A, Gallego-Delgado M, Lista-Araujo MT, Torres-Pérez J, Merino-Merino AM, Gil-Polo C, Cantero-Lozano D, Lorenzo-Hernandez SM, Eiros-Bachiller	Clinical and genetic features of AGel amyloidosis caused by novel gelsolin variant and its impact on cardiac function and conduction disorders	Amyloid. 2024; 19: 5.21-3	5.2	Neurofisiología Clínica, Neurología, Oftalmología, Cardiología
Romaris P, Ortiz M, Cahuana NH et al [Martin Audera P]	Comparison of two methods for the determination of glucose in an Atellica Siemens analyzer [Abstract]	Clin Chim Acta. 2024; 558; 1	3.2	Análisis Clinicos
Romero Del Rincón C, Gonzalez-Martinez A, Quintas S et al [Iglesias Díez F]	RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine	Eur J Neurol . 2024; 31(4): e16203	4.5	Neurología
Romero-Carrete CJ, Alquézar-Arbé A, Herrera Mateo S et al [López-Díez MP]	Timing of previous heart failure hospitalization as a prognostic factor for emergency department heart failure patients	Intern Emerg Med. 2024; 19(4): 1089-1098.	3.2	Urgencias
Romero-Gutiérrez M, Alonso P, Berenguer M et al [Gómez J]	Reproductive and pregnancy control in Wilson disease patients in Spain	Eur J Gastroenterol Hepatol . 2024; 36(11): 1340-1345	2.3	Aparato Digestivo
Romero-Gutierrez M, Barajas J, Gomez M et al [Fernandez C]	Systemic therapy of hepatocellular carcinoma on non-cirrhotic liver: a prospective spanish multicentre study [AbstractTHU-493]	J Hepatol. 2024; 80: S453-S453	26.8	Aparato Digestivo
Romero-Gutiérrez M, Pascual S, Márquez L et al [Fernández C]	Spontaneously ruptured hepatocellular carcinoma on non-cirrhotic liver: A prospective case series	Gastroenterol Hepatol . 2024; 47(7): 683-690	2.2	Aparato Digestivo
Romero-Mascarell C, Giordano A, Riestra S et al [Sicilia B]	Proximal Crohn's disease location is associated with a more benign course of perianal Crohn's disease (the PERIAPROX study) [Abstract P419]	J Crohns Colitis. 2024; 18: I857-I858	8.3	Aparato Digestivo
Rubin De Celix C, Ricart E, Martín-Arranz MD et al [Arias L]	Frequency and effectiveness of dose de-escalation of biologic therapy in Inflammatory Bowel Disease: The RAINBOW-IBD study of ENEIDA [Abstract P844]	J Crohns Colitis. 2024; 18: I1557-I1559	8.3	Aparato Digestivo
Rubio MJ, Manzano A, de Sande LM et al [Hernando B]	Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study	BMC Cancer . 2024; 24(1): 803	3.4	Oncología Médica
Ruiz Ramirez P, Loras C, Gornals J et al [Sicilia B]	Long-term follow-up of the PROTDILAT study; LONG-PROTDILAT Prospective multicenter randomized comparative study of endoscopic treatment of strictures in Crohn's disease (CD): self-expandable metal stent (SEMS) vs endoscopic balloon dilatation (EBD) [Abstract P649]	J Crohns Colitis. 2024; 18: I1226-I1226	8.3	Aparato Digestivo
Ruiz-Cobo JC, Llaneras J, Forns X et al [Badía E]	Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir	Aliment Pharmacol Ther . 2024; 60(2): 201-211	6.6	Aparato Digestivo
Ruiz-Ramos J, Alquézar-Arbé A, Juanes-Borrego A et al [González-Ferreira L]	Association of Benzodiazepine Prescription With Short-Term Prognosis in Elderly Patients Attended in Emergency Department: Results From the EDEN PROJECT.	Pharmacoepidemiol Drug Saf . 2024; 33(11): e70044	2.4	Urgencias
Sadaba Sagredo M, SubinasA, Romani S et al [Robles J]	Discordance between fractional flow reserve and nonhyperemic index with a fiber-optic pressure wire. READI EPIC-14	REC Interv Cardiol. 2024; 6: 158-165	1.2	Cardiología
Sáez-Llorens X, Norero X, Mussi-Pinhata MM et al [Merino Arribas JM]	Safety and immunogenicity of a ChAd155-vectored respiratory syncytial virus vaccine in infants 6-7 months of age: a phase 1/2 randomized trial	J Infect Dis . 2024; 229(1): 95-107	5	Pediatría
Salmanton-García J, Marchesi F, Farina F et al [Labrador J, González-López TJ]	Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022	EClinicalMedicine . 2024: 71: 102553	9.6	Hematología y Hemoterapia
Salvador Sánchez L, Rodríguez Conesa N, Sánchez Ramón S, Rey Novoa M	Addressing sexual violence in health services	Aten Primaria . 2024; 56(11): 102837	1.8	Ginecología
Sánchez R, Dorado S, Ruíz-Heredia Y et al [Cuevas B]	Author Correction: Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA	Sci Rep . 2024; 14(1): 7400	3.8	Hematología y Hemoterapia
Sanchez-Rodriguez C, Gago-Viega A, Pagán J et al [Gil Luque S]	Evaluation of the accuracy of the predictive algorithm of response to anti-CGRP monoclonal antibodies in patients with migraine older than 65 years: external validation study [Abstract P058]	J Headache Pain. 2024; 25: 1.	7.3	Neurología
Santaliestra M, Garrote M, Noya MS et al [Cuevas B ]	Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia	Leukemia . 2024; 38(12): 2636-2643	12.8	Hematología y Hemoterapia
Santaliestra M, Garrote M, Noya MS et al [Cuevas B ]	Prognostic Value of Response to First-Line Hydroxyurea According to Ipset Stratification in Essential Thrombocythemia [Abstract 241]	Blood. 2024;	21.1	Hematología y Hemoterapia
Santos-García D, de Deus T, Cores C et al [Cubo E]	Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study	Mov Disord Clin Pract . 2024; 11(7): 830-849	2.6	Neurología
Santos-García D, López-Manzanares L, Muro I et al [Cubo E]	Use of the MNCD Classification to Monitor Clinical Stage and Response to Levodopa-Entacapone-Carbidopa Intestinal Gel Infusion in Advanced Parkinson's Disease	Brain Sci . 2024; 14(12): 1244	2.7	Neurología
Sanz Segura P, Gomollón F, Casas D et al [Arias L]	Psoriasis induced by antiTNF therapy in inflammatory bowel disease: Therapeutic management and evolution of both diseases in a nationwide cohort study.	Dig Liver Dis . 2024; 56(12): 2060-2068	4	Aparato Digestivo
Scharloo F, Cogliati Dezza F, López-Hernández I et al [Morán Rodríguez MÁ]	Clinical characteristics, predisposing factors and outcomes for Enterococcus faecalis versus Enterococcus faecium bloodstream infections: a prospective multicentre cohort study	Eur J Clin Microbiol Infect Dis . 2024 Oct;43(10):2011-2022.	3.7	Medicina Interna
Segura-Díaz A, Stuckey R, Florido Y et al [Cuevas B]	DNMT3A/TET2/ASXL1 Mutations are an Age-independent Thrombotic Risk Factor in Polycythemia Vera Patients: An Observational Study	Thromb Haemost . 2024; 124(7): 669-675	5	Hematología y Hemoterapia
Simón-Vicente L, Rodríguez-Cano S, Delgado-Benito V et al [Cubo Delgado E]	Cybersickness. A systematic literature review of adverse effects related to virtual reality	Neurologia (Engl Ed). 2024; 39(8): 701-709	2.9	Neurología
Simón-Vicente L, Rodríguez-Fernández A, Rivadeneyra-Posadas J et al [Calvo S, Mariscal N, García-Bustillo Á, Aguado L, Cubo E]	Validation of ActiGraph and Fitbit in the assessment of energy expenditure in Huntington's disease	Gait Posture . 2024: 109: 89-94	2.2	Neurología, Unidad A. Investigación
Sobas M, Knopinska Posluszny W, Piatkowska Jakubas B et al [Labrador J]	Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience	Ann Hematol . 2024; 103(2): 451-461.	3.5	Hematología y Hemoterapia
Solana-Altabella A, Navarro Vicente I, Sobas M et al [Labrador J]	Treatment Approaches for Blastic Plasmacytoid Dendritic Cell Neoplasm: Data from the Pethema and PALG Epidemiologic Registry [Abstract 320]	Blood. 2024;	21.1	Hematología y Hemoterapia
Sotelo M, Pelaez M, Basterretxea L et al [Rodriguez Ledesma I]	Real-world data (RWD) with avelumab in patients (pts) with locally advanced or metastatic urothelial cancer (la-mUC): The AVEBLADDER study [Abstract e16559]	J Clin Oncol. 2024; 42: 16.	42.1	Oncología Médica
Stewart S, Seco-Meseguer E, Diago-Sempere E et al [Saiz-Rodriguez M]	Phase IV adaptive randomised clinical trials evaluating efficacy and cost-efficacy of pre-emptive pharmacogenetic genotyping strategies in the Spanish National Health System: iPHARMGx Master Protocol and PREVESTATGx nested clinical trial	BMJ Open . 2024; 14(11): e089823	2.4	Unidad A. Investigación
Suárez EU, Boluda B, Lavilla E et al [ Labrador J]	Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?	Ann Hematol . 2024; 103(8): 2845-2851	3	Hematología y Hemoterapia
Suárez Ferrer C, Mesonero Gismero F, Caballol B et al [Saiz Chumillas R]	Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohort.	Gastroenterol Hepatol . 2024; 47(10): 502197	2.2	Aparato Digestivo
Supervía A, Caballero-Bermejo AF, Puiguriguer J et al [Callado F]	Seven- and thirty-day mortality in digoxin poisoning: Results from the DIGITOX study	Am J Emerg Med . 2024: 81: 92-98	2.7	Urgencias
T C, Minga E, Karakatsoulis G et al [Labrador J]	Survival Outcomes of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Treated in the Chemoimmunotherapy Vs BTK Inhibitor (BTKi) Eras: A European Research Initiative on CLL (ERIC) Study [Abstrac 4619]	Blood. 2024;	21.1	Hematología y Hemoterapia
Tapiolas I, Manosa M, Troya J et al [Sicilia B]	The ileorectal anastomosis after a total colectomy is a feasible and valid surgical alternative in the treatment of inflammatory bowel disease [Abstract P655]	J Crohns Colitis. 2024; 18: I1239-I1239	8.3	Aparato Digestivo
Terroba-Seara S, Oulego-Erroz I, Palanca-Arias D et al [Bustamante-Hervás C, Vega-Del-Val C]	Association between early echocardiography screening of low systemic blood flow and intraventricular hemorrhage in preterm infants: a multicenter cohort study	J Perinatol . 2024; 44(10): 1496-1503	2.4	Pediatría
Torre-Puente R, Rotinen-Diaz M, Fernández-Gutierrez L et al	Frontal Plane Correction of Hallux Valgus Deformity With a Minimally Invasive Third Generation Tecnique: Short-Term Radiographic Outcomes of a Prospective Case Series	J Foot Ankle Surg . 2024; 63(3): 404-410	1.3	Traumatología
Trejo-Gabriel-Galán JM	Euthanasia and assisted suicide in neurological diseases: a systematic review	Neurologia (Engl Ed). 2024; 39(2): 170-177.	2.9	Neurología
Troya J, Pousada G, Micán R et al [Buzón L]	Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48-96 weeks of RETROBIC Study	J Antimicrob Chemother. 2024; 79(3): 595-607	3.9	Medicina Interna
Valladares-Ayerbes M, Safont MJ, González Flores E et al [López-Muñoz AM[	Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study	Clin Transl Oncol . 2024; 26(10): 2640-2651.	2.8	Oncología Médica
Vázquez-Sánchez F, Gómez-Menéndez AI, López-Veloso M et al [Calvo-Simal S, García-López B]	A Proposal for Neurography Referral in Patients with Carpal Tunnel Syndrome Based on Clinical Symptoms and Demographic Variables of 797 Patients	Diagnostics (Basel) . 2024; 14(3): 297	3	Medicina Interna, Neurofisiología Clínica, Unidad A. Investigación
Vega P, Huguet JM, Gómez E et al [SIcilia B]	IBD-PODCAST Spain: A Close Look at Current Daily Clinical Practice in IBD Management	Dig Dis Sci . 2024; 69(3): 749-765	2.5	Aparato Digestivo
Vegas Miguel MI, Mateos-Agut M	Role of the mother and role of the father in Spanish adolescents and their relationship with the development of aggressiveness	Revista sobre la Infancia y Adolescencia. 2024; 27: 63	0.3	Psiquiatría
Velamazán R, López-Guillén P, Martínez-Domínguez SJ et al [Chivato Martín-Falquina I]	Symptomatic gallstone disease: Recurrence patterns and risk factors for relapse after first admission, the RELAPSTONE study	United European Gastroenterol J . 2024; 12(3): 286-298	5.8	Aparato Digestivo
Velasco Puyó P, Tagarro A, Garcia-Obregon S et al [Portugal Rodríguez R]	Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities	Pediatr Blood Cancer . 2024; 71(8): e31120	2.4	Pediatría
Vírseda-Chamorro M, Salinas-Casado J, Adot-Zurbano JM et al	Can We Differentiate Between Organic and Functional Bladder Outlet Obstruction in Males With Parkinson's Disease?	Neurourol Urodyn . 2025 Jan;44(1):171-177	1.8	Urología
Zabana Y, Rodriguez-Lago I, Sicilia B et al	Incidence and risk factors of infection in patients with inflammatory bowel disease: longitudinal prospective INFEII registry of GETECCU [Abstract P817]	J Crohns Colitis. 2024; 18: I1508-I1510	8.3	Aparato Digestivo

Total publicaciones: 271

Total factor de impacto: 1944.8700